






Title of Document: ACTIN-BINDING PROTEIN 1 AND 
DYNAMIN-2 MODULATE ATTENUATION 
OF B-CELL SIGNALING AND REGULATE 
B-CELL FUNCTION.   
  
 Margaret Kathryn Seeley-Fallen 
Doctor of Philosophy, 2014 
  
Directed By: Dr. Wenxia Song, Associate Professor, Cell 
Biology and Molecular Genetics  
 
 
B-cells mediate humoral immune responses with production of an amazingly 
diverse repertoire of antigen specific antibodies.  Antigen binding to the B-cell receptor 
(BCR) induces coordinated BCR signaling and BCR-mediated antigen internalization, 
processing, and presentation to helper T-cells, necessary for generation of humoral 
memory.  Prolonged or uncontrolled BCR signaling has been linked to development of 
autoimmunity; therefore controlled attenuation of B-cell signaling is required for 
maintenance of B-cell tolerance.  This study investigates the role of an actin adaptor 
protein, actin-binding protein 1 (Abp1/HIP-55/SH3P7), in BCR-mediated signal 





bone marrow chimeric mice, in which only B-cells lack Abp1 expression, the number of 
spontaneous germinal center and marginal zone B-cells, and levels of autoantibody are 
significantly increased.  Serum levels of T-independent antibody and total IgM and IgG 
antibodies are elevated in Abp1
-/-
 mice, whereas T-dependent IgG responses are reduced 
and fail to undergo affinity maturation.  Upon binding membrane-associated antigen, 
surface BCR clustering is enhanced and B-cell contraction delayed in Abp1
−/−
 B cells, 
concurrent with slow but persistent increases in F-actin at BCR signalosomes.  
Furthermore, BCR signaling is enhanced in Abp1
−/−
 B cells, including Ca
2+
 flux and 
phosphorylation of B-cell linker protein (BLNK), mitogen-activated protein kinase kinase 
MEK1/2, and extracellular signal-regulated kinase (ERK), coinciding with reductions in 
recruitment of the inhibitory signaling molecules, hematopoietic progenitor kinase 1 
(HPK1) and SH2-containing inositol 5-phosphatase (SHIP-1) to BCR signalosomes.  Our 
previous studies demonstrated a role for Abp1 in BCR internalization by linking the actin 
cytoskeleton to the endocytic machinery protein dynamin2.  This study shows that 
dyanmin2 is recruited to the BCR upon antigen binding, and its recruitment is dependent 
on its proline rich domain (PRD).  BCR internalization and trafficking to late endosomes 
requires the PRD, GTPase function, and tyrosine phosphorylation sites of dynamin2.  B-
cells expressing a GTPase dead mutant of dynamin2 exhibit enhanced BCR clustering 
and signaling.  These results indicate Abp1 negatively regulates BCR signaling by 
coupling actin remodeling to B-cell contraction, activation of inhibitory signaling 
molecules, and the endocytic machinery protein dynamin2, revealing a novel regulatory 
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Chapter 1: Introduction 
1.1 B-lymphocytes and humoral immunity 
Protection against invading pathogens is mediated by two major branches of 
immunity; first, the more rapid innate immune response, followed by an adaptive immune 
response (1).  The innate immune response provides immediate protection against 
infection utilizing a limited number of receptors and secreted proteins that are encoded in 
the germline, and recognize molecular patterns common to many pathogens.  While 
innate immunity does not confer long-lasting immunity to the host, it does contribute to 
the induction of the adaptive immune response.  If pathogens breach the initial protective 
defenses of the innate immune response, the adaptive response will be engaged, leading 
to the expansion of antigen specific lymphocytes that precisely target pathogens and 
provide immunological memory to stave off subsequent infection with the same 
pathogen.  
The adaptive immune response can be further divided into two major branches; 
cell-mediated and humoral immunity.  While the cell-mediated response is primarily 
mediated by T lymphocytes (T-cells), humoral immunity is primarily driven by B 
lymphocytes (B-cells).  The hallmark of humoral immunity is antigen induced production 
of antibodies (immunoglobulin, Ig) by the B-cells, which are generated with increasing 
specificity for the antigen throughout the course of an infection.  Antibody (Ab) is a 
protein complex composed of two identical heavy chains joined to two identical light 




Figure 1.1  Antibody Structure and isotypes.  Antibody, also known as 
immunoglobulin, is composed to two identical heavy chains (light blue – top image) 
associated by disulfide bonds to two identical light chains (dark blue – top image).  The 
N-terminus of the heavy and light chains, comprising the variable region, forms the 
antigen binding region of the antibody or the membrane bound immunoglobulin.  There 
are five major C-terminal isotypes of immunoglobulin, including IgG, IgM, IgD, IgA, 
and IgE (inset image).  At the surface of B-cells, membrane bound immunoglobulin is 
non-covalently associated with the signal transduction unit of the BCR, the Igα/β 
heterodimer.  Upon BCR crosslinking by antigen, tyrosines within the ITAMs of the 
Igα/β heterodimer become phosphorylated, and serve to recruit signaling molecules 
necessary for B-cell signal transduction. - Inset image modified from Janeway’s 
Immunobiology, 8
th
 edition (2011).   
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of high sequence variation (the variable region, or V-region), with which the antibody 
binds antigens of immense and changing diversity encountered throughout the lifetime of 
a host (6).  In addition to variability within the V-region of the Ig, there are five major 
isotypes of Ig determined by the conserved regions in the C-terminus (constant region or 
C-region).  The Ig isotype determines its effector mechanism.  Mature naïve B-cells 
predominantly express IgM (µ) and IgD (δ) isotypes, whereas antigenic encounter drives 
isotype switching to IgG (γ), IgA (α), or IgE (ε) isotypes.  B-cells express a surface 
bound form of Ig that contains a transmembrane domain as well as a short cytoplasmic 
domain at its C-terminus.  Membrane Ig (mIg) is non-covalently associated Igα/Igβ 
heterodimer, forming the B-cell receptor (BCR, Fig. 1.1)(5).  As B-cells develop from 
hematopoietic precursors to fully activated effector cells, they rely upon signals generated 
from the BCR to determine their fate.  Signaling through a pre-BCR and later the mature 
BCR can in some instances lead to cell survival and proliferation, and in others to cell 
death.  In the immunological periphery, mature B-cells sense and respond to antigenic 
encounter through their BCR.  Once the BCR binds antigen it transduces this encounter 
into intracellular signals via its associated Igα/Igβ heterodimer.  These intracellular 
signals eventuate in up-regulation of genes required for B-cell survival, proliferation, and 
differentiation into antibody secreting plasma cells.  Furthermore, the B-cell internalizes 
the BCR bound antigen for processing and presentation to helper T-cells, which is 
required for generation of immunological memory.  Signals received from helper T-cells 
are also critical for somatic hypermutation (SHM) and class-switch recombination (CSR) 
for isotype switching leading to BCR/antibody affinity maturation.  The affinity 
maturation process enables enhanced antigen specific B-cell activation as well as 
4 
 
production of secreted antibodies with much higher affinity for antigen.  Secreted 
antibody acts to neutralize pathogens, by opsonizing them for clearance by other cells of 
the immune system, or by complement mediated cytolysis of the pathogen.     
1.2 B-cell development 
 Conventional B-cell development begins in the bone marrow (BM), where 









) (Fig. 1.2) (7, 8).  Stimulatory contact with interleukin-7 
(IL-7) producing bone marrow stromal cells aids in the initiation of Ig heavy chain gene 
rearrangement within the pro-B-cell (9).  IL-7 supports both the generation and expansion 
of progenitors, as well as immunoglobulin gene recombination.   Joining of diversity 
(DH) and joining (JH) heavy chain gene segments of Ig occurs at the early pro-B-cell stage 
while joining of variable (VH) and DJ segments occurs in the late pro-B-cell stage.   Upon 
successful completion of heavy chain VDJ gene rearrangement, the pro-B-cell transitions 






, Fig. 1.2).  The rearranged heavy chain of IgM is 
expressed at the surface of the pre-B-cell in a complex with a surrogate light chain; this 
complex is termed the pre-BCR (Fig. 1.2) (10).  Unsuccessful VDJ recombination can 
lead to a blockage in B-cell development at this stage, and in some cases lead to cell 
death, however, successful completion of the pre-BCR in association with Igα/Igβ sends 
a signal for proliferation and discontinuation of heavy chain VDJ recombination before 
the cells then proceed to the next stage in development.  Cytoplasmic Bruton’s tryrosine 
kinase (Btk), the membrane phosphatase CD45R/B220, CD24 (heat shock antigen; 
HSA), CD25 (IL-2 receptor), and CD19 (BCR co-receptor) are also expressed at the pre-  
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Figure 1.2  B-cell development.  B-cell development begins in the BM, where HSCs 
develop into pro-B-cells.  Interactions with IL-7 producing BM stromal cells initiates Ig 
heavy chain gene rearrangement.  The rearranged heavy chain associates with a surrogate 
light chain, forming the Pre-BCR.  Successful expression of the Pre-BCR at the surface 
of B-cells marks the transition to the pre-B-cell stage.  The next stage is highlighted by 
successful rearrangement of the Ig light chain gene.  When the rearranged Ig light chain 
is expressed at the cell surface with the Ig heavy chain, it is termed the mature BCR, and 
Pre B-cells transition to the Immature B-cell stage.  At this stage the cells undergo a 
process of negative selection, to ensure the B-cells do not bind to self-molecules, and 
then the B-cells leave the BM, and continue to mature in secondary lymphoid tissues 
from Transitional 1 (T1) to Transitional 2 (T2) B-cells.  Conventional mature naïve B-
cells in the immunological periphery consist of marginal zone B-cells (MZ B-cells), and 
Follicular B-cells (FO B-cells).  As mature naïve B-cells encounter antigen in the 
presence co-stimulatory signals, they proliferate and differentiate into antibody secreting 
plasma cells.  When FO B-cells process and present antigenic peptide to receive help 
signals from helper T-cells, they migrate and differentiate into germinal center B-cells, 
which undergo isotype switching and affinity maturation, and can differentiate into long-
lived high affinity plasma or memory B-cells. – Image modified from Cambier et al. 







B-cell stage, and are necessary for transition to the next B-cell stage (11).  The next stage 
is highlighted by the successful rearrangement of a light chain gene, which leads to cell 
surface expression of a fully formed IgM-based BCR.  At this point the cell is considered 






, Fig. 1.2) (2-4, 12).  The immature B-cells in 
the bone marrow now undergo a process of negative selection which enables the deletion 
of B-cells which strongly bind to self-antigen.  During this process, the fate of the 
immature B-cell depends upon the strength of the signal originating from the surface Ig.  
Generally, there are four major outcomes for B-cells which bind to host/self-molecules 
(self-reactive B-cells):  cell death by apoptosis, rearrangement of heavy and light chains 
to produce a new receptor (receptor editing), initiation of anergy (a permanent state of 
unresponsiveness to antigens), or clonal ignorance as the antigen is either in low 
concentration, sequestered, or absent (13, 14).  This process thereby ensures what is 
known as central B-cell tolerance, and B-cells which escape negative selection, either by 
not binding to self-molecules or binding only minimally then migrate to the 
immunological periphery.  
Immature B-cells leave the bone marrow and migrate to secondary lymphoid 
tissues where they continue to mature.  B-cells newly arriving in the secondary lymphoid 
tissues have high surface expression of IgM, and low surface expression of IgD and are 






, Fig. 1.2) (12, 15).  The cells 
continue to mature into Transitional 2 B-cells (T2, B220+/IgMhigh/IgDhigh) that express 
high levels of both surface IgM and IgD (Fig. 1.2). The development and maintenance of 
the T1 and T2 cells depends on signals from the BCR and through the BAFF receptor (B-
cell activating factor belonging to the tumor-necrosis factor family) (16, 17).  These cells 
8 
 
undergo a second round of negative selection in the periphery to ensure tolerance to self-
antigens which are not available in the bone marrow; this process ensures what is known 
as peripheral tolerance.  If the cells survive the second round of selection, they will 
progress to a more mature phenotype based on the expression and activation levels of key 
proteins such as Btk, CD45/B220, Syk and the Igα chain (18-22).  Conventional mature 







, Fig. 1.2) enriched in the marginal zones of the spleen and 
recirculating follicular B-cells (FO, B220+/IgMlow/IgDhigh) which pass through the 
peripheral lymphatic system and the follicles of the lymph nodes and spleen where it is 
speculated they receive signals for survival (23-25).  FO B-cells constitute the vast 
majority of recirculating B-cells (26).  MZ B-cells have a more restricted BCR repertoire 
than their FO counterparts, and the receptors have been shown to be biased toward 
bacterial cell-wall components.   Additionally, MZ B-cells have been show to engage in 
immune responses as early as four hours after antigenic encounter, which is in part due to 
a lower threshold than FO B-cells for activation, proliferation, and differentiation into 
antibody secreting cells (24).  MZ B-cells are of indispensable importance in responding 
to T-cell independent antigens, i.e. antigens which generally do not elicit T-cell help. 
(27).  Once the mature FO and MZ B-cells encounter their cognate antigen and co-
stimulatory signals, they undergo a series of transcriptional modifications which instruct 
the cells to undergo clonal expansion and isotype switching.  If FO B-cells receive T-cell 







proliferate rapidly, undergo affinity maturation, isotype switching, and finally become 
memory B-cells and long lived plasma cells (Fig. 1.2) (26, 28-30).       
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 In addition to the conventional B-cells mentioned above, commonly referred to as 
B2 cells, another subset of B-cells with antigen receptors of limited diversity exists, 
termed B1 B-cells (31, 32).  B1 B-cells arise from the fetal liver early in embryonic 
development, and are self-renewing in the periphery.  B1 B-cells do not require T cell 
help, and they possess cell-cycle and activation properties distinct from conventional B2 
B-cells.  They reside predominantly in the peritoneal  (PerC) and pleural cavities, and are 
a major source of “natural”, “innate”, or “T-cell independent” antibody, or antibody 
specific for polymeric antigens, such as polysaccharides and lipids (33-35).  These cells 
can be further divided into B1a and B1b subsets based on the expression of cell surface 

















).      
1.3 B-cell effector mechanisms and immunological memory 
B-cells encounter and recognize both T-cell independent and T-cell dependent 
antigens in the immunological periphery, which may be either soluble or presented on the 
surface of antigen presenting cells (APCs).  T-cell independent antigens include 
predominantly polysaccharide antigens or mitogenic stimuli, which stimulate humoral 
antibody responses in the absence of T-cell help.  T-cell independent antibody response is 
predominantly secreted IgM, however, recent evidence suggest that a low level of IgG 
antibody is also produced in the absence of T-cell help.  T-cell dependent antigens, on the 
other hand are usually protein antigens, and once bound by the membrane BCR, induce a 
series of cellular modifications which allow the B-cells to generate a greatly sustained 
and more precise response to the invading pathogen.   
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Upon binding cognate T-cell independent antigen, the Igα/Igβ of the BCR signal 
for B-cell activation, including up-regulation of chemokine receptors for homing to T-cell 
rich areas of secondary lymphoid tissues (36, 37), as well as BCR/antigen complex 
internalization.  Once internalized, the antigens are cleaved and loaded onto major 
histocompatibility complex class II molecules (MHCII) within specialized compartments 
termed MHC-class II containing compartments (MIIC), and delivered to the cell surface 
in preparation for presentation to CD4
+
 T-cells.  Within the T-cell rich zones, the B-cells 
receive additional signals for activation and proliferation from CD4
+ 
T-cells that have 
been activated by antigenic peptide presented by dendritic cells (DCs), which alters T-
cell response to chemokines necessary for directing the T-cells to the B-cell follicle (37).  
B-cells interact with their cognate T-cells by binding one another via multiple cell surface 
molecules, and in turn promote further activation.  In addition to MHCII loaded with 
antigenic peptide, which binds the T-cell receptor (TCR) on the surface of the CD4+ T-
cells, antigenic stimulation of the B-cells drives the up-regulation of the co-stimulatory 
molecules B7.1 and B7.2, which bind CD28 on the T-cell surface.  CD40, which is 
constitutively expressed on B-cells, interacts with CD40 ligand (CD40L/CD154) on 
activated T-cells (38).  In addition to cell surface molecule-mediated interaction between 
the B and T-cells, activated CD4
+ 
T-cells secrete IL-2, IL-4 and IL-5, which promotes 
production of short lived terminally differentiated antibody secreting cells (plasma cells) 





B-cells, and densely packed follicular dendritic cells (36).  Here the GC precursors 
undergo intense proliferation, and after several days, a defined GC can be observed 






Fig. 1.3  Germinal center formation.   Upon antigenic encounter, B-cells undergo 
clonal expansion within the dark zone of the germinal center.  The B-cells undergo 
somatic hypermutation (SHM), which introduces point mutations into genes within the 
V-region of Ig heavy and light chains.  The B-cells migrate to a follicular dendritic cell 
(FDC) and T-follicular helper cell (TFH) rich zone, termed the light zone.  As the B-cells 
encounter antigen again on FDCs, the B-cells with higher affinity BCRs (as a result of the 
SHM) internalize, process, and present antigen to the TFH-cells faster and to a greater 
extent than clones with lower affinity BCRs.  These clones preferentially receive help 
from the TFH-cells in the form of signals for survival and class switch recombination 
(CSR) to express different mIg isotypes.  10% of the highest affinity B-cell clones 
undergo iterative cycles between the dark and light zones, promoting clonal expansion of 
high affinity GC B-cell, which terminally differentiate into long lived high affinity 
memory B-cells and plasma cells. Image modified from Klein et al. (2008).  Nature 












Within the germinal centers, the B-cells undergo  further proliferation, forming a 
B-cell dense area termed the dark zone (Fig. 1.3) (39).  The rapidly dividing B-cells down 
regulate cell-surface expression of immunoglobulin, and initiate a phase of affinity 
maturation.  Affinity maturation occurs in activated B-cells, when activation-induced 
cytidine deaminase (AID) introduces point mutations into genes within the V-region of Ig 
heavy and light chains, by a process known as somatic hypermutation (SHM).  This 
process acts to diversify the antibody repertoire by altering the affinity of Ig for antigen, 
and requires additional stimulatory signals from activated T-cells.  The B-cells then begin 
to re-express Ig at their cell surface, and migrate in a chemokine dependent manner to a 
follicular dendritic cell (FDC), T-follicular helper cell (TFH) and macrophage rich zone, 
termed the light zone (Fig. 1.3).  As the B-cells encounter antigen again on FDCs in the 
light zone, the B-cells with higher affinity BCRs (as a result of SHM) are capable of 
internalizing and processing and presenting antigen to the TFH-cells faster and to a greater 
extent than clones with lower affinity BCRs (30).  The higher affinity clones will then 
preferentially receive help from the activated TFH-cells, and therefore preferentially be 
selected for survival and receive signals to undergo CSR (class switch recombination, 
also known as isotype switching) to express a different mIg isotype.  Recent research has 
discovered that approximately 10% of the highest affinity B-cell clones, which as a result 
capturing and presenting antigen the fastest and to the greatest extent, will undergo 
iterative cycles between the dark and light zones, thereby promoting selective clonal 
expansion of GC B-cells with the strongest mIg/antigen binding capacity (30).  The high 
affinity and class switched GC B-cells, with T-cell help, can finally differentiate into long 
lived high affinity memory B-cells and plasma cells (Fig. 1.2) (26, 28, 29).  While B-cells 
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can be activated withoutT-cell help, affinity maturation and memory B cell differentiation 
require T-cell help.       
Isotype switching is another mechanism whereby activated B-cells adapt to 
respond more specifically to invading pathogens.  During CSR, the rearranged V-region 
gene segments of the Ig μ (IgM) and δ (IgD) heavy chains recombine with downstream γ, 
α or ε constant regions, resulting in the production of IgG, IgA or IgE antibodies.  While 
primary and T-independent Ab responses are dominated by low affinity secreted IgM, 
secondary antibody responses to T-cell dependent antigens that elicit T-cell help are 
primarily composed of higher affinity IgG, as well as IgA and IgE.  While the V-region 
of the mIg or secreted antibody confers its antigen specificity, the C-region of the 
antibody is responsible for aiding in the recruitment of effector cells or molecules 
necessary for clearance of specific pathogens.  The Fc (Fragment crystallizable) portions 
of different isotypes are recognized by isotype specific Fc receptors, activating various 
phagocytic cells, such as macrophages and neutrophils, which aid in clearance of 
pathogens opsonized with antibodies, and activate immune responses.  Additionally, the 
Fc portion of secreted IgM and IgG, when bound to the surface of pathogens, recruit 
complement cascade proteins, and activate complement-mediate lysis of the pathogen.  
IgE binds to the Fcε receptor I on mast cells, basophils, and eosinophils, which triggers 
the release of inflammatory mediators.  The Fc portion of specific secreted antibody 
isotypes can also aid in delivering antibody to sites where antibody is not generated, 
through a process of active transport.  In these cases, a group of Fc receptors are 
responsible for transport of IgA or IgG across epithelial cells to mucous secretions such 
as tears and milk (IgA), as well as bile and fetal blood circulation (IgG).  Furthermore, Fc 
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receptor-mediated endocytosis of Ig, in certain cases, protects antibodies from 
degradation, extending their lifetime (40).       
B cells differentiate into long lived plasma cells or memory B-cells via affinity 
maturation and isotype switching in the germinal center, before entering the circulation.  
The long lived plasma cells migrate to the bone marrow which provides a survival niche. 
In the bone marrow, the long-lived plasma cells continuously secret high affinity 
antibodies which act to protect the host, in some cases for the lifetime of the animal.  
Long lived high affinity memory B-cells circulate within the host, or migrate to the 
marginal zone of the spleen, where they are poised to rapidly differentiate into high 
affinity antibody secreting plasma cells in the event of antigenic re-exposure [25].  
Generation of long lived high affinity antibody secreting plasma cells and antigen 
experienced memory B-cells are thus a hallmark of the adaptive immune response and 
the basis of the long-term protection induced by immunization. 
1.4 B-cell dysregulation:  immunodeficiency, autoimmunity, and B-cell 
cancers 
In healthy individuals, B-cells work with other branches of the immune system to 
generate a robust immune response towards invading pathogens, with the outcome of 
pathogen clearance and procurement of long lived antigenic memory.  After a pathogen is 
cleared from the body, B cell-mediated antibody responses are down-regulated, and B-
cell populations return to a resting state.  Within a healthy individual, there is a delicate 
balance between too few B-cells and too many B-cells, as well as an ability to respond to 
antigens versus an over- or under-reactive response to perceived antigenic threats.  The 
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best studied cases in which B-cells contribute to a disease state include 
immunodeficiency, autoimmunity, and B-cell cancers (leukemia and lymphoma).   
Primary immunodeficiency (PI) is caused by genetic mutations, and results in 
impairment or complete lack of some aspect of the immune system.  Consequently, the 
main symptom of PIs is an inability to fight off infections.  PIs have been associated with 
defects in almost every cell type of the immune system, and while some PI’s are caused 
by defects in one cell type, others may have more broad defects observed in multiple cell 
types.  With regards to B-cells, there are two major categories of immunodeficiency: 
those in which all or individual B-cell subsets are absent or reduced, and those in which 
B-cells (either because of inherent defects or defects in other “helper” populations) are 
incapable of generating a robust humoral immune response.  An example of one of the 
best known PI’s includes X-linked agammaglobulinemia (XLA), also known as Bruton 
agammaglobulinemia.  XLA is the result of a mutation of the BTK gene, and while Pro-
B-cells with BTK mutation are present in normal numbers, they are unable to mature to 
pre-B-cells (41).  Patients with XLA are especially susceptible to recurrent bacterial 
infections, usually of the respiratory and gastrointestinal tract.  Another example of B-cell 
immunodeficiency is X-linked hyper-IgM (XHM), which is due to a mutation in the gene 
for CD40 ligand (CD40L/CD154). While B-cells in patients with XHM can initiate an 
IgM response, they are incapable of undergoing class-switch recombination, and 
therefore over produce IgM, while having little or no other antibody isotype production 
(42).  People who suffer from XHM have increased susceptibility to infection with 
bacteria, viruses, fungi, and parasites. In addition, they are at increased risk for 
developing autoimmune disorders and malignancies (43).   
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Autoimmune disease is speculated to arise as a result of genetic mutations 
(whether from environmental/viral/bacterial/toxin exposure and/or inheritance), and in 
many cases results in overactive B-cell signaling, or impaired negative signaling, which 
promotes selective survival and proliferation of B-cell clones with “auto-reactive” BCRs, 
which are normally eliminated by negative selection during B-cell development.  The 
plasma cells that differentiate from these auto-reactive B cells produce self-reactive 
antibodies, also known as auto-antibodies (autoAb), that can have specificity for a vast 
number of host molecules (e.g. anti-ds-DNA, anti-histone, etc).  AutoAbs have been 
detected in many autoimmune disease models, including Type I diabetes, rheumatoid 
arthritis, multiple sclerosis, systemic lupus erythematosus, psoriasis, thyroiditis, heart 
disease and myasthenia gravis (44).  In many cases, the autoAbs target host molecules or 
cells for destruction, whether by complement mediated cytolysis or phagocytosis by other 
cell types, thereby being a critical immunopathological factor.   
The fundamental problem in treatment of autoimmune disease lies in the fact that 
the precise molecular mechanisms that promote the shift in B-cell tolerance towards a 
pathogenic antibody response remains elusive, therefore targeted treatments remain 
stalled or impractical.  However, recent studies have revealed a role for a subset of T and 
B-cells, called T- and B-regulatory cells (Tregs/Bregs), in preventing autoimmunity by 
means of suppressing the activation of a various immune cells.  While both Tregs and 
Bregs employ multiple means by which they aid in maintenance of T/B-cell tolerance to 
prevent autoimmunity, both cell types rely heavily on the production of the anti-
inflammatory cytokine IL-10 to moderate their suppressive activities (45, 46).  
Production of IL-10, whether by Tregs or Bregs, primarily aids in preventing activation 
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of effector T-cells and DC’s, which subsequently prevents activation of auto-reactive 
effector T/B-cells, and the induction of autoimmunity (45, 46).  Furthermore, production 
of IL-10 by Bregs has also been shown to promote the differentiation of Tregs (47).  
Current research utilizing T/Bregs has attempted to adoptively transfer either natural or 
induced T/Bregs to achieve targeted suppression of inflammatory or autoimmune disease 
progression, with promising results (48-50).        
Additional research aimed at preventing or suppressing autoimmune disease has 
focused on the role of aberrant cell signaling within auto-reactive prone cell subsets.  
Many of these studies have again focused on aberrant B-cell signaling, as production of 
autoAbs in many instances is a hallmark of autoimmune disease development.  Signaling 
molecules within B-cells discovered to aid in tolerance towards self-antigens play diverse 
roles in within B-cells.  These molecules include cell cycle modulators, actin mediators, 
negative regulatory kinases and phosphatases, as well as adaptor molecules (51-55).  Our 
recent research, as well as others, has highlighted a role for the actin regulating proteins 
Wiskott–Aldrich Syndrome protein (WASP) and Neural Wiskott–Aldrich Syndrome 
protein (N-WASP), as well as the negative regulatory signaling molecules Hematopoietic 
progenitor kinase 1 (HPK1) and SH2-domain-containing inositol 5-phosphatase (SHIP-1) 
in loss of B-cells tolerance (52, 54, 56, 57).  Briefly, B-cell specific loss of WASP, N-
WASP, SHIP-1, or HPK1 has been shown to promote induction of an autoimmune 
phenotype (52, 54, 56, 58, 59).       
B-cell cancers usually arise as a result of genetic mutations caused by viral 
infection, environmental or inherited factors (60).  In many cases, these B-cell 
modifications can cause constitutive activation, or deactivation of key regulatory 
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elements of B-cell singling (60), which in turn results in enhanced B-cell survival and 
proliferation, which are hallmarks of B-cell cancer.  These B-cell mutations can occur 
within almost any development subset, and give rise to distinct B-cell cancers (60).  
Uncontrolled proliferation of the cancerous B-cells can inhibit the growth/differentiation 
of normal B cells and other cells, which in turn leads to a wide variety of pathologies.  
Additionally, cancerous B-cells have also been shown to metastasize to areas of the body 
they are not normally found, where they then develop into tumors.  Many newly 
developed drugs to treat B-cell cancers deviate from traditional chemotherapeutic 
treatments (which are not cell specific, and in many cases simply target rapidly dividing 
cells), by specifically targeting B-cels for destruction (i.e. monoclonal Abs such as anti-
CD20 (Rituxan®)), or by disrupting B-cell specific signaling pathways, such as those 
therapies recently enlisted to regulate Btk, Phosphoinositide 3 kinase δ (PI3Kδ), BCR-
Abl (Gleevec®), and Syk signaling (60, 61).        
       As the diversity of B cell-mediated immune disorders and cancers 
continuously increases and targeted treatments are still lacking, the full elucidation of the 
cellular and molecular mechanisms by which BCR signaling is regulated for B-cell 
development, survival, activation, and attenuation becomes critical for diagnosis and  
treatment of B-cell immunodeficiency, autoimmunity, and B-cell cancer.       
1.5 The BCR and its signaling pathways 
The BCR is the antigen sensor of B cells, consisting of mIg associated with the 
Igα/Igβ heterodimer. The membrane Ig of the BCR is responsible for antigen binding, 
while the Igα/Igβ heterodimer propagates intracellular signals (62).  The mIg of the BCR 
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is composed of two identical heavy and light chains with which each BCR is able to bind 
two identical antigenic epitopes simultaneously (Fig. 1.1).  Each heavy chain is bound 
covalently by a disulfide bond to a single light chain, and the two heavy chains are bound 
together by one or more disulfide bonds.   The transmembrane domain anchors the mIg at 
the B cell surface, exposing two antigen binding variable regions for antigen binding. The 
non-covalent interaction between the mIg and the Igα/Igβ heterodimer involves their 
trans-membrane domains, and this association is required for expression of the BCR at 
the surface of B-cells (63).   Igα and Igβ are transmembrane proteins linked by disulfide 
bonds in the extracellular domains. The cytoplasmic domains of Igα and Igβ each contain 
one immunoreceptor tyrosine-based activation motif (ITAM) in their cytoplasmic tails 
with the sequence D/E XX-YXXφ-X6-8-YXXφ, where X is any amino acid and φ is a 
bulky hydrophobic amino acid (64, 65).   ITAMs are conserved signal transduction 
motifs shared by many signaling receptors within the immune system, including the 
signaling apparatus of T-cells, the TCR (65).  Upon B-cell activation by antigen binding, 
the ITAMs are phosphorylated at their tyrosine residues (Y), and phosphorylated ITAMs 
serve as docking sites for spleen tyrosine kinase (Syk), thereby initiating formation of a 
signaling platform known as a “signalosome”  (64, 66, 67).   
BCR signal activation requires receptor oligomerization into two dimensional 
clusters of different sizes depending on the valency and physical configuration of the 
antigen.  BCR clusters become preferentially associated with “lipid rafts” which are rich 
in cholesterol and glycosphingolipids, thereby forming relatively stable regions on the 
outer leaflet of the plasma membrane.  The ordered lipid environment acts to sequester or 
exclude molecules based on their biochemical properties (68-70).  Lipid rafts which are 
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enriched with signaling and cytoskeletal elements, have been shown to be important 
signaling and endocytosis sites (68-70).  Studies by Tolar et al. suggest that binding of 
antigen induces a conformational shift in the cytoplasmic domain of the Igα/β 
heterodimer, from a “closed” to an “open” conformation.  This conformational change 
has been proposed to allow phosphorylation of ITAMs within Igα/β by raft resident Src-
family kinases (SFK): particularly Lyn, which is the predominant SFK expressed in B 
cells (22, 71, 72).  Dual phosphorylation of ITAM tyrosines leads to the binding of  the 
Src-homology 2 (SH2) domain containing Syk via its tandem SH2 domains, recruiting it 
to surface signaling microdomains (Fig. 1.4) (73, 74).  Syk is then activated by Src 
kinases as well as auto-phosphorylation (75).  Syk acts as a key player in propagating a 
multitude of downstream signaling events, and disruption of  Syk signaling blocks most 
downstream BCR signaling events (76).  Activated Syk subsequently phosphorylates the 
major B-cell associated adaptor protein, B-cell Linker protein (BLNK/SLP-65), and these 
phosphorylated tyrosines act as  docking sites for multiple SH2 domain containing 
proteins such as Btk, Phospholipase Cγ2 (PLCγ2), Vav, and the adaptor protein Grb-2 
(Fig. 1.4) (77-79). Scaffolding/adaptor proteins such as BLNK are essential for linking 
BCRs to downstream kinases by recruiting them and their substrates into the proximity of 
clustered BCRs.  The importance of such adaptor molecules is underscored by studies 
that showed that BLNK deficient mice display profound defects in B-cell signaling and 
development (77, 80, 81).      
PI3K, which upon recruitment by the BCR co-receptor CD19 or the adaptor 















Figure 1.4  The BCR and its signaling pathways.  B-cell signaling is initiated when 
mIg binds antigen.  Immediately following antigen engagement, the BCRs translocate to 
lipid rafts, where the signaling apartus of the BCR (the Igα/β heterodimer) comes into 
contact with raft resident Src kinases.  The Src kinases phosphoryalte tyrosine residues 
within the ITAM sequence of Igα/β, which then serve as docking sites for the key B-cell 
signaling kinase Syk.  Syk inturn, phosphorylates and activates a multitude of 
downstream kinases, GTPases, and adaptor proteins, which act to  propagate downstream 
signals necessary for actin cytoskeltal modificaiton, and transicriptional regulation of 
cellular differentiation, activation, proliferation, and survival.  The complex nature of 
BCR signaling allows a mulititude of cellular responses, which also depend upon the 
maturational state of the B-cell, the nature of the antigen bound, the duration and 
magnitude of the signal, as well as engagement of co-receptors.  The duration and 
magnitude of BCR mediated signaling are limited by a variety signaling elements 
inclding co-ligation of the BCR with FcγRIIB by immune complex which activates 
negative regulatory SHIP-1 and SHP1, by activation of HPK1 (with subsequent down-
regulation of the major adaptor protein BLNK), as well as BCR internalization.  Image 
modified from Cell Signaling Technologies,  







4,5-bisphosphate (PIP2), to form PIP3 (82, 83).  PIP3 then severs as a docking site for 
molecules containing pleckstrin homology (PH) domains, thereby recruiting them to 
signalosomes (84, 85).  Recruitment of Btk to the membrane occurs by its interaction 
with BLNK as well as the interactions of its (PH) domain with phosphatidylinositol 
3,4,5-trisphosphate (PIP3) in lipid rafts.  Once recruited to the plasma membrane, Btk 
becomes a target for phosphorylation by Src family kinases and Syk within a kinase 
activation loop, which enables Btk to auto-phosphorylate and become fully activated (86-
89).  Once bound to BLNK and fully activated, Btk acts in concert with Syk to 
phosphorylate PLCγ2, which is recruited by BLNK (90, 91).  The activation of both Btk 
and PLCγ2 in turn positively feeds back into PI3K activation and activation of the Ras-
Raf-MEK1/2- Extracellular signal regulated kinase (ERK) pathways (Fig. 1.4) (92, 93).  
Furthermore, Btk is responsible for activating the actin nucleation promoting factor 
WASP, which is necessary for dynamic actin reorganization required for B-cell antigenic 
responses (89).  Additionally, Syk, Btk and PI3K work in concert to activate the 
serine/threonine kinase Akt (Fig. 1.4) (94, 95), which then acts to induce B-cell 
proliferation by inhibiting the pro-apoptotic protein BAD (Bcl-associated death 
promoter) (96). Mutational studies of Btk have revealed that the PH domain of Btk is 
necessary for its activation, and that Btk activation is critical for B-cell development in 
humans.  A point mutation in the PH domain of Btk, which blocks the recruitment of Btk 
to the plasma membrane leads to humoral immunity defects (97).   
PLCγ2, activated by Btk and Syk (90, 98, 99), cleaves PIP2, generating inositol 
trisphosphate (IP3) and diacylglycerol (DAG, Fig. 1.4).  The binding of IP3 to its specific 
receptor on the endoplasmic reticulum (ER) causes the release of intracellular calcium 
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stores. The depletion of ER Ca
2+
 promotes the activation of calcium-release-activated 
channels (CRAC) at the plasma membrane and allows for the influx of extracellular Ca
2+
 
ions (Fig.1.4) (100, 101).  DAG, in concert with calcium, activates protein kinase C-β 
(PKC-β), which eventuates in activation of the transcription factor nuclear factor kappa B 
(NF-κB) by phosphorylating  IκB Kinase (IKK, Fig. 1.4) (102).  NF-κB then up-regulates 
anti-apoptotic proteins such as Bcl-xl and cyclin D2 (103, 104).  DAG also activates Ras 
guanyl nucleotide-releasing protein (RasGRP), a potent activator of Ras.  Ras is upstream 
of the Raf/MEK1/2 pathway, and Ras activation results in the activation of the mitogen 
activated protein kinase (MAPK) ERK (105, 106).  Ca
2+
 also activates calcineurin, which 
in turn activates the transcription factor NFAT (nuclear factor of activated T cells, Fig. 
1.4).  Both NFAT and NF-κB are essential for transcriptional activation of genes required 
for B-cell  proliferation, survival and differentiation (107). 
The interaction of Vav and Growth factor receptor-bound protein 2 (Grb2)/ Son-
of-sevenless (SOS, a guanine exchange factor) with phosphorylated tyrosines on both 
CD19 and BLNK activate the Ras and Rho family GTPases respectively.  SOS and PKC-
β activated RasGRP work in concert to activate Ras followed by subsequent ERK 
activation (Fig. 1.4).  Activation of the Rho-family GTPase Rac leads to activation of the 
MAP kinases c-Jun NH2-terminal kinase (JNK) and p38 (Fig. 1.4) (76, 108-110).  The 
MAP kinase JNK then activates the transcription factors c-jun and ATF-2 (110), while 
ERK activates Elk-1 and c-myc (111), and p38 activates ATF-2 (112), all of which 
cooperate with NF-κB and NFAT to determine the cellular response to antigen 
engagement (103, 110, 111, 113).  
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The BCR also utilizes co-receptors, such as CD19, to control and amplify BCR 
initiated signals.  CD19 is a B-cell specific co-receptor, which is expressed early in B-cell 
development.  On the B-cell plasma membrane, CD19 is predominantly expressed in a 
complex with CD21 (a complement receptor), and tetraspanin CD81 (114).  When CD21 
binds antigens tagged with complement, it acts to crosslink the BCR and CD19 complex, 
and effectively lowers the threshold for B-cell activation (115).  Co-ligation of the BCR 
and the CD19 containing complex enables recruitment of the signaling molecules Vav, 
PI3K, and Lyn to CD19, and subsequent activation of PLCγ2 and MAP kinase pathways 
(115).  B-cells deficient in CD19 are defective in initiating BCR stimulated signaling, as 
well as recruitment of downstream effector, and cell spreading, when incubated with 
antigen presenting membranes (116).  Mice deficient in CD19 or CD21 show reduced 
humoral immune responses towards T-cell dependent antigens, reduced germinal center 
formation, and defects in antibody secretion as well as defective affinity maturation (117-
119).   
BCR signaling is relatively transient and tightly controlled by various inhibitory 
molecules, including phosphatases and kinases.  Down regulation of BCR signaling has 
been shown to be important, as lack of signal attenuation has been associated with a 
number of autoimmune disorders (53, 120).   One of the best studied mechanisms of BCR 
signal attenuation occurs when antibody-antigen immune complexes co-ligate the BCR 
with the low affinity Fc-gamma receptor IIB (FcγRIIB) co-receptor.  This receptor is 
composed of an extracellular Fc-binding domain and an intracellular domain which 
contains an immunoreceptor tyrosine-based inhibitory motif (ITIM) (53).  As its name 
suggests, the FcγRIIB receptor binds the Fc Region of IgG.  When IgG is produced to 
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sufficient levels during an immune response, and most of the remaining antigen is bound 
with IgG, the BCR and FcγRIIB bind the antigen and antibody portions of the immune 
complex, and this co-ligation brings the ITIM of the FcγRIIB into close proximity of the 
lipid raft resident kinase Lyn.  Lyn subsequently phosphorylates the tyrosine residue 
within the ITIM, thereby providing a docking site for the inhibitory phosphatases SH2-
domain containing protein tyrosine phosphatase (SHP1), and SH2-domain-containing 
inositol 5-phosphatase (SHIP-1 – Fig.1.4) (121).  SHP1 is a protein tyrosine phosphatase 
which blocks signal activation by dephosphorylation, while SHIP-1 is an inositol 
phosphatase that specifically hydrolyzes PIP3 to PIP2, thereby removing the docking site 
for PH domain containing signaling molecules, e.g. Btk, Akt, and PLCγ2 (59).  Of note, 
BCR activation by antigen alone also induces SHIP-1 activation.  Additionally, SHIP-1 
has been shown to bind BCR ITAMs with only one of the two tyrosines phosphorylated 
in anergic B-cells, which is critical for maintenance of the anergic state (122).  As a result 
of the action of these two phosphatases, BCR mediated cell survival, cellular 
proliferation, antibody production and cytokine release are disrupted (123-125).  Thus, 
these two inhibitory molecules work in concert to attenuate BCR signaling, which is 
necessary to maintain B-cell tolerance (44).       
Another known mechanism of B-cell signal attenuation involves the protein 
HPK1, a serine/threonine kinase.  BCR signaling activates HPK1 by preferentially 
linking HPK1 with the adaptor molecule BLNK (Fig. 1.4).  Once bound, HPK1 
phosphorylates BLNK at threonine 152, which induces BLNK/14-3-3 binding (55).  
Once bound to Thr152, 14-3-3 is suggested to recruit a currently unknown E3 ligase, 
which ubiquitinates BLNK at the Lysine residues Lys-37, Lys-38, and Lys-42 (55).  This 
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ubiquitination then promotes proteasomal degradation of BLNK, and subsequent down 
regulation of BCR signaling (55).  HPK1 deficiency has been shown to be associated 
with up-regulated MAPK activation,  specifically, ERK, JNK, and p38, as well as IKK 
activation, B-cell proliferation, and up-regulation of several activation markers (55).  
Dysregulated B-cell signaling profiles, resulting from HPK1 deficiency, have been shown 
to be associated with the increased antibody production and experimental autoimmune 
encephalomyelitis (56, 126).  
1.6 BCR mediated antigen processing and presentation 
In addition to induction of signaling from the BCR, necessary for the 
implementation of genetic modifications for a multitude of cellular responses, antigen 
binding also promotes the internalization of the BCR/antigen complex, which in turn 
serves to down-regulate signaling at the B-cell surface (127, 128).  The BCR/antigen 
complex is internalized constitutively at low levels by fluid-phase pinocytosis into early 
endosomes, after which many BCRs are recycled back to the cell surface (129).  
However, it has been demonstrated that BCR cross-linking by multivalent antigens can 
substantially enhance the rate of antigen up-take and processing for presentation to CD4
+
 
T-cells (130, 131).  As such, antigens at very low levels can still stimulate an adaptive 
immune response.  The major mechanism for BCR internalization is clathrin-mediated 
endocytosis (CME) (128).  Upon binding its cognate antigen, the BCR is rapidly 
translocated to lipid rafts rich in cholesterol, glycosphingolipid, phosphatidylinositides, 
and signaling molecules.  Recognition of the specific internalization motif on the 
cytoplasmic tail of Igβ, and cis regulatory elements in Igα, leads to the recruitment and 
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binding of the adaptor protein AP-2 (132, 133).   AP-2 then aids in the recruitment of 
clathrin (134).  A study from our lab, in collaboration with Dr. Francis Brodsky, showed 
BCR induced recruitment of clathrin to the plasma membrane and BCR-containing 
vesicles, and demonstrated that the Src-kinase inhibitor PP2 blocks this recruitment 
(128).  The phosphorylation of clathrin in lipid rafts by Src-kinases following BCR 
crosslinking is required for BCR internalization, which was demonstrated by inhibition of 
clathrin phosphorylation and subsequent BCR internalization by the disruption of lipid 
rafts (135).  Once clathrin has been recruited to the plasma membrane and 
phosphorylated, the membrane begins to invaginate to form a coated-pit.  Coated pit 
invagination is driven by local membrane changes in lipid composition, natural curvature 
of the clathrin triskelion, recruitment of BAR domain containing proteins, and forces 
applied by the actin cytoskeleton (136-139).  This process initiates the formation of the 
actin associated endocytic platform.  The Bar-domain containing proteins recruited to the 
clathrin pit include endophilin and amphiphysin.  Endophilin acts to alter local lipid 
compositions at the plasma membrane via its acyl transferase activity, and binds 
dynamin, the large GTPase “mechanoenzyme” which catalyzes the pinching off of the 
newly formed vesicles (140).  Amphiphysin, which also plays a major role in recruiting 
dynamin to endocytic vesicles during CME, also binds AP-2 and clathrin (132, 141-144).  
After the internalizing vesicle has grown into a deeply invaginated pit, proteins such as 
dynamin, amphiphysin, and endophilin interact with filamentous actin (F-actin) to 
promote vesicle scission (139).  The actual scission step occurs when dynamin 
Guanosine-5'-triphosphate (GTP) is hydrolyzed, and the prompt for this hydrolysis may 
include interactions with PIP2, sorting nexin-9, amphiphysin, and dynamin GED domains 
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(145).  Dynamin’s interaction with F-actin and the nascent endocytic vesicle most likely 
occurs via interactions with syndapin oligomers, profilin, cortactin, and actin-binding 
protein 1(Abp1) (145-150).  Syndapin oligomers themselves recruit the actin regulating 
protein N-WASP to the plasma membrane where (like WASP) they cause localized F-
actin rearrangement via Arp2/3 (146).  Once the vesicles have pinched off, the ATPase 
Hsc70 is recruited to the clathrin coated vesicle, where it aids in the release of the clathrin 
coat (151).  Then, the internalizing vesicles fuse with one another, and form early 
endosomes (152).  
According the maturation model of endosomal compartment trafficking, the early 
endosome undergoes acidification by acquiring proton pumps from Golgi. As it 
progresses to the interior of the cell, endosome membrane buds inward via the endosomal 
sorting complex required for transport (ESCRT) system, forming multivesicular bodies, 
while continuously acquiring lysosomal proteins from Golgi, such as lysosomal-
associated membrane protein 1  (LAMP-1) and protein hydrolases (153).   At this stage 
the multivesicular body is generally termed the late endosome (Fig. 1.5).  The reduced 
pH activates proteases, which in turn cleave the antigen into peptide fragments.   
During this process  newly synthesized MHC-II molecules from the ER and Golgi are 
delivered to late endosomes by vesicular transport, after which this compartment is 
termed MIIC in antigen presenting cells (154).  This is where the antigenic peptide is 
loaded onto MHCII molecules, and then shuttled to the surface of the cell for presentation 
to CD4
+
 T-cells (Fig.1.5).  CD4
+
 T-cells recognize the antigenic peptide-MHCII complex 






1.5  BCR mediated antigen processing and presentation.  Upon BCR ligation, the 
signaling apparatus of the BCR initiates signals to direct BCR/antigen complex 
internalization into early endosomes via CME.  As the early endosomes internalize they 
begin to decrease in pH.  The enocytosing vesicles acquire LAMP-1 and protein 
hydrolases.  Reduced pH within the vesicles serves to activate acid proteases, which 
cleave the internalized antigen into fragments.  MHCII containing vesicles from the ER 
fuse with the late endosome, now termed the MIIC, where antigenic peptide is loaded on 
to the newly made MHCII, then shuttled to the surface of the B-cell for presentation to 
CD4
+
 TH cells, which in turn provide signals for enhanced B-cell activation and clearance 
of T-dependent antigens.  Image modified from Kurosaki et al. (2010). Annual Reviews 




intracellular signals sufficient for T-cells activation when the antigen-derived peptide is 
complexed with a MHC molecule (155).   
It has become apparent in recent years that BCR-mediated signaling and 
BCR/antigen trafficking for processing and presentation are closely linked .  While it has 
been shown that phosphorylation of the ITAMs within the Igα/β heterodimer is ultimately 
not necessary for BCR internalization, stable co-expression of mIg with the Igα/β 
heterodimer is required (156).  As mentioned previously, while BCR crosslinking is not 
necessary for BCR/mono-valent antigen internalization, crosslinking  by multivalent 
antigens greatly enhances the speed of antigen processing and presentation (130).  It was 
shown that the nature of the BCR/antigen interaction affects both BCR mediated 
signaling and endocytosis.  Antigens that only minimally crosslink BCRs are rapidly 
internalized for processing and presentation, and generate relatively transient BCR signal 
activation (157).  On the other hand, large multivalent antigens that highly cross link 
BCRs at the surface of the cells are internalized much more slowly, and generate elevated 
and prolonged signaling profiles (157).  B-cells deficient in Lyn were unable to 
internalize their BCRs (158), while another study demonstrated the inability of Syk 
deficient B-cells to fuse BCR/antigen containing endosomal compartments with 
compartments containing MHCII, thereby disabling their ability to form peptide-MHCII 
complexes for antigenic presentation (159).  A role for these early kinases was further 
defined by the finding that treatment of B-cells with the Src-family kinase inhibitor PP2 
prevented both the recruitment and phosphorylation of clathrin, thereby severely reducing 
BCR mediated internalization (128).    
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Early studies speculated that BCR/antigen internalization served to extinguish 
BCR mediated signaling, however, recent studies have suggested that while some aspects 
of the signaling are extinguished upon BCR internalization, sequential phosphorylation of 
downstream kinases continue to take place as the BCR/antigen complex traffic through 
endosomal compartments for antigenic processing (160).  It was shown that upon 
blocking BCR/antigen internalization with the dynamin I and II disrupting agent 
Dynasore, BCR proximal and distal MAP kinases were recruited to the plasma 
membrane, where they became hyperphosphorylated, which led to dysregulation of B-
cell gene transcription (160).  As such, these data suggest that the subcellular localization 
of the BCR regulates or “compartmentalizes” sequential aspects of BCR mediated 
signaling, thereby regulating B-cell activation (160).  This and the aforementioned 
studies strongly suggest that BCR signaling and BCR endocytosis regulate each other. 
1.7 BCR dynamics during B-cell activation 
Recent studies have indicated that the mobility and organization of BCRs at the 
surface of B-cells influence the activation kinetics and magnitude of the B-cell signaling 
(161-163).  Advances in high resolution and live-cell imaging techniques have allowed 
better real time analysis of BCR dynamics in both resting cells and upon receptor 
engagement.  While BCR clustering has been shown to be essential for the BCR to 
initiate signal transduction, it has been suggested, through direct stochastic optical 
reconstruction microscopy (114) and quantitative bifluorescence complementation assays 
(164), that the BCRs at the surface of the unstimulated B-cell may be present in 
nanoclusters that are not visible using conventional microscopy techniques.  However, 
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this work remains controversial.  It was suggested that the BCRs in these nanoclusters are 
likely in an inhibitory conformation (164, 165), but that their presence is probably 
required for mediating some level of tonic signaling required for B-cell survival (114). 
Tolar et al. showed that the BCR itself maintains an intrinsic ability to cluster into 
oligomers, which is dependent upon the Cµ4 domain of mIgM, as well as a short N-
terminal sequence within the transmembrane domain of mIgM (166).  And while 
expression of the full length wild-type (wt) BCR at the surface of the B-cell requires 
antigenic ligation for clustering and signal induction, expression of a truncated BCR, 
where the extracellular domain only contains the Cµ4 segment, is sufficient to induce 
clustering and signal initiation in the absence of extracellular signals (166).  These results 
suggest that elements within the Fc portion of mIgM may be hidden or “sterically 
blocked” in the absence of antigenic binding, and binding unveils these regions necessary 
for receptor clustering (166). 
Upon antigen binding, BCRs increase lateral mobility, and they begin to migrate 
to form microclusters (167, 168).  As the microclusters form, they become preferentially 
associated with lipid rafts, which enables raft resident kinases to phosphorylate Igα/Igβ, 
initiating signaling (116, 166, 169).  BCRs within the signaling active microclusters, also 
referred to as signalosomes, become relatively immobile (166), but continue to grow by 
recruiting more BCRs into the microcluster over the course of several minutes.  
Concurrent with microcluster growth, B-cells interacting with antigen presenting 
surfaces, whether on APCs in vivo, or on artificial antigen presenting surfaces in vitro, 
spread along the presenting surface.  The spreading allows the cell to accumulate more 
antigen, thereby activating more BCRs, all while simultaneously recruiting more BCRs 
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into the immobilized microclusters.  As the microclusters grow, they migrate towards one 
pole of the cell where they coalesce into a central cluster, also called a supramolecular 
activation complex (SMAC).  While many of the studies showing formation of the B-cell 
SMAC are in response to antigen presented by antigen presenting surfaces, recent data 
from our lab showed that the SMAC also forms upon B-cell stimulation by soluble 
multivalent antigen.  However, these SMACs are more transient than those formed 
between B-cells and antigen presenting surfaces (170).  In cells interacting with antigen 
presenting surfaces, the centripetal movement of microclusters into a central cluster takes 
place at the B-cell surface directly contacting the antigen presenting surface, which is 
termed the “contact zone”.  The SMAC, which forms in the contact zone, is similar in 
nature to the originally identified T-cell immunological synapse (IS) that is formed 
between a T-cell and an APC.  However the two differ in their requirements for 
formation.  The T-cell immunological synapse requires co-engagement of adhesion 
molecules between the T-cell and the APC, while the B-cell SMAC does not, although 
adhesion molecule ligation can enhance BCR mediated singling, especially when 
antigens are presented at a low density (171).  Additionally, the B-cell SMAC forms upon 
stimulation with soluble multivalent antigen, while the T-cell IS does not.  These unique 
characteristics of B-cell SMAC formation with subsequent B-cell activation allow the B-
cell to respond to a much wider variety of antigens compared to T-cells.  Finally, the 
SMAC formed in B-cells is much more transient than the IS formed in T-cells, which is 
likely due to the rapid internalization of the BCR/antigen complex necessary for antigen 
processing and presentation in the B-cells.                   
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     It has also been shown that receptor clustering is a target for negative 
regulation, as co-ligation of the BCR and FcγRIIB by immune complex inhibits BCR 
interactions with lipid rafts, microcluster formation, as well as BCR central cluster 
formation (172, 173).  Taken together with the above studies, recent evidence further 
support the unfolding paradigm that BCR reorganization at the surface of B-cells is 
necessary for appropriate B-cell response to soluble and membrane associated antigen. 
1.8 Actin dynamics during B-cell activation 
Early studies suggested that B-cell activation by antigen ligation induced actin 
remodeling within the cell (174).  Recent studies have also indicated that the actin 
cytoskeleton can act to moderate the levels and duration of BCR mediated signaling in 
both resting B-cells, also known as “tonic” signaling, and BCR stimulated cells (161, 
175).  The cortical actin cytoskeleton, which lies directly beneath the plasma membrane, 
is the primary actin structure in resting B-cells.  The cytoskeleton is linked to the plasma 
membrane by the ERM (ezrin/radixin/moesin) family proteins (176, 177).  These proteins 
are capable of binding both F-actin and plasma membrane proteins.  In unstimulated 
cells, the cortical actin cytoskeleton has been suggested to act as a “barrier” to the 
movement of BCRs at the cell surface, thereby preventing oligomerization and 
spontaneous activation of unligated surface BCRs.  By linking to membrane anchor 
proteins via its interaction with ERM proteins, the cortical actin cytoskeleton is suggested 
to act like a picket fence, limiting lateral movement of membrane proteins which have 
tails that extend into the cytoplasm.  A study by Treanor et al. showed that unligated 
BCRs in actin- and ezrin-poor regions had enhanced lateral mobility, when compared to 
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BCRs in actin- and ezrin-rich regions (178).  The “barrier” hypothesis was further 
supported when cells treated with actin disrupting agents, in the absence of antigenic 
stimulation, showed Ca
2+
 flux, signaling molecule activation, and activation marker up-
regulation, similar to those of cells treated with anti-IgM (178).  This study further 
showed that the cytoplasmic domain of Igβ is the domain which influences the ability of 
the BCR complex to diffuse through the cortical cytoskeleton network (178).     
In response to antigenic stimulation, BCR mediated signaling promotes a rapid 
and transient disassembly of the cortical actin cytoskeleton, which is necessary for the 
increased lateral mobility of the BCRs, and initiation of BCR microcluster formation 
(Fig. 1.6) (167, 168).  The disassembly requires BCR-mediated activation of Rap-
GTPases necessary for the dephosphorylation and activation of the actin severing protein 
cofilin (167), as well as a transient dephosphorylation of the ERM family of proteins.  
ERM dephosphorylation enables disassociation of the underlying cytoskeleton from the 
plasma membrane (168), leading to the disassembly of the cortical actin cytoskeleton.  In 
B-cells the ERM family protein ezrin has been shown to link the actin cytoskeleton to the 
plasma membrane via its interaction with the lipid raft resident Csk-binding protein, and 
its dephosphorylation upon B-cell activation disrupts this interaction (179).  Following 
the initial depolymerization of the cortical actin cytoskeleton upon BCR engagement, the 
cytoskeleton undergoes rapid reassembly, which appears to take place predominantly at 
sites of actively signaling BCR microclusters (Fig. 1.6), suggesting the signals emanating 
from these clusters generate signals for de-novo actin polymerization (170).  Recent work 
by Ketchum et al. showed that treatment of B-cells with actin cytoskeleton disrupting 






Fig. 1.6 Coordination of actin remodeling with reorganization of BCRs at the cell 
surface. (A) Upon antigen binding to the BCR, the cortical actin network undergoes 
rapid and transient depolymerization and detachment from the plasma membrane. The 
actin depolymerization releases mobility barriers, and enables the BCRs and BCR 
nanoclusters to interact.  Antigen binding also induces early activation of Btk. (B) 
Activated Btk induces the activation and recruitment of WASP (W) to the cell surface, 
where it acts to stimulate directed actin polymerization by its ability to bind and activate 
Arp2/3, and suppress the activation of N-WASP (N-W).  The directed actin 
polymerization drives B-cell spreading and facilitates BCR clustering and signaling.  
Extension of filopodia and lamellipodia allows the cell to gather more antigen, and their 
contraction transports BCR-antigen towards the center of the contact zone, thereby 
forming larger clusters.  (C) Later SHIP-1 activation acts to inhibit Btk, and thus WASP 
activation, thereby releasing the suppressive control of WASP on N-WASP.  Activated 
N-WASP aids in the clearance of actin from the B-cell contact zone, which stimulates the 
contraction and coalescence of BCR microclusters into a central cluster and subsequent 
BCR internalization, leading to BCR signal attenuation at the cell surface.  Image 









suggesting a necessity for an actively polymerizing cytoskeleton.  The data generated 
from our lab demonstrate that BCR signaling activates actin nucleation.   promoting 
proteins such as WASP (hematopoietic specific) and N-WASP (ubiquitously expressed), 
which results in membrane dynamics associated with the formation of filopodia and 
lamellipodia required for cell motility and cell shape changes (Fig. 1.6) (180).  In B-cells 
interacting with antigen presenting surfaces, the initial B-cell contact occurs by filopodia, 
which are supported by actin bundles, which occurs before BCR microclusters become 
detectable.  As the B-cells come to rest on the antigenpresenting surface, F-actin rapidly 
accumulates in the contact zone, which promotes multiple rounds of extensions and 
retractions of filopodia and lamellipodia, which aid in both gathering more antigen to 
activate more BCRs, as well as B-cell spreading on the antigen presenting surface (Fig. 
1.6) (170, 181).  Newly activated BCR microclusters often form at the edge of the actin 
rich structures, and as they retract, the signaling BCR microclusters move towards the 
center of the B-cell/antigen-presenting surface contact zone.  As F-actin continues to 
accumulate at the contact zone, the B-cells continue to spread along the antigen 
presenting surface over the course of several minutes.  After the B-cell has reached 
maximal spread, the levels of F-actin in the B-cell contact zone begin to diminish.  An 
actin ring at the outer edge of the spreading membrane is retained, while the level of F-
actin begins to reduce in the center of the contact zone, where BCR microclusters 
aggregate to form the B-cell central cluster (Fig. 1.6).  At the same time, dynamic 
extensions of filopodia and lamellipodia decrease, the B-cell membrane in total begins to 
retract, resulting in a reduction in the total contact zone area, and the B-cell central 
cluster continues to sequester BCR microclusters (Fig. 1.6)(170, 181).  These studies 
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suggest that as the B-cell switches from actively spreading upon the antigen presenting 
surface to contracting, which facilitates BCR central cluster formation, that the B-cell is 
likely switching from actively undergoing actin polymerization to depolymerization. 
However,  the direct mechanistic links for this switch have yet to be uncovered.     
Reorganization of the actin cytoskeleton, which initiates B-cell morphological 
changes associated with initial BCR microcluster formation, B-cell spreading, B-cell 
contraction, and BCR central cluster formation require signals from the stimulated BCR.  
Signaling molecules such as Syk, CD19, PLCγ2, Vav, Btk, and Rap have been shown to 
be required for appropriate actin cytoskeleton rearrangement during B-cell activation 
(116, 159, 169, 182).  Our lab has shown that the Tec kinase family member Btk is 
necessary for BCR-induced de-novo actin polymerization, as well as BCR microcluster 
formation, B-cell spreading, and central cluster formation upon encounter with antigen 
presenting membranes (Fig. 1.6) (181).  Defects in Btk deficient cells are so profound, 
that the deficient B-cells are unable to establish stable contact with the antigen presenting 
surfaces.  Additionally, other Tec kinases have been shown to be important for formation 
of the T-cell immunological synapse (183).  Our lab discovered that defects in actin 
regulation caused by mutations in the PH domain of Btk, which prevents its recruitment 
to the plasma membrane, are more severe than gene knockout of individual actin 
regulators such as WASP, which suggests that Btk may play a role in activating multiple 
actin cytoskeleton regulatory proteins (52, 181).  As Btk is the major downstream 
signaling component of the BCR co-receptor CD19, is comes as no surprise that co-
stimulation of CD19 induces enhanced actin polymerization, which leads to enhanced 
antigen stimulated BCR micro-cluster formation as well as B-cell spreading (116, 184).  
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Our lab has also identified SHIP-1 as a negative regulator of actin polymerization and F-
actin accumulation upon BCR ligation, as SHIP-1-deficient cells show enhanced F-actin 
accumulation in the B-cell contact zone, increased B-cell spreading, and an inability to 
form BCR central clusters, which is associated with greatly reduced B-cell contraction 
(Fig. 1.6) (181).  SHIP-1 had previously been identified as a negative regulator of BCR 
mediated signaling, and is known to moderate the activation levels of key B-cell 
signaling molecules such as Btk, PLCγ2, and Akt (59, 124).  However, the observed actin 
related defects in SHIP-1-deficient cells are likely primarily mediated by SHIP-1 
inhibitory actions on Btk, as treatment of the SHIP-1
-/-
  cells with the Btk inhibitor (LFM-
A13) reverse the observed defects (181).  Accordingly, a model for actin mediated 
dynamics upon BCR ligation includes BCR-initiated activation of Btk, which induces 
actin polymerization to promote BCR microcluster formation and cell spreading (Fig. 
1.6).  As SHIP-1 becomes activated, it exerts is negative regulatory effects by reducing  
the activation of Btk, thereby disabling actin polymerization, driving inhibition of B-cell 
spreading and promoting B-cell contraction and subsequent accumulation of BCR 
microclusters into a central cluster (Fig. 1.6).  The actin dynamics observed upon BCR 
ligation are therefore a result of the balance between Btk and SHIP activation.             
In addition to BCR-antigen binding initiating signaling cascades which promote 
mobilization of actin cytoskeletal factors necessary for optimal B-cell response and BCR 
internalization, it has been discovered in recent years that actin cytoskeleton dynamics 
both positively and negatively feed back into BCR mediated signaling (185, 186).  The 
primary steps in which actin works to positively feed into enhanced BCR mediated 
signaling include initial BCR microcluster formation, microcluster growth and eventual 
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coalescence, as well as signaling molecule recruitment.  In Jasplakinolide treated B-cells, 
which acts to stabilize the actin network, neither soluble nor membrane bound antigen 
were able to induce significant levels of BCR mediated signaling.  However, as 
mentioned previously, disruption of the actin network by treatment with latrunculin 
caused microcluster formation of BCRs, and BCR mediated signaling similar in nature to 
IgM crosslinking, in the absence of antigenic stimulation.  As such, it is noted that the 
transient disassociation of the cortical actin cytoskeleton is necessary for proper BCR 
transduced signaling, and microcluster formation.  In addition, recent studies have 
suggested that the actin cytoskeleton may sever to partition other positively regulating 
signaling molecules away from the BCR in resting cells.  One such example is CD19, 
which in complex with CD21/CD81 appears to be partitioned away from BCRs by the 
cytoskeleton in resting B-cells (114).  Moreover, additional downstream signaling 
molecules necessary for B-cell response are indirectly transported to signaling active 
BCR microclusters by interactions with a multitude of actin binding proteins.  One such 
example includes the recruitment of the signaling adaptor molecule Grb2 by its 
interaction with WASP.  Additionally, actin polymerization is necessary for enhanced 
BCR clustering consequently amplifying BCR signaling.  One mechanism by which actin 
amplifies BCR signaling is by promoting B-cell spreading on antigen presenting surfaces, 
which allows the capture of more antigen and therefore the activation of more BCRs 
(187).  Another mechanism by which the actin cytoskeleton aids in amplifying BCR 
clustering and signaling is by shuttling both BCRs and BCR microclusters.  Actin 
polymerization at BCR microclusters, as well as retrograde actin flow which takes place 
at the periphery of the B-cell contact zone, directionally moves BCRs and BCR 
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microclusters to merge, and eventually form a central cluster.  This is supported by 
published data from our lab which shows that treatment of cells with latrunculin prevents 
the coalescence of BCR microclusters into central clusters.                       
Conversely, actin has been implicated in negatively regulating BCR signaling as 
well.  Evidence for a link between actin dynamics and negative regulation of BCR 
mediated signaling began coming to light when studies showed that disruption of 
function or knockout out of proteins associated with actin regulation were connected to 
diverse autoimmune phenotypes, which generally occur as a consequence of overactive 
B-cell signaling.  One example identified includes the deficiency of the actin nucleation 
factor WASP, which results in reduced humoral immune responses to pathogens, but also 
wide spread systemic autoimmunity (52, 58).  Recent studies from our lab have focused 
on the mechanisms whereby actin dynamics control negative regulation of BCR 
signaling.  Our studies and those of others have shown that when BCR microclusters 
coalesce with one another, their interactions with early singling molecules, such as Syk, 
and lipid raft association begin to diminish.  This is concurrent with decreasing levels of 
F-actin in the vicinity of the central cluster, likely due to local actin depolymerization, 
which is suggested to reduce membrane dynamics and cellular protrusions, consequently 
aiding in the coalescence of BCR microclusters to form a central cluster.  As the central 
cluster is formed, the B-cell transitions from an active signaling to an attenuation phase, 
which occurs simultaneously as the B-cell switches from actively spreading to 
contracting on antigen presenting membranes.  Inhibition or delay of B-cell contraction 
has been shown by our lab to result in persistent BCR microclusters, F-actin 
accumulation within the contact zone, and prolonged and enhanced signal activation, as 
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well as failure to form a central cluster.  Our lab has specifically shown that  B-cell 
specific gene knockout of the actin nucleation promoting factor N-WASP (54), and the 
negative regulatory signaling molecule SHIP-1(181),  result in an impaired transition 
from spreading to contracting . This defect is concurrent with an inability to transition to 
the signal attenuation phase, which leads to enhanced and prolonged cell signaling and 
BCR microcluster formation.  Moreover, the serum levels of autoAbs are significantly 




 mice, providing strong evidence 
that actin dynamics are essential in negatively regulating BCR mediated signaling.   
Another mechanism whereby dynamically reorganizing actin may act to promote 
BCR signal down-regulation is by the recruitment of negative regulatory elements to 
BCR signalosomes.  For instance, actin reorganization is necessary for recruitment of 
Abp1 to both the T-cell and B-cell surface, and Abp1 has been shown to be necessary for 
the recruitment of HPK1 to the T-cell immunological synapse.  HPK1 in turn has been 
shown to be a negative regulator of both B and T-cell singling (55, 126).  Our lab has 
shown that N-WASP is recruited to the B-cell contact site upon BCR/antigen ligation, 
and B-cell conditional knockout of N-WASP resulted in decreased activation of SHIP1, 
suggesting that N-WASP may be responsible for bringing SHIP1 to BCR 
microsignalosomes, thereby mediating BCR signal down-regulation (54).     
1.9 Abp1 in lymphocyte activation and endocytosis 
 Abp1, also known as SH3P7 and HPK1-interacting protein of 55 kDa (HIP-55), 
was identified in a screen for Src homology-3 (SH3) domain containing molecules in 
yeast (188), and was later shown to be involved in actin-dependent endocytosis in yeast 
46 
 
(189).  Kessels et. al cloned the mammalian homologue of Abp1, and he and others 
discovered that Abp1 is ubiquitously expressed in the mouse, although it is expressed at 
low levels in the ovaries and skeletal muscles (190-192).   Abp1, a member of the debrin 
family of actin-binding proteins, contains multiple protein-protein interaction domains.  
The 55 kDa phospho-protein contains two N-terminal actin binding domains (actin-
depolymerizing factor homology domain (ADF) and Helical domain), a centrally located 
proline rich domain (PRD) which contains two Src-tyrosine phosphorylation consensus 
sites, and finally a C-terminal SH3 domain (Fig. 1.7).  Early studies showed that Abp1 
binds to F-actin, but not monomeric G-actin, via its two independent actin binding 
domains with a 1:5M saturation stoichiometry, however, its binding does not alter 
filament dynamics (191, 192).    Abp1 is recruited to the leading edge of migrating cells, 
fibroblast lamellipodia, and to the cell membrane upon BCR and TCR ligation, where it 
colocalizes with actin, and its recruitment appears to depend upon de novo actin 
polymerization (150, 191, 192).  In yeast, Abp1 can directly influence actin 
polymerization by activating the actin nucleator Arp2/3.  However, while mammalian 
Abp1 also binds F-actin, it lacks the additional acidic domains necessary for Arp2/3 
activation (189, 193).  However, Pinyol et al. have shown that Abp1 can directly bind to 
and activate N-WASP (an activator of Arp2/3) with the help of Cdc42 in neuronal cells 
(Fig. 1.7) (194).  The two tyrosine phosphorylation (YxxP) motifs at position 334 and 
344 have been shown to be phosphorylated by Src family, Syk, and Zap-70 kinases in 
vitro (191, 195, 196).  Finally, the SH3 domain of Abp1 has been implicated in directly 








 Figure 1.7  Structure and known binding partners of Abp1.  Abp1 is a 55 kDa 
phospho-protein that has been implicated in modulating cell signaling and internalization 
events.  It contains two N-terminal F-acting binding domains (ADF and Helical), a 
centrally located PRD domain, which contains two consensus tyrosine phosphorylation 
sites which are substrates for Src/Syk/Zap70 kinases, and a C-terminal SH3 domain.  The 
SH3 domain of Abp1 has shown to bind the GTPase Dyn2, where the interaction is 
necessary for Tf and BCR internalization, as well as HPK1, an upstream kinase essential 
for B and T-cell signal propagation.  Abp1 has also been show to bind the F-actin 







transduction, actin polymerization, endocytosis, cellular adhesion, as well as cell 
migration (Fig. 1.7) (149, 190, 194, 196).  
While Abp1 itself does not have any intrinsic enzymatic activity, its combined 
protein interaction domains implicate Abp1 as an important scaffolding molecule for 
coordinating signal transduction with actin-mediated events such as cell surface receptor 
dynamics and endocytosis.  As such, early reports showed that Abp1 was phosphorylated 
after BCR or TCR ligation, suggesting that it may represent a common effector of antigen 
receptor-signaling pathways in lymphocytes (191, 197).  Our lab showed that this 
phosphorylation is required for Abp1 recruitment to the plasma membrane upon BCR 
crosslinking, as a phosphorylation mutant of Abp1 showed defective recruitment (150).  
A report by Ensenat et al. discovered that Abp1 specifically bound to the MAP4K HPK1 
via its SH3 domain and HPK1’s PRD in 293T cells.  HPK1 is a MAP4K that is able to 
activate the JNK pathway by activating multiple MAP3Ks, which then activate multiple 
MAP2Ks (126).  Ensenat et al. discovered that HPK1 and JNK activity were enhanced by 
Abp1 binding (190).  Activated JNK in turn phosphorylates and activates the 
transcription factor c-jun, which is a component of the AP-1 transcription factor that 
regulates cell proliferation and apoptosis (110).   Recent studies in B and T-cells show 
that HPK1 acts as a negative regulator of multiple aspects of BCR and TCR singling 
respectively.  In T-cells HPK1 acts to negatively regulate NFAT activation, T-cell 
proliferation, T-cell-dependent antibody responses, cytokine production, and induction of 
autoimmunity (55, 56, 126), while in B-cells, HPK1 has been shown to negatively 
regulate activation of BLNK, MAPK’s (p38, ERK, and JNK), PLCγ2, and IκB kinase 
(55).  HPK1-deficient B-cells are hyper-proliferative, and show enhanced Ca
2+
 flux upon 
49 
 
BCR stimulation (55).  Recent studies utilizing T-cells derived from Abp1
-/-
 mice showed 
that these T-cells cells appeared to have decreased activation of several key T-cell 
signaling/adaptor molecules including the p38, linker for activation of T-cells (LAT), and 
PLCγ1, as well as defective up-regulation of the activation marker CD69 (195).  As a 
likely consequence of the signaling defects observed in the Abp1
-/-
 T-cells, the Abp1 
knockout mice display reduced T-cell proliferation, cytokine production, and reduced 
humoral immune response to T-dependent antigens (195).  In B-cells, in addition to 
tyrosine phosphorylation, the recruitment of Abp1 to the plasma membrane also requires 
actin reorganization, as the recruitment is abolished upon treatment with the actin 
disrupting agent Latrunculin (150).  A study by Kessels et al. discovered that the 
constitutively active form of Rac, a GTPase that acts to moderate actin polymerization, 
caused a rapid accumulation of Abp1 to sites of cell growth such as fibroblast 
lamellipodia or the leading edge of migrating cells (192).  The findings that BCR 
signaling induces the phosphorylation of Abp1 and that Abp1 is necessary for optimal 
activation of signaling molecules downstream of the TCR raises the possibility that Abp1 
may serve as an adaptor protein that links upstream to downstream signaling events of the 
BCR for B-cell activation.  The ability of Abp1 to interact with the actin cytoskeleton 
directly and actin moderating elements also suggests Abp1 as a possible link between 
BCR mediated signaling and actin cytoskeleton dynamics upon BCR engagement. 
 Abp1 has long been recognized as important for endocytosis within many 
different cell types.  The earliest studies of Abp1 in yeast indicated that Abp1 was 
essential for actin-dependent endocytosis.  As mentioned previously, yeast Abp1 binds to 
F-actin, while having the ability to directly activate the actin nucleator Arp2/3, thereby 
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directly influencing actin polymerization dynamics.  However, mammalian Abp1 does 
not retain this capability.  Abp1 was shown to function in receptor-mediated endocytosis 
of transferrin, by its interaction with the GTPase dynamin 2 (Dyn2), which acts to pinch 
off endocytosing vesicles from the cell surface (149, 198).  Our lab published research 
showing that Abp1 can interact with Dyn2 in B-cells, and this interaction requires the 
SH3 domain of Abp1 and the PRD of Dyn2 (Fig. 1.7) (150).  Importantly, Abp1 is 
necessary for high efficiency BCR-mediated antigen processing and presentation (150).   
1.10 The role of dynamin 2 in moderating signal transduction and actin 
dependent endocytosis 
 Dynamin is a 100 kDa GTPase which acts as a molecular motor necessary for 
pinching off nascent endocytosing vesicles from a variety of intracellular membranes 
(143, 199-202), and has more recently been implicated in moderating actin dynamics and 
cell signaling.  Dynamin has three major isoforms, dynamin 1 which is neuron specific, 
dynamin 2 which is ubiquitously expressed, and dynamin 3 which is predominantly 
expressed in the testis, brain, and lung (202).  Dynamin is composed of five domains: an 
N-terminal GTPase domain, a middle domain, a PH domain, a GTPase effector domain 
(GED), and a C-terminal PRD (Fig. 1.8) (203).  Dynamin is recruited to sites of 
endocytosis, where it oligomerizes to form spiral collar-like structures which constrict to 
pinch off the nascent vesicles (Fig. 1.8) (204).  The GTPase activity of dynamin is greatly 
enhanced by self oligomerization (>100-fold) into spiral-like structures.  The 
oligomerization is mediated via the interaction of the GED of one molecule with the 





















Figure 1.8  Structure and known binding partners of Dyn2.  Dyn2 is a 100 kDa 
GTPase, which has been shown to be necessary for scission of newly formed budding 
vesicles from a variety of membranes.  Dyn2 contains an N-terminal GTP-ase domain, 
followed by a “middle” domain, a PH domain, a GED, and a C-terminal PRD.  The 
GTPase domain of Dyn is necessary for its pinchase activity, which releases budding 
vesicles from membranes.  The “middle” domain of Dyn is proposed to predominantly 
serve as a structural motif, which aids in Dyn-Dyn interactions.  With its PH domain, 
Dyn is binds membrane lipids.  The GED, while also serving as a structural component in 
Dyn-Dyn binding, predominantly acts as a GTPase effector for Dyn, serving to greatly 
increase Dyn’s intrinsic GTPase function.  The C-terminal PRD of dynamin has been 
implicated in binding a vast number of SH3 domain containing proteins which have 
broad ranging functions within cells including signal propagation and actin cytoskeleton 
modification.  Dyn also has two consensus tyrosine phosphorylation sites which are 
substrates for Src family kinases.  Inset image depicts collars formed by Dyn-Dyn 
interactions, and GED initiated Dyn GTP hydrolysis resulting in scission of a membrane 









activity (205, 206).  The middle domain of Dyn has also been proposed to aid in self-
oligomerization (207).  The PH domain of dynamin binds to the lipid PI(4,5)P2 at the 
plasma membrane, and the binding is speculated to increase membrane curvature.  It is 
not surprising that deletion mutants of this domain show reduced receptor-mediated 
endocytosis (208, 209).  Preliminary data has shown that the PRD of dynamin is 
necessary for its recruitment to clathrin-coated pits (150, 210).  Additionally, the PRD of 
dynamin has been shown to bind the SH3 domain of numerous proteins involved in a 
variety of cellular processes, including clathrin-mediated endocytosis and actin 
modulation (211).  Some of these proteins include amphiphysin (210), endophilin (210), 
PLCγ (212), Grb (213), Cortactin (148), Vav (214), and Abp1(150).   
As early as 1999, Ahn et al. showed that Dyn2 can be tyrosine phosphorylated at 
positions 231 and 597 by Src kinases in response to β adrenergic receptor stimulation, 
and this phosphorylation was shown to be important for the internalization of the β2 
adrenergic receptor (215).  Later, Sajahn et al. showed that phosphorylation of Dyn2 was 
necessary for caveolae-mediated endocytosis in endothelial cells (216).  However, in 
mast cells, FcεRI ligation induces the de-phosphorylation of Dyn2, which was shown to 
hasten CME of the FcεRI (217).  As such, it remains unclear whether phosphorylation of 
dynamin is necessary for its recruitment or function during CME of signaling BCRs.  
While it is unknown whether dynamin itself must be phosphorylated, our lab has shown 
that BCR-mediated signaling is necessary for the recruitment of dynamin to the B-cell 
surface and the BCR, as B-cells treated with the Src kinase inhibitor PP2 display 
defective recruitment of dynamin upon BCR engagement (Bruce K. Brown, Ph.D., un-
published data).  Recent work by Malhotra et al. has also indicated that upon BCR 
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stimulation, Dyn2 is recruited to endocytosing BCRs in a complex with Grb2 and Vav, 
which is dependent upon phosphorylation and activation of LAB (linker for activation of 
B-cells) (218, 219).  Moreover, small interfering RNA–mediated gene silencing of Dyn2 
in Jurkat T cells reduced levels of activated pERK, pJNK, and pPLCγ1, with the eventual 
outcome of reducing IL-2 promoter activity as well as CD69 up-regulation upon TCR 
stimulation (214).  Further investigation revealed that the PRD of dynamin was necessary 
for IL-2 promoter activation, and more specifically a constitutive interaction with Vav1 
was required for TCR signals resulting in IL-2 promoter activation (214).  These results 
suggest that dynamin, while essential for the physical removal of nascent vesicles from 
the plasma membrane, may also contribute, by proxy, to receptor signal transduction.     
In addition to providing physical force to remove endocytosing vesicles from the 
plasma membrane and possible roles in signal transduction from the BCR, recent studies 
have suggested dynamin as a link between cellular endocytosis machinery and the actin 
cytoskeleton.  Our lab has previously shown that actin remodeling is critical for signal 
enhanced BCR endocytosis but is not required for constitutive endocytosis of BCRs at 
the cell surface (137), which suggests that BCR signaling can up-regulate receptor 
internalization by inducing actin remodeling.  While our lab has shown that Dyn2 
recruitment upon BCR crosslinking is independent of F-actin (Bruce K. Brown, Ph.D., 
un-published data), dynamin has been shown to be linked to actin in a variety of ways.  
Dynamin directly interacts with Vav (214, 218) which serves as a guanine nucleotide 
exchange factor (GEF) for Rho family GTPases, cortactin which activates the Arp2/3 
complex (220), syndapins which aid in activation of N-WASP (221), profilin which 
promotes ATP exchange on monomeric actin for actin filament elongation (222), and 
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Abp1 (149, 150).  In rat fibroblasts, siRNA knockdown or dominant negative transfection 
of a GTPase mutant of dynamin (dynamin-K44A), induced mislocalization of Rac, 
consequently interfering with Rac induced actin polymerization at the leading edge of 
lamellipodia (223).  Moreover, Gomez et.al defined Dyn2 as a critical regulator of the 
actin cytoskeleton in response to TCR engagement, as Jurkat T-cells with shRNA-Dyn2 
knockdown showed diminished actin reorganization to the immunological synapse (214).  
As mentioned above, Abp1 has been shown to directly bind F-actin and is necessary for 
BCR internalization and subsequent antigen processing and presentation (150).  Abp1 
and Dyn2 constitutively interact, and they are both recruited to the plasma membrane 
upon BCR crosslinking (150).  In light of the preceding studies, it is becoming clearer 
that Dyn2 plays an indirect role in recruitment of actin to sites of signaling receptors/sites 
of endocytosis.  How Dyn2 works to coordinate this recruitment has yet to be fully 
fleshed out.    
1.11 Rationale/Aims 
B-cells, as the key mediators of humoral immunity, rely upon tight regulation of 
BCR-mediated signaling in response to pathogenic encounter to ensure an appropriate 
response.  The absence or breakdown of regulated signaling can lead to diverse 
complications ranging from immunodeficiency to autoimmunity.  BCR-initiated 
signaling and BCR/antigen internalization for processing and presentation are essential 
for the production of high affinity and long-lasting antibodies that can effectively 
neutralize pathogens.  The major question that will be addressed in this dissertation is 
how the processes of BCR-mediated signal transduction, dynamic actin rearrangements, 
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and subsequent BCR internalization for antigen processing are linked to generate a robust 
humoral immune response.   More specifically, I have examined the role of Abp1 and 
Dyn2 in coordinating these processes, and my research has discovered that both Abp1 
and Dyn2 are involved in modulating  BCR signaling and subsequent BCR 
internalization for antigen processing and presentation, by linking actin to signaling and 
the endocytic apparatus.  My studies focused primarily upon the role of Abp1 as a 
negative regulator of BCR-mediated signaling and dynamic actin re-organization, as well 
as its contribution to regulating peripheral B-cell development, response to immunization, 
and controlling B-cell autoimmunity.  I also examined the role of Dyn2 in regulation of 
BCR-mediated signals, by modulating BCR clustering and subsequent BCR 
internalization.  Furthermore, I have examined the role of individual domains of Dyn2 
necessary for governing these processes.    
1.11.1 Aim 1. The role of Abp1 in regulation of BCR signaling, B-cell development, 
and immune response. 
This aim was designed to examine the hypothesis that the actin adaptor molecule 
Abp1 acts to link actin dynamics to BCR signaling and internalization, thereby aiding in 
B-cell immune response.  To address this hypothesis, I examined whether Abp1 was 
recruited to signaling active BCR microclusters in B-cells stimulated with antigen 
presenting surfaces, and the effect of Abp1 knockout on 1) the morphology of B-cells, 
and BCR clustering, 2) F-actin accumulation at surface BCRs, and the activation of other 
known actin-regulating proteins, 3) activation of BCR proximal and distal signaling 
molecules, 4) the development of B-cell subsets, 5) spontaneous GC B-cell development 
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in the absence of immunization, and autoAb production, 6) and BCR affinity maturation, 
and T-dependent and T-independent antibody responses.  To investigate this hypothesis, 
we utilized both germline Abp1 knockout and Abp1
-/- 
-chimeric mice which specifically 
lack Abp1expression in only B-cells.  This work will shed light upon the dynamic and 
interwoven processes of BCR signaling and actin reorganization as they relate to B-cell 
signal regulation, activation, development, and B-cell-mediated immune responses. 
1.11.2 Aim 2. The role of Dyn2 in regulating BCR signal transduction and 
internalization. 
This aim was designed to examine the hypothesis that BCR-initiated signaling 
regulates the cellular location of Dyn2, that Dyn2 plays a role in further propagating BCR 
mediated signaing and BCR internalization.  More specifically, I sought to examine the 
domains or function of Dyn2 necessary for its recruitment to the plasma membrane, as 
well as those necessary for BCR internalization upon BCR crosslinking, and the effect of 
a Dyn2 GTPase mutation on BCR clustering and signal transduction.  To investigate this 
hypothesis, I transfected B-cells with dominant negative mutants of Dyn2 conjugated to 
green fluorescent protein (GFP), including GFP-Dyn-K44A (a GTPase mutant), GFP-
DynΔPRD (Dyn2 lacking its PRD), GFP-Dyn2-Y231/597F (a phosphorylation mutant of 
Dyn2), as well as full length Dyn2, and examined 1) their recruitment to the BCR upon 
receptor crosslinking, 2) internalization of the BCRs in the differentially transfected cells, 
3) their ability to recruit the actin adaptor molecule Abp1, and 4) BCR clustering kinetics 
and signal propagation in cells transfected with the GTPase dead mutant of Dyn2.  
Furthermore, I sought to examine BCR internalization in B-cells treated with the small 
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molecule inhibitor of dynamin GTPase function, Dynasore.  This work will shed light 
upon the coordination between BCR signal propagation, actin dynamics, and BCR 

















Chapter 2:  Actin binding protein 1 links B-cell antigen 
receptor to negative signaling pathways 
2.1 Abstract 
Prolonged or uncontrolled B-cell receptor signaling has been associated with 
autoimmunity.  We previously demonstrated a role for actin in BCR signal attenuation. 
This study reveals that Actin-binding protein 1 (Abp1/HIP-55/SH3P7) is a critical 
negative regulator of BCR signaling, and links actin remodeling with negative regulatory 
pathways of the BCR.  In both Abp1
-/-
 and bone marrow chimeric mice where only B-
cells lack Abp1 expression, the number of spontaneous germinal center and marginal 
zone B-cells in the spleen and levels of autoAb are significantly increased, while B-cell 
development in the bone marrow is unaltered.  Serum levels of T-independent antibody 
and total IgM and IgG are elevated, while T-dependent antibody responses are markedly 
reduced and fail to undergo affinity maturation.  Upon activation, surface BCR clustering 
is enhanced and B-cell contraction delayed in Abp1
-/- 
B-cells; concurrent with slow but 
persistent increases in F-actin at BCR signalosomes. Furthermore, BCR signaling is 
enhanced in Abp1
-/-
 B-cells compared to wild-type B-cells, including increased levels of 
Cat
2+ 
flux and phosphorylated BLNK, MEK1/2 and ERK, coinciding with reductions in 
the recruitment of the inhibitory signaling molecules HPK1 and SHIP-1 to BCR 
signalosomes.  My results indicate that Abp1 contributes to maintenance of B-cell 
tolerance via negatively regulating BCR signaling by coupling actin remodeling to B-cell 
contraction and the activation of inhibitory signaling molecules, which contributes to the 
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regulation of peripheral B-cell development and antibody responses.  This study reveals a 
novel mechanism for negative regulation of BCR signaling.       
2.2 Introduction 
B-lymphocytes are responsible for mounting antibody responses as well as 
regulating other branches of immune responses against infectious agents.  B-cells are 
activated by signal transduction mediated by their BCRs (161).  Recent studies using high 
resolution live cell imaging have enabled a better understanding of the molecular 
dynamics of the early events of BCR signaling (114, 168, 172, 224).  Upon binding 
antigen, surface BCRs rapidly reorganize from monomers and nanoclusters into 
microclusters (161).  BCR microclusters recruit and stabilize surrounding lipid rafts, 
which brings lipid raft-resident Src kinases into physical proximity of receptors and 
induces the phosphorylation of the ITAMs in the cytoplasmic tails of the BCR (113, 225).  
Phosphorylated ITAMs provide docking and activation sites for the tyrosine kinase Syk.  
These events lead to the recruitment and phosphorylation of proximal signaling 
molecules to BCR microclusters, activating signal cascades. Ultimately BCR signaling 
induces transcriptional activation of genes required for B-cell survival and proliferation 
(226, 227).     
 The level and duration of BCR signaling is tightly regulated.  Prolonged or 
uncontrollable BCR signaling is associated with B-cell-mediated autoimmunity (44, 120).  
Downregulation of BCR signaling is mediated by various phosphatases and kinases, 
including SHIP-1 (59, 124) and HPK1(55).  While SHIP-1 is the primary downstream 
component of the inhibitory co-receptor FcγRIIB, BCR activation also activates SHIP-1 
61 
 
through Lyn-mediated phosphorylation (59, 228).  In anergic B-cells, SHIP-1 binds to 
partially phosphorylated ITAMs of the BCR, thereby maintaining their anergic state 
(122).  SHIP-1 inhibits the activation of PLCγ2, Btk, and Akt by converting their 
membrane docking sites, PtdIns(3,4,5)P3, into PtdIn(3,4)P2, consequently blocking their 
signal transduction (59, 124).  B-cell-specific SHIP-1 deficiency causes hyper-
responsiveness and impaired positive selection of B-cells in germinal centers (57).  
HPK1, a Ste20 serine/threonine kinase, inhibits BCR signaling by inducing the threonine 
phosphorylation and subsequent ubiquitination and degredation of BLNK (55), the key 
adaptor protein of necessary for BCR signal transduction.  HPK1 deficiency leads to 
increases in the activation levels of BLNK, MAP kinases, NF-κB, and B-cell 
proliferation (55).  Furthermore, HPK1-deficient mice are more susceptible to 
experimentally induced autoimmune encephalomyelitis (126).  
 In addition to inhibitory phosphatase and kinases, one of the earliest events of 
BCR activation, receptor clustering, is also a target for negative regulation.  BCR-
FcγRIIB colligation by immune complexes inhibits BCR clustering (173).  We have 
recently demonstrated that the coalescence of BCR microclusters into a central cluster 
facilitates BCR signal attenuation (181).  This coalescence process requires actin-
mediated B-cell contraction and SHIP-1 activation (181).         
 Actin is critical for both amplification and downregulation of BCR signaling.  The 
earliest signals from the BCR induce transient disassociation and disassembly of cortical 
actin beneath the plasma membrane, which increases the lateral mobility of surface BCRs 
(167, 168, 178).  Actin disassembly frees surface BCRs from confinement generated by 
the cortical actin to form microclusters, facilitating signal initiation.  Following actin 
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disassembly, actin reassembles in a polarized fashion in the vicinity of BCR 
microclusters, driving surface BCRs to one pole of cells (170, 175).  The microclusters 
recruit more BCRs and coalesce with one another.  When engaging antigen presented on 
a cell surface, such as those of follicular dendritic cells, actin reassembly expands the 
contact of B-cells with the presenting surface.  B-cell spreading increases the number of 
BCRs engaged, thereby enhancing BCR signaling, which further promotes BCR 
microcluster formation (187).  Upon maximimal spread, the level of F-actin starts to 
decrease in the region of the B-cell membrane contacting the antigen presenting surface, 
and the B-cell membrane contracts, which facilitates the coalescence of BCR 
microclusters, promoting signal downregulation (170, 181, 187, 229).  Persistent actin 
accumulation at the B-cell contact zone and delayed B-cell contraction, caused by B-cell-
specific N-WASP knockout, lead to increased and prolonged BCR signaling, and results 
in elevated numbers of spontaneously formed germinal center B-cells and autoantibody 
production (54).  These data indicate that actin remodeling is closely coordinated with the 
reorganization and signaling of surface BCRs. However, the molecular mechanisms 
underlying the communication between actin and BCR signaling has not been fully 
elucidated. 
 Abp1 is an adaptor protein that contains multiple interaction domains, including 
an ADF domain at its N-terminus, a highly conserved SH3 domain at its C-terminus, and 
a helical domain and PRD in the center (190-192).  Its ability to simultaneously bind to 
F-actin and a PRD-containing molecule implicates a role for Abp1 in mediating 
communications between actin and BCR signaling.  While the yeast homolog of Abp1 
binds to and directly activates Arp2/3 (193), mammalian Abp1 does not retain this 
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capability, but can indirectly regulate actin polymerization by binding to N-WASP in 
neurons (194).  Additionally, Abp1 has been shown to be involved in synaptic vesicle 
recycling in neuronal cells (230), and neutrophil phagocytosis and migration by linking 
actin with these processes (196, 231).  A regulatory role for Abp1 in signaling was first 
demonstrated in T-cells.  While T-cell-development is normal in Abp1
-/-
 mice, T-cells  
from Abp1
-/-
 mice display decreases in signal transduction from the TCR with subsequent 
reductions in T-cell proliferation and cytokine production in vitro (195).  Furthermore, T-
cell-dependent antibody responses are reduced in Abp1
-/-
 mice (195).  In T-cells, Abp1 is 
recruited to the IS and responsible for recruiting the kinase HPK1 (232).  However, the 
molecular mechanism by which Abp1 contributes to TCR signaling and T-cell activation 
remains elusive. In B-cells, BCR activation induces the phosphorylation of two 
consensus tyrosine motifs within the PRD of Abp1 (150, 191).  Our lab has shown that 
Abp1 phosphorylation and BCR-induced actin remodeling are required for Abp1 
recruitment to the cell surface (150).  We also previously demonstrated that Abp1 is 
required for BCR-mediated antigen internalization and processing (150), and that 
antigen-induced BCR internalization requires actin remodeling (170, 181).  Abp1 binds 
to both F-actin and Dyn2 via its ADF-H/Helical and SH3 domains, respectively (149, 
150, 191).  However, how Abp1 contributes to BCR signaling remains elusive.  
 In this study, I demonstrate that Abp1 is a negative regulator of BCR signaling 
and B-cell activation. Abp1
-/-
 B-cells display greater levels of BCR signaling than wt B-
cells, which correlates with increased numbers of spontaneously formed GC B-cells and 
autoAb production in Abp1
-/-
 mice and Abp1
-/- 
bone marrow chimeric mice.  Abp1
-/-
 mice 
display decreased T-dependent Ab responses, and defective affinity maturation, however 
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conversely show increased total serum levels of IgM and IgG, and an enhanced T-
independent Ab response.  My mechanistic examination suggests that Abp1 attenuates 
BCR signaling by promoting BCR microcluster coalescence and B-cell contraction, and 
by recruiting the inhibitory molecules SHIP-1 and HPK1 to BCR microclusters. Thus, my 
results reveal Abp1 as a novel mechanistic link between actin remodeling and negative 
signaling, exerting a B-cell-intrinsic inhibition on B-cell activation.  
2.3 Materials and Methods 
2.3.1 Mice and cell culture 
Wild-type C57BL/6 mice expressing either CD 45.1 or CD 45.2, and µMT (B-cell 
null) mice were purchased from The Jackson Laboratory (Bar Harbor, ME).  Abp1 
knockout mice (Abp1
-/-
) were generated and crossed onto a C57BL/6 background, as 
previously described (195).  To isolate splenic B-cells, single-cell suspensions of 
splenocytes were subjected to density-gradient centrifugation in Ficoll (Sigma-Aldrich, St 
Louse, MO) to obtain mononuclear cells, treated with anti-Thy1.2 monoclonal Ab (mAb) 
(BD Biosciences, Franklin Lakes, NJ) and guinea pig complement (Rockland 
Immunochemicals, Gilbertsville, PA) to remove T cells, and panned for 2 h to remove 
monocytes.  BM was flushed from mouse femurs with PBS supplemented with 3% fetal 
bovine serum (FBS), and subjected to density-gradient centrifugation in Ficoll (233).  
Peritoneal cells were flushed from the peritoneal cavity with phosphate buffered saline 
(PBS) supplemented with 3% FBS (234).  All animal work was reviewed and approved 




2.3.2 Flow cytometry  
For flow cytometric analyses, cell suspensions from BM, spleen, or peritoneal 
cavity were incubated with Fcγ Receptor blocking Abs (anti-mouse CD16/CD32, BD 
Bioscience) on ice, and stained at optimal dilutions of conjugated Abs in PBS 
supplemented with 1% FBS. Anti-mouse Abs and reagents used to stain BM cells 
included Pacific Blue-anti-CD24 (BioLegend, San Diego, CA), biotinylated anti-Ly-51 
(BP-1), streptavidin-PE, FITC-anti-CD43, PerCP-Cy5.5-anti-B220, and APC-anti-IgM 
(BD Biosciences) (7, 235).  Anti-mouse Abs and reagents used to stain transitional 1 
(T1), transitional 2 (T2), follicular (FO), and isotype switched (IS) splenic B-cells 
included biotinylated-anti-IgD (Southern Biotech, Birmingham, AL), Alexa Fluor (AF) 
405-streptavidin (Life Technologies, Carlsbad, CA), PerCP-Cy5.5-anti-B220, and FITC-
anti-IgM (BD Biosciences) (236).  Anti-mouse Abs and reagents used to stain splenic 
marginal zone B-cells (MZ) included Pacific Blue-anti-CD21 (BioLegend), PerCP-
Cy5.5-anti-B220, and PE-anti-CD23 (BD Biosciences) (236).  Anti-mouse Abs and 
reagents to stain B1a and B1B-cells from the peritoneal cavity included biotinylated-anti-
IgD (Southern Biotech), PE-Cy5- streptavidin, FITC-anti-IgM, and APC-anti-CD5 (BD 
Biosciences), and eFlour 450-anti-CD11b (eBiosciences, San Diego, CA) (237).  Anti-
mouse Abs and reagents to stain splenic GC B-cells included biotinylated-anti-CD95 (BD 
Biosciences) AF488-streptavidin (Invitrogen, Carlsbad, CA), PE-anti-GL7, and PerCP-
Cy5.5-anti-B220 (BD Biosciences) (238).  
To determine the level of Abp1 expression in each B-cell subset, the preceding 
samples were fixed with 4% paraformaldehyde, permeabilized with 0.05% saponin, and 
stained with goat-anti-Abp1 Ab, followed by fluorescently conjugated secondary Ab.  
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Goat-anti-mouse Abp1 Ab was generated by immunization of a goat with GST-Abp1 
fusion proteins by Alpha Diagnostics International (San Antonio, TX) and purified using 
protein G-Sepharose column (150).   
To analyze intracellular signaling molecules, splenic B-cells were incubated with 
FcγR blocking mAb at 4
o
C, stained with APC anti-mouse CD19 Ab (BD Biosciences) to 
label B-cells, washed, activated with 10 µg/ml F(ab’)2-goat-anti-mouse IgG+M (Jackson 
ImmunoResearch), fixed, and stained with Abs specific for phosphotyrosine mAb 4G10 
(pY, EMD Millipore, Billerica, MA), pBLNK (Santa Cruz Biotechnology, Santa Cruz, 
CA), pMEK1/2, pERK, pp38, or pJNK (Cell Signaling Technology, Danvers, MA) 
followed by fluorescently conjugated secondary Abs.  Cells were pretreated and treated 
during stimulation with the MEK1/2 (U0126, 10 μM, InvivoGen, San Diego, CA) or JNK 
(SP600125, 10 μM, A.G. Scientific Inc., San Diego, CA) as controls to confirm 
specificity of pERK and pJNK Ab labeling.  
To determine the expression levels of mIgM, signaling, and actin-related 
molecules in unstimulated splenic B-cells, B-cells were treated with FcγR–block Ab, 
labeled with PerCP Cy5.5 anti-mouse B220 Ab, fixed, permeabilized, and labeled with 
Abs or reagents, including anti-mouse IgM (BD Biosciences), anti-BLNK, anti-SHIP-1, 
anti-WASP, anti-N-WASP (Santa Cruz Biotechnology), anti-MEK, anti-ERK, anti-JNK, 
and anti-HPK1 (Cells Signaling Technologies), and AF488 Phalloidin for F-actin (Life 
Technologies), followed by fluorescently conjugated secondary Abs where necessary. 
Cells were analyzed with a FACSCanto II flow cytometer and FACSDiva 




2.3.3 Immunohistochemistry  
Spleens from wt and Abp1
-/-
 mice were embedded in O.C.T Compound (Sakura 
Finetek, Torrance, CA), and frozen in liquid nitrogen. Sections (10 µm) were collected 
using a cryostat.  Samples were fixed in acetone, blocked with goat serum (Jackson 
ImmunoResearch, West Grove, PA) and avidin/biotin (Sigma Aldrich), and then stained 
with optimal concentrations of the following Abs/reagents: biotinylated-anti-IgD 
(Southern Biotech), AF405-streptavidin (Life Technologies), AF 488-anti-Thy1.2 
(eBioscience), and AF 647-peanut agglutinin (PNA) (Life Technologies).  Cells were 
imaged using a Zeiss LSM 710 Confocal Microscope (Carl Zeiss Microscopy, Jenna, 
Germany). GC size was calculated using Zen Lite 2011 Software (Carl Zeiss Microcopy).    
2.3.4 Bone marrow chimera mice  
BM chimeric mice were generated using a previously published method (10). 
C57BL/6 wt recipient mice expressing CD45.1 were lethally irradiated (1000 cGy).  BM 
from Abp1
-/-
 or wt mice (CD45.2
+
) was mixed at a 20:80 ratio with B-cell null μMT BM 
(1 × 10
7
 total BM cells in 150 µl of PBS) and transplanted via retro-orbital injection into 
the lethally irradiated mice (52).  To eliminate previously activated B-cell populations in 
transfered BM cells, BM from young Abp1
-/-
 and wt donors (4–5 wk) depleted of plasma 
B-cells was used.  Plasma cells were depleted by incubating cells with biotin-conjugated 
rat anti-CD138 (BD Biosciences) followed by EasySep Streptavidin RapidSpheres and 
EasySep Magnet (Stem Cell Technologies, Vancouver, BC).  Donor sera were also pre-
screened to verify absence of anti-double stranded DNA (dsDNA) antibodies.  Irradiated 
mice without BM transplant died within 14 days.  Four months post adoptive transfer, the 
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) in the spleen, as well as their expression of CD45.1, CD45.2, and 
Abp1 were analyzed by flow cytometry and analyzed with FlowJo, (PE anti-mouse 
Thy1.2 [BD Biosciences], AF488 anti-mouse CD19 [Biolegend], PerCP Cy5.5 anti-
mouse CD45.1 and APC anti-mouse CD45.2 [BD Biosciences]).  After reconstitution, B-
cells in lethally irradiated recipients (CD45.1
+
) were entirely donor derived (CD45.2
+
).         
2.3.5 Serological analysis 
The presence of anti-nuclear Ab (ANA) in sera was tested using ANA (HEp-2) 
antigen substrate slides as per manufacturer instructions (MBL International Corporation, 
Des Plaines, IL).  The serum levels of anti-dsDNA in wt, Abp1
-/-
, wt-Ch, and Abp1
-/-
-Ch 
were quantified by Enzyme-Linked Immunosorbent Assay (ELISA) using a previously 
published protocol (52).  Briefly, ELISA plates were pre-coated at 4°C with dsDNA (10 
mg/ml, Sigma-Aldrich).  After blocking, the plates were incubated with diluted triplicate 
serum samples and goat anti–mouse IgG-horseradish peroxidase (HRP) (Jackson 
ImmunoResearch).  HRP was detected using OptEIA TMB substrate (BD Bioscience). 
2.3.6 Immunizations 
To analyze T cell–independent and T-cell dependent antigen responses, mice 
were immunized by intraperitoneal (i.p.) injection of (4-hydroxy-3-nitrophenyl)acetyl 
(NP) conjugated to either Ficoll (NP-Ficoll, T-cell independent antigen) or keyhole 
limpet hemocyanin (NP-KLH, T-cell dependent antigen) (Biosearch Technologies, 
Petaluma, CA) in PBS or Sigma Adjuvant System (Sigma Aldrich) respectively (40 
µg/mouse in 200 µl volume).  For T-cell dependent experiments, mice were boosted on 
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day 28 with a second injection of NP-KLH.  To determine anti-NP Ab concentration in 
response to NP-Ficoll or NP-KLH immunization, NP30-BSA (Biosearch Technologies) 
coated ELISA plates were incubated with diluted serum, followed by HRP-conjugated 
anti-mouse Abs including anti-IgM, or a cocktail of anti-IgG1, IgG2a, IgG2b, and IgG3 
(Southern Biotech) (239).  HRP was detected using OptEIA TMB substrate.  The samples 
were run in triplicate and corrected for background binding.  Total serum Abs were 
analyzed by coating ELISA plates directly with diluted serum, followed by HRP 
conjugated anti-mouse Abs.  Relative IgG affinity from the serum of NP-KLH 
immunized mice was assessed as the concentration ratio of IgG bound to NP4-BSA 
versus NP30-BSA on day 7 and day 35 after the first immunization (57). 
2.3.7 Preparation of mono-biotinylated Fab’ antibody  
Mono-biotinylated Fab’ fragment of anti-mouse Ab (mB-Fab’-anti-IgG+M) was 
generated from the F(ab’)2 fragment (Jackson ImmunoResearch) using a published 
protocol (240).  The disulfide bond that links the two Fab fragments was reduced using 2-
mercaptoethylamine, and the reduced cysteine was biotinylated by maleimide activated 
biotin (Thermo Scientific, Waltham, MA).  Fab’ was further purified using Amicon Ultra 
centrifugal filters (Millipore).  One biotin per Fab’ was confirmed using a biotin 
quantification kit (Thermo Scientific).  Fab’ was labeled with AF546 (AF546-mB-Fab’-
anti-IgG+M) based on the manufacturer-recommended protocol (Invitrogen).  
2.3.8 Preparation of antigen tethered planar lipid bilayers  
Liposomes were made by combining 1,2-dioleoyl-sn-glycero-3-phosphocholine 
and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-cap-biotin (Avanti Polar Lipids, 
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Alabaster, AL) in a 100:1 molar ratio, using the Avanti Polar Lipids Extruder.  Coverslip 
chambers (Nunc/Thermo Scientific) were coated with the planar lipid bilayer by 
incubating with the liposomes (0.05 mM) for 10 min (72).  After extensive washes, the 
coated coverslip chamber was incubated with 1 µg/ml streptavidin (Jackson 
ImmunoResearch Laboratories), followed by 1 µg/ml AF546-mB-Fab’–anti-IgG+M 
mixed with 4 µg/ml mB-Fab’–anti-IgG+M Ab.  For a non-antigen control, surface BCRs 
were labeled by incubating with AF546-Fab’–anti-IgG+M (5 μg/ml) on ice for 30 min. 
The labeled B-cells were then incubated with biotinylated holo-transferrin (Tf; 8 μg/ml, 
an equal molar concentration of 5 μg/ml mB-Fab′–anti-Ig+M; Sigma-Aldrich) tethered to 
lipid bilayers by streptavidin. 
2.3.9 Total internal reflection microscopic analysis 
Images were acquired using a Nikon laser TIRF system on an inverted 
microscope (Nikon TE2000-PFS, Nikon Instruments Inc., Melville, NY) equipped with a 
60X, NA 1.49 Apochromat TIRF objective (Nikon), a Coolsnap HQ2 CCD camera 
(Roper Scientific, Trenton, NJ), and two solid-state lasers of wavelength 491 and 561 nm.  
Interference refection images (IRM), AF488, and AF546 were acquired sequentially.  To 
image intracellular molecules, B-cells were incubated with mB-Fab’-anti-Ig-tethered 
lipid bilayers at 37ºC for varying lengths of time.  Cells were then fixed with 4% 
paraformaldehyde, permeabilized with 0.05% saponin, and stained for Abp1, HPK1 (Cell 
Singling Technology), pSHIP-1 (Y1020, Cell Singling Technology), pSyk (Cell 
Signaling Technologies), pWASP (S483/S484, Bethyl Laboratory, Montgomery, TX), 
and pN-WASP (Y256, Millipore).  F-actin was stained using AF488-phalloidin. The B-
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cell contact area was determined based on IRM images using MATLAB software (The 
MathWorks, Natick, MA).  The total and mean fluorescence intensity of each staining in 
the B-cell contact zone was determined using Andor iQ software (Andor Technology, 
Belfast, UK).  Relative intensity of IRM and fluorescence intensity of BCRs, or 
intracellular molecules along lines drawn across cells were measured using Andor iQ 
software (Andor Technology).  Background fluorescence generated by mB-Fab’-anti-Ig 
tethered to lipid bilayers in the absence of B-cells or secondary antibody controls, was 
subtracted. For each set of data, more than 50 individual cells from three independent 
experiments were analyzed. 
2.3.10 Confocal microscopic analysis 
Splenic B-cells were incubated with FcR blocking mAb for 10 min on ice, stained 
with Cy3-Fab-goat-anti-mouse IgM (Jackson ImmunoResearch) to label BCRs, washed, 
and activated with 10 µg/ml F(ab’)2-goat-anti-mouse IgG+M (Jackson ImmunoResearch) 
at 37
o
C.  Cells were fixed at designated time point with 4% paraformaldehyde, and 
imaged with a Zeiss LSM 710 confocal Microscope (Carl Zeiss Microscopy).  For each 
set of data, more than 50 individual cells from three independent experiments were 
analyzed. 
2.3.11 Calcium analysis 
The intracellular calcium flux was measured by flow cytometry using the 
calcium-sensitive dyes Fluo4 AM and Fura Red (Molecular Probes, Eugene, OR) and 
manufacturer-recommended protocols.  Splenic B-cells were stained with 2 µg/ml Fluo4 
and 5 µg/ml Fura Red for 30 min at 37°C, washed, and analyzed using a FACSAria flow 
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cytometer (BD Biosciences).  The basal fluorescence intensity of Fluo4 AM and Fura 
Red were measured for 60 s before stimulation with 10 µg/ml F(ab’)2-goat anti-mouse 
IgG+M (Jackson ImmunoResearch) at 37°C.  The fluorescence intensity of Fluo4 AM 
and Fura Red in fluorescence levels were then measured for 300 s.  The relative levels of 
intracellular calcium were determined by a ratio of Fluo4 AM to Fura Red emission 
values using FlowJo software (Tree Star, Ashland, OR). 
2.3.12 Statistical analysis 
Data analysis was performed using Excel software (Microsoft, Redmond, WA) 
and analyzed using the Student’s t test.  The statistical differences between groups are 
indicated with p-values in the related graphs as: *, p < 0.05; **, p < 0.01; ***, p < 0.001. 
2.4 Results 
2.4.1 B-cell-specific Abp1 deficiency is sufficient to increase the development of 
marginal zone and germinal center B-cells. 
Previous studies have shown that there is no significant defect in T cell 
development in Abp1
-/-
 mice (195), but whether Abp1 contributes to B-cell development 
and maturation has not been fully examined.  To determine whether and at which stage 
Abp1 may play a role in B-cell development, B-cell subsets in the bone marrow, spleen, 
and PerC in Abp1
-/-
 mice were analyzed, in comparison with those in wt mice.  The Abp1 
knockout mouse model was developed and characterized by Han et al. (195), and we 
previously confirmed the absence of the Abp1 gene and protein expression in the Abp1 
knockout mice (150).  Bone marrow cells, splenocytes and peritoneal cells were isolated 
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from 6-8 week old wt and Abp1
-/-
 mice, labeled with antibodies specific to cell surface 
markers indicative of pre-determined maturational stage, and examined by flow 
cytometry.  I utilized Hardy Classification to identify B-cells at different maturation 













































) B-cell populations (Fig. 2.1A).  Cells 
were quantified as a percentage of total bone marrow isolated, and I observed no 
significant differences in the isolated BM B-cell subsets (Fig. 2.1B).  Splenocytes were 
































) B-cells (Fig. 
2.2A).  B-cell subsets in the spleen were quantified as the average number of cell type 
isolated per spleen (Fig. 2.2B).  Analysis showed that the Abp1
-/- 
mice had significantly 
greater numbers of MZ B-cells compared to their wt counterparts (Fig. 2.2B).  Peritoneal 
















) cell populations (Fig. 2.3A).  B-cell subsets in PerC were quantified as the 
average number of cell type isolated per peritoneal cavity (Fig. 2.3B).  The results from 
flow cytometry analysis showed that the numbers of B1a B-cells in the peritoneal cavity 
were significantly increased, compared to those of wt mice (Fig.2.3).  Taken together, 
these results suggest that Abp1 is involved in the negative regulation of marginal zone 
and B1a B-cell development in the spleen and peritoneal cavity, but not in early B-cell 
development in bone marrow. 
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Fig. 2.1  Abp1 deficiency does not affect B-cell maturation in the bone marrow. (A-
B) Cells from BM of wt and Abp1
-/-
 mice were labeled with Abs specific for surface 
markers of pre-pro- (A), pro- (B), early pre- (C), late pre- (D), immature (E) and re-
circulating mature B-cells (F) in the BM, and analyzed using flow cytometry.  Shown are 
representative dot plots (A), and the average percentage (+S.D.) of total cells extracted 
from BM (B) (n=5). 
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Fig. 2.2  Abp1 deficiency affects the development of  splenic MZ B-cells.  (A-B) Cells 
from spleens of wt and Abp1
-/-
 mice were labeled with Abs specific for surface markers 
of transitional 1 (T1), transitional 2 (T2), follicular (FO), isotype switched (IS) and 
marginal zone (MZ) B-cells in the spleen, and analyzed using flow cytometry.  Shown 
are representative dot plots (A), and the average number (+S.D.) of total cells extracted 
from splenn (B) (n=5).   p<0.05 
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Fig. 2.3  Abp1 deficiency affects the expansion of  PerC B1a B-cells.  (A-B) Cells 
from PerC of wt and Abp1
-/-
 mice were labeled with Abs specific for surface markers of 
B1a and B1b B-cell subsets, and analyzed using flow cytometry.  Shown are 
representative dot plots (A), the average number (+S.D.) of cells extracted from PerC (B) 
(n=4).  p<0.05 
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The isolated effect of Abp1 deficiency on the development of peripheral B-cells 
led to the question of whether Apb1 is differentially expressed in the various B-cell 
subsets.  To address this question, I determined the levels of Abp1 protein expression in 
each B-cell subset by intracellular staining of Abp1 by flow cytometry (Fig. 2.4). Results 
were normalized to the mean fluorescent intensity (MFI) of Abp1 in isotype switched 
(IS) B-cells, which displayed the highest expression level among all B-cell subsets.  
Indeed, the expression level of Abp1 protein increased as the B-cells matured, and the 
mature B-cells in the spleen expressed a significantly higher level of Abp1 than pro- and 
pre-B-cells in the bone marrow.  Together with the previous experiments, the data 
indicate that Abp1 deficiency appears to only affect the maturation of specific subsets of 
peripheral B-cells, and this may be due to differential expression levels of Abp1 within 
the various subsets.  
Since peripheral mature B-cells are activated in B-cell follicles to form germinal centers, 
I determined the number and distribution of germinal center B-cells in the spleen of non-
immunized mice using flow cytometry and immunohistochemistry.  Germinal center B-







) (Fig. 2.5A).  In the spleen of non-immunized Abp1
-/-
 mice, the 
number of GC B-cells was significantly higher than that in the wt mice (Fig. 2.5B).  
Consistent with the results of flow cytometry analysis, immunohistological examination 
showed more frequent and larger PNA
+
 germinal centers in the spleens of Abp1
-/-
 than 
that in wt mice (Fig. 2.5C-D). Additionally, Abp1
-/-
 mice also exhibit splenomegaly (Fig. 
2.5E), as previously reported (230).  These results indicate a role for Abp1 in suppressing 







Fig. 2.4  Abp1 differentially expressed in B-cell subsets. Abp1 expression levels in 
different B-cell subsets. BM cells and splenocytes from wt mice labeled as in Fig 2.1-2.3 
were stained with anti-Abp1 Ab. Shown are the average MFIs of Abp1 as a percent of the 







                                   
       













Fig. 2.5  Abp1 deficiency promotes spontaneous differentiation of GC B-cells, and 
initiation of splenomegaly.  (A-B) GC B-cell development in Abp1
-/-
 mice. Cells from 
spleens of wt and Abp1
-/-
 mice were labeled with Abs specific for surface markers of GC 
B-cells, and analyzed using flow cytometry. Shown are representative dot plots (A),  and 
the average number (+S.D.) of GC-B-cells extracted from spleen (B) (n=4). (C) 
Immunofluorescent stained images of spleen sections from mice (6 months old). Bars, 
100 μm (n=12 sections/4 wt or Abp1
-/-
 mice). (D) Average numbers of PNA
+
 GCs per 
spleen section and average length of GC (μmx20) (+S.D., n=12 sections/4 wt or Abp1
-/-
 
mice). (E) Spleen weight of 6-8 weeks old mice as a percentage of body mass (+S.D.) 





To examine whether the phenotype observed in Abp1
-/- 
mice is B-cell intrinsic, I 
generated bone marrow chimeric mice in which only B-cell lack Abp1 expression (52).  
Cells from bone marrow (Fig. 2.6 A-C), and spleens (Fig. 2.6 D-F) of lethally irradiated 
CD45.1
+
 wt C57BL/6 transplanted with BM from Apb1
-/-
 or wt mice (both CD45.2
+
) 
mixed at a 20:80 ratio with μMT BM, were labeled with Abs specific for surface markers 
of B-cells in the bone marrow (A), B and T-cells in the spleen (D), and analyzed by flow 
cytometry for both expression CD45.1 and CD45.2 and cell number  to determine re-





-Ch) BM (Fig. 2.6C), and splenic cells (Fig. 2.6F) stained positive for CD45.2 
expression (donor cells), and the percentage of B-cells extracted from the bone marrow 
(Fig. 2.6B) and B and T-cells from the spleen (Fig. 2.6E) were comparable those found in 
wt C57Bl6 mice.  To confirm B-cell chimerism, B-cells from the BM and spleen were 
further labeled with anti-Abp1 Ab to determine Abp1 protein expression within various 
cell subsets from wt-Ch and Abp1
-/-
-Ch (Fig. 2.7).  Flow cytometry confirmed that only 
B-cells lacked Abp1 expression in fully reconstituted Abp1
-/-
-Ch (Fig. 2.7).  Finally, GC 
and MZ numbers were analyzed in both wt-Ch and Abp1
-/-





-Ch mice displayed elevated numbers of spontaneous GC and MZ B-cells 
in the spleen, compared to those in wt-Ch (Fig. 2.8).  
Taken together, these results suggest that Abp1 exerts a B-cell intrinsic inhibition 
on the spontaneous development of GC B-cells and differentiation of MZ and B1a B-
cells, but is not involved in early B-cell maturation in the bone marrow.     
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Fig. 2.6  Reconstitution of bone marrow chimera mice. Lethally irradiated wt 
C57BL/6 (CD45.1
+
) were transplanted with BM from Apb1
-/-
 or wt mice (CD45.2
+
) 
mixed at a 20:80 ratio with BM from B-cell null μMT mice. Four months post 





-Ch) BM chimera mice were labeled with Abs specific for surface markers of B-cells 
(A) in the BM, for B and T-cells in the spleen (D) and for CD45.1 and CD45.2, and 
analyzed using flow cytometry. Shown are representative dot plots (A and D), the 
average percentage (+S.D.) of total cells extracted from MB (B) and B and T-cells from 
the spleen (E), as well as the relative expression of CD45.1 and CD45.2 in total BM cells, 























Fig. 2.7  Only B-cells in Abp1
-/-
 bone marrow chimeric mice lack the expression of 
Abp1.  BM cells and splenocytes from Abp1
-/-
 and wt BM chimeric mice were labeled 
with Abs specific for the surface markers of total B-cells in the BM and spleen, and MZ 
and GC B-cells in the spleen.  The cells were fixed, permeabilized, and stained for Abp1. 























            
 
Fig. 2.8  B-cell-specific Abp1 deficiency is sufficient to increase the differentiation of 
MZ and development of spontaneous GC B-cells. (A) MZ and GC  B-cell subsets in 
Abp1
-/-
-Ch and wt-Ch mice. Cells from spleens were labeled for surface markers of MZ 
and GC- B-cells, and analyzed by flow cytometry.  Shown are average percentages of 
MZ and GC B-cells per B220
+





2.4.2 Production of autoAb, T-independent Ab responses, and total Ab increase 
while T-dependent high affinity Ab responses decrease in Abp1
-/-
 mice. 
Spontaneous GC formation has been described as a characteristic of autoimmune 
susceptible mouse strains (241).  To determine whether the formation of spontaneous GC 
B-cells in Abp1
-/-
 mice is associated with B-cell-mediated autoimmunity, I monitored the 
production of autoAbs in the sera of non-immunized wt and Abp1
-/-
 mice.  Using an anti-
nuclear antibody slide test (ANA), I found that while wt mice did eventually become 
positive for the presence of anti-nuclear antibodies, Abp1
-/-
 mice were positive with 
autoAb much earlier, with 17% positive within 1.5 months and 50% positive by 6 
months, compared to 0% of the wt mice (Fig. 2.9A). I further quantified anti-double 
stranded DNA (dsDNA) antibodies in the sera of non-immunized wt and Abp1
-/-
 mice at 
1.5, or 6 months of age, using ELISA (Fig. 2.9B).  In agreements with the results of the 
ANA test, Abp1
-/-
 mice had significantly higher levels of anti-dsDNA antibody 
production than wt mice by 6 months of age.  Furthermore, Abp1
-/-
-Ch mice also showed 
elevated levels of anti-dsDNA Ab compared to wt-Ch mice, 4 months after bone marrow 
transplant (Fig. 2.9B).    
To determine whether the increased numbers of marginal zone, GC, and B1a B-
cells in Abp1
-/-
 mice have any impact on antibody responses, I immunized wt and Abp1
-/-
 
mice with the T-independent antigen NP-Ficoll once or the T-dependent antigen NP-
KLH twice, 28 days apart, and quantified NP-specific and total IgM and/or IgG in the 
serum using ELISA.  In response to NP-Ficoll, Abp1
-/-
 mice exhibited significant 
increases in both NP-specific (Fig. 2.10A) and total IgM (Fig. 2.10B) throughout the time 
course compared to wt mice.  In response to NP-KLH, Abp1
-/-









-Ch mice. (A) 
Immunofluorescence microscopy analysis of anti-nuclear Ab in the serum of non-
immunized wt and Abp1
-/-
 mice (n=4~9) at different ages. (B) ELISA quantification of 
anti-dsDNA Ab in the serum of wt and Abp1
-/- 
mice of 1.5 and 6 months of age, and wt-
Ch and Abp1
-/-
-Ch mice at 1 and 4 months post transplant. Dots represent individual 





Fig. 2.10  Production of T-independent Ab responses, and total Ab increases while 
T-dependent high affinity Ab responses decrease in Abp1
-/-
 mice.  (A-F) 6~8 weeks 
old mice (n=4~5) were immunized with NP-Ficoll (A-B) or NP-KLH (C-F).  NP-specific 
IgM (A, C), total IgM (B, D), NP-specific IgG (E), or total IgG (F) in the serum (µg/ml) 
determined by ELISA. (G) Relative affinity of NP-specific IgG in NP-KLH- immunized 
mice assessed as ratios of IgG bound to NP4 versus NP30 by ELISA (+SD, n=4~5). *, 
p<0.05, **, p>0.01, ***, P<0.001 
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slightly elevated antigen-specific IgM at day 35, 7 days after the boost, but the level of 
total IgM was significantly increased throughout the time course compared to those in wt 
mice (Fig 2.10C-D).  Similar to a previous report (195), the serum level of antigen-
specific IgG was decreased in Abp1
-/-
 knockout mice, compared to that of wt mice (Fig. 
2.10E).  This decrease was especially dramatic after the boost with NP-KLH (Fig. 2.10E), 
indicating that the secondary antibody response is more severely affected by Abp1 
deficiency than the primary antibody response.  However, the level of total IgG in the 
serum was significantly increased in Abp1
-/-
 mice during both the primary and secondary 
antibody responses (Fig. 2.10F), similar to the total IgM.  I further evaluated Ab affinity 
in NP-KLH immunized mice by determining the ratio of Ab binding to low (NP4) and 
high valent (NP30) antigen by ELISA.  The ratio was significantly increased in wt mice 
but not in Abp1
-/-
 mice post boost (Fig. 2.10G). Thus, while Abp1
-/-
 mice display impaired 
affinity maturation, and are defective in mounting T-dependent Ab responses, they 
conversely have elevated T-independent, non-specific, and self-reactive Ab responses.  
2.4.3 Abp1 deficiency augments B-cell spread and BCR clustering.  
As the increased production of spontaneous GC B-cells and autoAb is a B-cell-
intrinsic effect, I further examined the impact of Abp1 deficiency on early events of 
BCR-mediated B-cell activation, including BCR clustering and B-cell morphological 
changes.  I labeled and cross-linked surface BCRs using AF546 labeled, mono-
biotinylated Fab’ fragment of anti-mouse IgG+M antibody (AF546-mB-Fab’–anti-Ig) 
that was tethered to planar lipid bilayers by streptavidin (Fab’-anti-Ig-tethered lipid 
bilayer).  This activation system allow us to use interference reflection microscopy (IRM) 
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to analyze the area of the B-cell membrane region that contacts the Fab’-anti-Ig-tethered 
surface (B-cell contact zone), which reflects B-cell spreading and contraction, as well as 
total internal reflection fluorescence microscopy (TIRF) to analyze and quantify relative 
amounts of fluorescently labeled BCRs and Abp1 at the B-cell contact zone.  I also 
analyzed BCR clustering in B-cells stimulated by AF546-mB-Fab’-anti IgG+M, cross-
linked by soluble streptavidin using confocal microscopy.  I found that the contact area of 
Abp1
-/-
 B-cells did not reduce after 3 min of activation as with wt B-cells, consequently 
being significantly more spread than that of wt B-cells at 7 and 9 min, indicating an 
inhibition of cell contraction (Fig. 2.11A-B).  The total fluorescence intensity (TFI) of 
labeled BCRs in the contact zone of Abp1
-/-
 B-cells continuously increased over time, 
compared to wt B-cells that reached a plateau at 3 min and decreased by 9 min (Fig. 
2.11A and C).  However, the labeled BCRs remained punctuate throughout the contact 
zone of Abp1
-/-
 B-cells, and did not coalesce into a central cluster by 7 min as in wt B-
cells (Fig. 2.11A).  Furthermore, mean fluorescence intensity (MFI) of BCR staining in 
the contact zone of Abp1
-/-
 B-cells was lower than that of wt B-cells (Fig. 2.11D), even 
though the TFI of BCRs was higher in Abp1
-/-
 than wt B-cells (Fig. 2.11C).  In response 
to cross-linking with mB-Fab’-anti-Ig plus soluble streptavidin, a significantly higher 
percentage of Abp1
-/-
 B-cells showed polarized BCR caps than wt B-cells as early as 1 
min of activation  (Fig. 2.12 A-B). Together, these results indicate that Abp1
-/- 
B-cells 
sequester greater amounts of BCRs in the contact zone or polarized BCR caps upon 
encountering membrane-associated or soluble antigen, but are defective in the contraction  
process and formation of BCR central clusters. 






Fig. 2.11  Abp1 knockout augments B-cell spread and BCR clustering. (A-D) IRM 
and TIRF analysis of wt and Abp1
-/-
 splenic B-cells incubated with Fab’-anti-Ig-tethered 
lipid bilayers. Representative images, bar 5 µm, (n=3) (A). Average contact area (B), TFI 
(C), and MFI (D) of labeled BCRs from > 50 cells per time point (n=3), quantified using 























   
Fig. 2.12  Earlier and greater percentage of capping in Abp1
-/-
 B-cells. (A-B) 
Confocal analysis of splenic B-cells stained with AF546-mB-Fab’–anti-IgG+M then 
streptavidin to activate. Representative images at 1 min (A), and average percentage 
(+S.D.) of cells showing polarized BCR caps (B) quantified from >100 cells per time 





2.4.4 Abp1 is recruited to the leading edge of the spreading B-cells upon BCR 
activation. 
We have previously shown Abp1 is recruited to the cell surface upon B-cell 
treatment with soluble antigen, and that its tyrosine phosphorylation is necessary for this 
recruitment (150). To better understand the mechanism by which Abp1 contributes to 
BCR signaling, I examined the spatial relationship of Abp1 with BCRs at the cell surface.  
Upon incubation with Fab’-anti-Ig-tethered lipid bilayer, Abp1 was readily recruited to 
the B-cell contact zone as early as 1 min of activation, as BCR microclusters just became 
visible (Fig. 2.13A).  While the contact zone area and size of BCR clusters change over 
time, Abp1 predominantly accumulated at the outer edge of the contact zone, and did not 
significantly colocalize with surface BCRs throughout the activation process (Fig. 2.13A-
B).  The MFI of Abp1 in the contact zone rose over time, with a dramatic peak observed 
at 7 min of activation (Fig. 2.13C), concurrent with B-cell contraction, but long after peak 
BCR TFI and maximal B-cell spread (Fig. 2.11B-C).  These results indicate Abp1 is 
specifically recruited to the leading edge of the B-cell membrane, predominantly during 
B-cell contraction, in response to BCR activation.  
2.4.5 BCR signaling is enhanced in Abp1
-/-
 B-cells. 
Increased numbers of spontaneous germinal center B-cells, autoAb, and total 
antibody suggest enhanced B-cell activation.  To investigate this possibility, I examined 
BCR-induced activation of proximal and distal signaling molecules in Abp1
-/-
 B-cells.  
Isolated splenic B-cells were activated by BCR cross-linking for various times, labeled 








Fig. 2.13  BCR activation induces recruitment of Abp1 to the outer edge of the 
spreading B-cell. (A) TIRF and IRM analysis of Abp1 in the contact zone of splenic B-
cells incubated with Fab’-anti-Ig-tethered lipid bilayers. Representative images (n=3), bar 
5 µm. (B) Relative intensity of IRM, and fluorescence intensity of BCRs and Abp1 
across the blue line in cells at 3 and 7 min from (A). (C) Average MFI of Abp1 (±S.D.) 



















BCR, and analyzed using flow cytometry.  Abp1
-/-
 B-cells exhibited increased levels of 
tyrosine phosphorylation (pY) (Fig. 2.14A) and phosphorylated BLNK (pBLNK) (Fig. 
2.14B), the key B-cell adaptor molecule, upon BCR cross-linking. However, the 
activation of downstream MAP kinases was differentially impacted by Abp1 deficiency.  
The levels of phosphorylated MEK1/2 (pMEK1/2) (Fig. 2.14C) and its downstream 
target the MAP kinase ERK (pERK) (Fig. 2.14D) were significantly increased upon BCR 
activation in Abp1
-/-
 B-cells, compared to wt B-cells.  Not only were the peak levels of 
the phosphorylated forms of these signaling molecules higher in Abp1
-/- 
B-cells, but the 
levels of these phosphorylated proteins also took much longer to return to basal levels 
(Fig. 2.14A-D).  In contrast, the level of phosphorylated JNK (pJNK) was significantly 
reduced (Fig. 2.14E), while the level of phosphorylated p38 (pp38) was not affected in 
Abp1
-/-
 B-cells (Fig. 2.14F). Treatment with ERK or JNK inhibitors reduced the levels of 
pERK and pJNK to basal levels (Fig. 2.14D-E), confirming staining specificity.  
Consistent with enhanced proximal signaling, Abp1
-/-
 B-cells displayed a higher level of 
calcium flux in response to BCR stimulation than their wt counterpart. There was no 
significant difference in the expression levels of membrane IgM, BLNK, MEK1/2, ERK 
and JNK between resting Abp1
-/- 
and wt B-cells (Fig. 2.15).  This result indicates that the 
enhanced and prolonged signaling in Abp1
-/-
 B-cells is not due to increased expression of 










Fig. 2.14  BCR signaling is enhanced in Abp1
-/-
 B-cells. (A-F) Splenic B-cells from wt 
and Abp1
-/-
 mice were activated with F(ab’)2-goat anti-mouse IgG+M, fixed, 
permeabilized, labeled for  phosphotyrosine (pY) (A), pBLNK (B), pMEK1/2 (C), pERK 
(D), pJNK (E), and pp38 (F), and analyzed by flow cytometry (average MFI ±S.D., n=3). 
(D-E) Upstream ERK and JNK inhibitor controls at indicated times. (G) Ca
2+
 flux in 
splenic B-cells activated with F(ab’)2-goat anti-mouse IgG+M using flow cytometry 









Fig. 2.15  The expression levels of membrane IgM and signaling molecules in 
unstimulated splenic B-cells. Splenic B-cells from resting wt and Abp1
-/-  
mice were 
labeled with anti-B220 Ab, fixed, permeabilized, and labeled for IgM (A), BLNK (B), 
MEK1/2 (C), ERK (D), and JNK (E).  Cells were analyzed by flow cytometry. Shown 







2.4.6 Abp1 is required for the recruitment of the inhibitory signaling molecules 
HPK1 and SHIP-1 to the B-cell contact zone. 
Enhanced signaling in Abp1
-/-
 B-cells suggests a negative regulatory role for Abp1 
in BCR signaling.  One possible mechanism by which Abp1 may negatively regulate 
signaling is by modulating inhibitory signaling molecules downstream the BCR.  To test 
this hypothesis, I examined the effects of Abp1 deficiency on the recruitment of two 
known inhibitory molecules, HPK1 and SHIP-1, to the BCR using TIRF.  After 
incubation with Fab’-anti-Ig tethered-lipid bilayer, I stained intracellular HPK1 or 
phosphorylated (activated) SHIP-1 (pSHIP-1) (Fig. 2.16 and 2.17), and quantified the 
relative levels of HPK1 or pSHIP1 in the B-cell contact zone (Fig. 2.16B and 2.17B) 
using TIRF.  In wt cells, HPK1 was detected as soon as 1 min of activation, peaked at 7 
min of activation, and reduced by 9 min (Fig. 2.16A-B).  While the Abp1
-/-
 B-cells 
showed the same trend of HPK1 recruitment, the MFI of HPK1 in the contact zone was 
significantly reduced throughout the time course (Fig. 2.16A-B).  Similar to the 
recruitment of HPK1, pSHIP-1 was detected in the contact zone of wt B-cells at 1 min; 
however significant accumulation of pSHIP did not occur until roughtly 7 min of 
activation (Fig. 2.17A-B).  Compared to wt B-cells, the peak MFI of pSHIP in the contact 
zone of Abp1
-/-
 B-cells at 7 min was significantly reduced (Fig. 2.17A-B). However, 
Abp1 deficiency had no significant effect on the recruitment of phosphorylated Syk 
(pSyk) to BCR clusters (Fig. 2.18A-B), as well as the expression levels of HPK1 and 
SHIP (Fig. 2.16C and 2.17C). These results indicate that Abp1 is required for the 
recruitment and activation of the key inhibitory molecules HPK1 and SHIP-1 





Fig. 2.16  Abp1 is required for recruitment of the inhibitory signaling molecule 
HPK1 to the B-cell contact zone.  (A-B) TIRF analysis of HPK1 in the contact zone of 
wt and Abp1
-/-
 B-cells incubated with Fab’-anti-Ig-tethered lipid bilayers. Shown are 
representative images (Bar, 5 µm).  (B) MFI of HPK1 (±S.D.) in the contact zone (50 
cells per time point, n=3).  (C) Resting splenic B-cells from wt and Abp1
-/-  
mice were 
labeled with anti-B220 Ab, fixed, permeabilized, and labeled for HPK1.  Cells were 







Fig. 2.17  Abp1 is required for recruitment of the inhibitory signaling molecule 
SHIP-1 to the B-cell contact zone.  (A-B) TIRF analysis of pSHIP-1 in the contact zone 
of wt and Abp1
-/-
 B-cells incubated with Fab’-anti-Ig-tethered lipid bilayers. Shown are 
representative images (Bar, 5 µm).  (B) MFI of pSHIP-1 (±S.D.) in the contact zone (50 
cells per time point, n=3).  (C) Resting splenic B-cells from wt and Abp1
-/-  
mice were 
labeled with anti-B220 Ab, fixed, permeabilized, and labeled for SHIP-1.  Cells were 




           
Fig. 2.18  Abp1 is not required for recruitment of the pSyk to the B-cell contact 
zone.  (A-B) TIRF analysis of pSyk in the contact zone of wt and Abp1
-/-
 B-cells 
incubated with Fab’-anti-Ig-tethered lipid bilayers. Shown are representative images 




2.4.7 Abp1 regulates BCR-induced actin reorganization. 
Increased B-cell spreading and BCR clustering at the surface of Abp1
-/-
 B-cells, 
which are known to be actin dependent, and the ability of Abp1 to bind to F-actin (191), 
suggest a role for Abp1 in BCR-induced actin remodeling.  To investigate this 
hypothesis, I examined the effects of Abp1 deficiency on F-actin accumulation at the B-
cell contact zone upon BCR activation.  F-actin was stained with fluorescently labeled 
phalloidin, and the distribution and relative levels of F-actin at the B-cell contact zone 
were imaged and quantified using TIRF.   In wt B-cells, the MFI of F-actin in the contact 
zone rapidly increased during the first 3 min of incubation with Fab’-anti-Ig-tethered 
lipid bilayer, peaked at ~3 min when B-cell spreading is maximal, and rapidly reduced as 
the B-cells contracted (Fig. 2.19A-B).  In contrast, the MFI of F-actin in the contact zone 
of Abp1
-/-
 B-cells rose much more slowly than that of wt B-cells, did not peak until 7 min, 
and remained at the peak level up to 9 min (Fig. 2.19A-B).  Consequently, the F-actin 
level in the contact zone of Abp1
-/-
 B-cells was significantly lower at 3 min but 
significantly higher at 7 and 9 min than that of wt B-cells.  As the levels of F-actin in 
resting B-cells was not altered by Abp1 deficiency (Fig. 2.19C), my data suggest that 
Abp1 may primarily contribute to signal-induced actin remodeling, more specifically,  
both the early accumulation and later clearance of F-actin from the B-cell contact zone.   
 Abp1 has been shown to regulate actin dynamics by interacting with the actin 
nucleation promoting factor N-WASP in neurons (194).  Our recent studies have 
demonstrated that WASP is required for actin assembly during B-cell spreading, 
however, N-WASP plays a unique role in actin clearance during B -cell contraction (54).  




Fig. 2.19  Abp1 regulates actin remodeling. (A-B) Splenic B-cells from wt and Abp1
-/-
 
mice were activated with Fab’-anti-Ig-tethered lipid bilayers, fixed, permeabilized, and 
stained with AF488 phalloidin for F-actin (A).  Shown are representative images (n=3), 
bar 5 µm. The MFI (±S.D.) of F-actin (B) in the contact zone quantified in > 50 cells per 
time point (n=3). (C) Resting splenic B-cells from wt and Abp1
-/-  
mice were labeled with 
anti-B220 Ab, fixed, permeabilized, and labeled for F-actin.  Cells were analyzed by flow 




WASP, I analyzed the impact of Abp1 deficiency on the recruitment and activation of 
these two actin regulators upon BCR activation.  Activated WASP and N-WASP were 
detected by TIRF, using antibodies specific for their phosphorylated form.   Similar to 
our previously published results, pWASP MFI peaked first at ~5 min of activation with 
Fab’-anti-Ig-tethered lipid bilayer, followed by pN-WASP (pN-WA), which peaked at ~7 
min (Fig. 2.20A-B and 2.21A-B) (54). In Abp1
-/-
 B-cells, pWASP MFI increased with the 
same kinetics and to similar levels as those of wt B-cells, but reduced more slowly after 
reaching maximal levels compared to wt (Fig. 2.20B). In contrast, pN-WASP MFI in the 
contact zone of Abp1
-/-
 B-cells was significantly lower than wt B-cells, even though wt 
and Abp1
-/-
 B-cells showed similar kinetics of recruitment (Fig. 2.21B). Flow cytometry 
analysis further confirmed the reduced levels of pN-WASP in Abp1
-/-
 B-cells (Fig. 
2.21C).  Abp1 deficiency has no significant effect on basal expression levels of WASP 
and N-WASP (Fig. 2.20C and 2.21D).  These results suggest that Abp1 regulates BCR-
induced actin remodeling by suppressing WASP activation, which induces F-actin 
accumulation and B-cell spreading, and by enhancing N-WASP activation, which triggers 
actin clearance and B-cell contraction.  
2.5 Discussion 
Abp1 is an actin-binding adaptor protein that is expressed widely from yeast to 
mammalian cells.  Previous studies have revealed a multitude of cellular funtions for 
Abp1 including:  endocytosis in a variety of cell types (149, 150, 198, 230, 232, 242), 
synaptic vesicle recycling in neurons (149, 230), phagocytosis (196, 243), cell migration 





Fig. 2.20. Abp1 regulates actin remodeling by modulating activation of the actin 
nucleation promoting factor WASP. (A-B) Splenic B-cells from wt and Abp1
-/-
 mice 
were activated with Fab’-anti-Ig-tethered lipid bilayers, fixed, permeabilized, and stained 
for p-WASP (A).  Representative images at 7 and 9 min (n=3), bar 5 µm. The MFI 
(±S.D.) of p-WASP (B) in the contact zone quantified in > 50 cells per time point (n=3). 
(C) Resting splenic B-cells from wt and Abp1
-/-  
mice were labeled with anti-B220 Ab, 
fixed, permeabilized, and labeled for pWASP.  Cells were analyzed by flow cytometry. 















Fig. 2.21. Abp1 regulates actin remodeling by modulating activation of the actin 
nucleation promoting factor N-WASP. (A-B) Splenic B-cells from wt and Abp1
-/-
 mice 
were activated with Fab’-anti-Ig-tethered lipid bilayers, fixed, permeabilized, and stained 
for pN-WASP (A).  Representative images at 7 min (n=3), bar 5 µm. The MFI (±S.D.) of 
pN-WASP (B) in the contact zone quantified in > 50 cells per time point (n=3). (C) 
Resting splenic B-cells from wt and Abp1
-/-
 mice were labeled with anti-B220 Ab, and 
either activated with F(ab’)2-goat anti-mouse IgG+M (C), or left un-activated (D), fixed, 
permeabilized, stained for pN-WASP (C) or total N-WASP (D), and analyzed by flow 

















study reveals a novel function for Abp1:  attenuation of BCR signaling, which contributes 
to the regulation of peripheral B-cell differentiation and Ab responses.  I demonstrate that 
Abp1 exerts a B-cell intrinsic inhibition on spontaneous activation and differentiation of 
mature follicular and self-reactive B-cells into GC B-cells and Ab-secreting cells, and on 
the generation of MZ and B1a B-cells.  Abp1 is required for B-cell affinity maturation 
and mounting effective T-dependent Ab responses.  In addition to its critical role in BCR 
uptake of antigen for processing (150), this study shows that Abp1 primarily contributes 
to the attenuation stage of BCR signaling by promoting B-cell contraction and 
coalescence of BCR microclusters into polarized central clusters, and by the recruitment 
of the inhibitory signaling molecules SHIP-1 and HPK1 to BCR microsignalosomes. 
 This study shows that the effects of Abp1 deficiency on the differentiation of MZ 
B-cells and spontaneous GC B-cells are B-cell intrinsic. The increased numbers of MZ, 
B1a, and GC B-cells provide an explanation for the enhanced T-independent response 
and elevated autoAb levels in Abp1
-/-
 mice. As expression levels of the BCR and 
signaling molecules are not altered in Abp1
-/-
 B-cells, my results support the notion that 
Abp1-mediated down-regulation of BCR signaling directly influences the differentiation 
of these peripheral B-cell subsets. These data also suggest that Abp1 is potentially 
involved in suppressing Ag-independent signals required for the differentiation of GC, 
MZ and B1a B-cells.  Actin dynamics are known to regulate tonic BCR signaling via 
modulating BCR-BCR and BCR-CD19 interactions (114).  Thus, it is possible that Abp1 
regulates tonic signaling in resting B-cells by modulating actin dynamics and receptor 





mice to generate high affinity Ab, while simultaneously 
producing high levels of non-specific IgG during T-dependent Ab responses, indicates 
defective affinity maturation.  In GCs, B-cells with higher affinity BCRs are selected to 
survive and differentiate, due to a greater ability to signal and capture/present antigen to 
T-cells than low affinity B-cells (36).  Enhanced/prolonged BCR signaling in Abp1
-/-
 B-
cells may interfere with affinity-dependent signal regulation.  Reductions in antigen 
uptake and presentation (150) likely ablate the ability of Abp1
-/- 
B-cells to acquire T-cell 
help.  Impairment in the activation of Abp1
-/-
 T-cells may further exacerbate the affinity 
maturation defect observed in Abp1
-/-
 mice. The affinity maturation defect provides 
another possible explanation for increased levels of autoAb in Abp1
-/-
 mice, as antigen-
specific B-cells are not preferentially selected from B-cell pools that also contain auto-
reactive B-cells. 
The negative regulatory function of Abp1 in BCR signaling shown in this study is 
in contrast to its positive regulatory role in TCR activation reported previously(195).  
Han et al. showed that Abp1 is required for the optimal activation of TCR signaling. 
While T-cell development and maturation was largely unchanged in Abp1
-/-
 mice, TCR-
induced phosphorylation of the adaptor protein LAT, and the key proximal signaling 
molecule PLCγ1, and activation of the MAP kinases Jnk and p38 were partially defective 
(195).  The defective TCR signaling was associated with reduced T-cell proliferation, 
cytokine production, and T-cell-dependent antibody responses in Abp1
-/-
 mice (195). 
Similar to T-cell development, Abp1 deficiency does not have a significant effect on B-
cell development in the bone marrow, possibly due to its relatively low expression level 
in B-cells of the bone marrow.  However, BCR signaling is enhanced in Abp1
-/-
 B-cells in 
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response to in vitro stimulation, exhibiting higher levels of tyrosine and BLNK 
phosphorylation, a key adaptor protein for proximal signaling from the BCR (246).  





B-cells display faster kinetics and  higher levels of Erk phosphorylation than wt B-cells. 
As the Abp1
-/-
 mice used in this study were generated by the same group that reported the 
T-cell study (195), and because I observed a similar defect in T-cell-dependent antibody 
responses in the Abp1
-/-
 mice, I suggest  that the opposing functions of Abp1 in T and B-
cells are not due to differences in the mouse model.   While the molecular mechanisms 
underlying differential regulation of BCR and TCR signaling remain unknown, my 
results demonstrate cell type-specific functions for Abp1 in signal regulation. 
 Based on its domain structure, it is logical to hypothesize that Abp1 would 
mediate signal regulation by interacting with signaling molecules via its SH3 domain and 
PRD.  However, the molecular details underlying its regulatory function remain 
unknown.  The results present here, and in previously published studies (149, 150, 190, 
194, 195) suggest three mechanisms by which Abp1 may promote signal attenuation, 
including:  1) modulating actin dynamics and actin-dependent early BCR activation 
events, 2) regulating the recruitment of inhibitory signaling molecules, and 3) by BCR 
internalization.  Recent studies using high resolution live cell imaging have revealed self-
clustering of BCR monomers and nano-sized clusters on the cell surface into 
microclusters as a critical event for BCR activation. The microclusters serve as signaling 
platforms for BCRs to recruit and interact with signaling molecules (114, 168, 172, 224). 
We have previously demonstrated that while BCR clustering initiates signaling, the 
ensuing coalescence of BCR microclusters into polarized central clusters acts to attenuate 
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BCR signaling activities (54, 170, 181).  The formation of BCR microclusters depends on 
actin remodeling, which not only directs the lateral movement of BCRs, but also 
mediates B-cell morphological changes induced by BCR activation including cell 
spreading, which amplifies BCR clustering, and cell contraction which drives 
coalescence of BCR microclusters (170, 181, 187).  The results presented here show that 
Abp1 is not critical for the formation of BCR microclusters and B-cell spreading.  Rather, 
it is required for B-cell contraction and coalescence of BCR microclusters.  The impact of 
Abp1 deficiency on the cellular events leading to signal attenuation may be attributed to 
its role in BCR-induced actin remodeling, where Abp1 plays a more prominent role in the 
clearance, rather than the early accumulation of F-actin in the B-cell contact zone.  In 
support of this hypothesis, failure to clear F-actin in the contact zone of N-WASP
-/-
 B-
cells has been linked to enhanced and prolonged BCR signaling (54).     
 How Abp1 regulates BCR-induced actin remodeling is not fully understood. 
While the yeast homolog Abp1p can induce actin polymerization by activating the actin 
nucleating factor Arp2/3 (193), mammalian Abp1 does not retain this capability. 
However, mammalian Abp1 has been shown to promote actin polymerization indirectly 
in neurons by direct interactions with N-WASP, which enhances the actin nucleation 
promoting activity of N-WASP (194).  Unlike neurons, B-cells and other types of 
immune cells express both N-WASP and its hematopoietic specific homolog WASP. Our 
recently published data show distinct functions for WASP in actin assembly and B-cell 
spreading, and of N-WASP in the clearance of F-actin for B-cell contraction (54).  
Furthermore, the study revealed a negative relationship between the two (54).  Here I 





 B-cells respectively. This suggests Abp1 preferentially promotes N-WASP activation, 
which suppresses WASP activation.  Similar recruitment kinetics for N-WASP (54) and 





 mice further support a functional relationship between the two and the notion that Abp1 
modifies actin remodeling by regulating N-WASP.    
 Abp1 has been shown to be responsible for bringing HPK1 to the IS formed 
between T-cells and antigen presenting cells by direct interaction via its SH3 domain and 
HPK1’s PRD domain (232).  If HPK1, recruited to the B-cell surface by Abp1, is 
activated by Src family or Syk kinases, it can bind and phosphorylate BLNK, which leads 
to the ubiquitination and down regulation of this key adaptor protein, and its downstream 
signaling pathways (55).  While I did not directly examine HPK1 activation in this study, 
the enhanced levels of phosphorylated BLNK and Erk, and elevated calcium influx in 
Abp1
-/-
 B-cells support the notion that Abp1 is involved in HPK1 activation.  To our 
surprise, BCR-induced activation and recruitment of the inhibitory phosphatase SHIP-1 
also requires Abp1. This represents a new mechanism by which Abp1 mediates its 
negative regulatory function in B-cell activation.  SHIP-1 is well known for its function 
in inhibiting major signaling molecules downstream of the BCR, including PLCγ2, Btk, 
and Akt (59, 124).  B-cell-specific gene deletion of SHIP-1 causes hyper-responsiveness 
and defective affinity maturation of B-cells (57), which is associated with enhanced BCR 
signaling observed at the B-cell contact zone, and inhibition of BCR microcluster 
coalescence and B-cell contraction (57, 59, 181).  Abp1
-/-
 mice and B-cells share many of 




 mice and B-cells , 
which indicates that recruitment of SHIP-1 and HPK1 to surface BCRs for activation is 
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likely the primary mechanism underlying Abp1 negative regulation of BCR signaling and 
B-cell activation.  The question remains, however, how does Abp1 bring SHIP-1 to the 
BCR signalosome. Possible mechanisms, including direct or indirect interaction of Abp1 
with SHIP-1 via other proteins, remain to be explored.  
 Abp1 can also promote signal attenuation by mediating BCR internalization. We 
have previously demonstrated that the expression of Abp1 is critical for efficient 
internalization and intracellular processing of BCR-bound antigen (150).  While BCR 
internalization itself does not turn off receptor signaling activity, instead changing the 
nature and location of BCR signaling (160), inhibition of BCR endocytosis by perturbing 
the actin cytoskeleton, or by N-WASP gene deletion is associated with enhanced 
signaling (54, 170, 247).  While Abp1 likely utilizes multiple mechanisms to attenuate 
BCR signaling, it should be noted that these mechanisms are likely interrelated, as Abp1-
associated actin remodeling may be important for the recruitment of inhibitory signaling 
molecules and BCR internalization, and recruited inhibitory signaling molecules can in 
turn regulate actin remodeling and actin-mediated cellular events. The interrelationship 
among these mechanisms is the subject of my future studies. 
 This study further demonstrates the importance of the actin cytoskeleton in the 
attenuation of BCR signaling and B-cell activation for the maintenance of B-cell 
tolerance.  I identified Abp1 as a missing link between actin remodeling, and signal 
down-regulation mechanisms, which expand our understanding of the molecular 
mechanism underlying the negative regulation of B-cell activation.   
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Chapter 3: Dynamin-2 regulates BCR internalization, and 
signal transduction.    
3.1 Abstract 
 B-cell activation is initiated by the binding of antigen to BCRs.  Optimal 
activation of B-cells depends on coordinated BCR signaling, antigen internalization and 
processing, as well as actin cytoskeletal rearrangement; however, the molecular nature of 
this coordination has yet to be fully illuminated.  The GTPase Dynamin is involved in 
endocytosis, actin remodeling, and signaling, thereby suggesting a role in coupling these 
cellular apparatuses. This study examined the domains or function of Dynamin2 (Dyn2) 
necessary for recruitment of Dyn2 to the plasma membrane, endocytosis of signaling 
active BCRs, regulation of the actin-mediated events of B-cell spreading and BCR 
clustering, and propagation of BCR signals.  This study utilized A20 B-cells transfected 
with green fluorescent protein (GFP) fusion proteins of wt full length Dyn2 (GFP-Dyn), 
truncated Dyn2 missing its PRD (GFP-DynΔPRD), a GTPase dead mutant of Dyn2 
(GFP-DynK44A), or a phosphorylation mutant of Dyn2 (GFP-DynY231/597F).  My 
results show that upon BCR crosslinking, Dyn2 is recruited to the plasma membrane, 
where it colocalizes with the BCR, and that the PRD of Dyn2 is necessary for this 
recruitment.  The tyrosine phosphorylation sites, GTPase function, and the PRD of Dyn2 
are required for efficient BCR transport to the late endosome.  Using the Dyn specific 
GTPase inhibitor Dynasore, I further confirmed the requirement for Dyn’s GTPase 
function for BCR transport to the late endosome.  In addition to Dyn2 recruitment and 
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BCR trafficking, the PRD of Dyn2, but not its GTPase and tyrosine phosphorylation 
sites, is necessary for recruitment of the actin adaptor protein Abp1 to the B-cell surface.  
Furthermore, in B-cells transfected with the GTPase dead mutant of Dyn2, actin-
dependent BCR clustering but not B-cell spreading is enhanced, which is associated with 
elevated global tyrosine phosphorylation and downstream JNK activation, compared to 
GFP-Dyn transfected and control cells.  These results suggest that Dyn2 is mobilized by 
BCR signaling to coordinate BCR internalization and signal propagation.              
3.2 Introduction 
B-cell signal transduction events are initiated when antigen triggers clustering of 
BCRs in lipid rafts, which induces phosphorylation and therefore activation of BCR 
proximal Src family kinases, which in turn phosphorylate the tyrosine residues in the 
cytoplasmic domain of Igα/β, the signal transducing units of the BCR.  The 
phosphorylated tyrosines (pY) serve as a docking site for the kinase Syk.  Syk, once 
bound, and activated itself, initiates the formation of signalosomes, recruiting various 
signaling molecules via linker proteins.  One consequence of antigenic stimulation is the 
activation of MAPK signaling pathways (248), leading to the activation of the MAPK’s 
p38, JNK, and ERK, which in turn activate transcription factors necessary for B-cell 
functions, including up-regulation of activation markers, proliferation, and survival.   
Another consequence of antigenic stimulation is enhanced endocytosis and 
trafficking of the BCR/antigen complex through the endosomal pathway, which in turn 
enhances B-cell antigen presentation capability (130, 131).  B cell antigen presentation to 
T cells is required for the differentiation of B cells to memory B cells, thereby generating 
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high affinity and long-lasting antibody responses.  BCR endocytosis is a predominantly 
CME event.  The endocytosing BCR/antigen complex transitions from early endosomes 
to LAMP1
+
 late endosomes.  Decreasing pH activates proteases in endosomes which act 
to fragment the antigen.  Within the late endosome, proteolytically cleaved antigenic 
peptides are loaded onto MHCII molecules, and the compartment is then termed a MIIC.  
Antigenic peptide-loaded MHC class II complexes are then shuttled to the surface of the 
B-cell for presentation to T-cells to acquire T-cell help (154).      
Previous work from our lab and others showed that actin remodeling is required 
for BCR internalization (137), B-cell signal propagation, as well as signal attenuation 
(168, 175).  In resting B-cells, the cortical actin cytoskeleton has been proposed to act as 
a barrier against BCR clustering and activation, which was demonstrated by the finding 
that treatment with an actin destabilizing drug lead to the initiation of BCR activation in 
the absence of BCR stimulation (178).  Upon antigenic encounter, the cortical actin 
cytoskeleton disassembles, allowing enhanced lateral mobility of BCRs, and BCR 
microcluster formation.  Actin then reassembles in polarized fashion, which serves to 
drive BCR microcluster formation, and direct the signaling active microclusters towards 
one pole of the cell.  When interacting with antigen presenting membranes, actin re-
polymerization drives B-cell spreading at the contact site between the B-cell and the 
presenting surface.  Spreading results in engagement of more BCRs, and therefore 
enhanced signaling.  After the cells reach maximal spread, the B-cell membrane then 
begins to contract, and F-actin begins to clear from the contact zone between the B-cell 
and antigen presenting surface. Contraction drives BCR microclusters coalescence and 
subsequent central cluster formation.  The contraction of the B-cell membrane with 
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concurrent BCR microcluster convergence to form a central cluster has been shown to 
promote BCR signal down-regulation.  As such, our lab has demonstrated that increased 
F-actin accumulation at the B-cell contact zone, or delayed B-cell contraction, due to 
either B-cell specific N-WASP or germline Abp1 knockout, is associated with impaired 
formation of BCR central clusters, reduced BCR internalization, and amplified and 
persistent B-cell signaling, as well as elevated autoAb production and spontaneous GC B-
cell formation (54, 249).  These data further strengthen the idea that actin remodeling 
upon BCR stimulation is coordinated with BCR signal transduction and endocytosis. 
However, the precise molecular mechanism has yet to be defined.  
 Dyn is a 100 kDa GTPase that has been most well-studied for its role in clathrin-
mediated endocytosis, where it is critical for scission of endocytic vesicles from the 
plasma membrane (203, 250-252).  There are three major isoforms of Dyn (Dyn1, 2, and 
3), and all Dyn family members contain a GTPase domain, a “middle’’ domain, and a 
GTPase effector domain (GED).  Intra-molecular interactions between the middle domain 
and GED are known to aid in Dyn self-assembly into ring-like and tubular structures at 
the base of endocytosing vesicles, where GTP hydrolysis causes the Dyn structure to 
constrict, acting to “pinch off” or release the vesicle from the donor membrane.  Dyn also 
contains a pleckstrin homology (PH) domain that binds the phosphoinositide PI(4,5)P2 at 
the plasma membrane (253), and a C-terminal proline rich domain (PRD) that is 
important for targeting to coated pits and mediating interactions with SH3 domain 
containing proteins (203, 250, 251).  Recent studies have also begun to implicate a role 
for Dyn in receptor mediated signal transduction, as well as actin modulation within cells.  
Chaturvedi et al. showed that B-cells treated with an inhibitor of Dyn GTPase function 
121 
 
(dynasore), caused differential regulation of proximal and distal BCR signaling 
molecules compared to untreated cells (160).  Malhotra et al. discovered that the B-cell 
adaptor protein LAB recruited a complex of Dyn2, Vav, and Grb2 in activated B-cells, 
and that this interaction was required for BCR internalization (218, 219).  In another 
study, the interaction between Dyn2 and Vav was shown to be necessary for proper actin 
accumulation at the immunological synapse (214).  Additionally, our lab has previously 
shown that Dyn2 interacts with the actin modulating protein Abp1 via its PRD domain 
(150).   
 Here I further investigated the domains or functions of Dyn2 necessary for its 
recruitment to the BCR upon BCR stimulation, and for BCR internalization and 
signaling.  I also examined the role of the GTPase domain of Dyn2 in moderating the 
actin-dependent events of B-cell spreading and BCR clustering in cells activated with 
antigen presenting surfaces.  My results show that the PRD of Dyn2 was necessary for its 
recruitment to the cell surface upon BCR stimulation.  Additionally, I found that the 
PRD, GTPase function, and tyrosine phosphorylation of Dyn2 are all necessary for the 
translocation of BCRs from the cell surface to late endosomes. Furthermore, I discovered 
that the GTPase function of Dyn2 is necessary for the actin dependent event of BCR 
clustering, but not B-cell spreading.  Finally I discovered that the GTPase domain of 
Dyn2 is required for appropriate BCR mediated signal propagation.  My results further 
support the notion that the Dyn2 not only aids in BCR endocytosis and signaling, but that 
the individual domains of Dyn2 likely play unique roles in aiding in endocytosis and 
BCR signal propagation.     
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3.3 Materials and Methods 
3.3.1 DNA constructs and transfection.  
B-cell lymphoma A20 IIA1.6 cells were cultured at 37
o 
C in Dulbecco's Modified 
Eagle Medium (DMEM) supplemented with 10% FBS.  Plasmid DNA constructs coding for 
GFP fusion proteins of Dyn 2 (GFP-Dyn), Dyn 2 with its PRD deleted (GFP-Dyn ∆PRD), a 
Dyn 2 phosphorylation mutant (GFP-DynY321/597F), and a Dyn 2 GTPase mutant (GFP-
DynK44A) were kindly provided by Dr. Mark McNiven, (Mayo Clinic, Rochester).  DNA 
constructs were introduced into A20 B-cells by electroporation using an A20 specific Lonza 
Nucleofection kit (Lonza, Cologne, Germany).   
3.3.2 Confocal analysis.  
A20 B-cells untransfected or transfected with GFP-Dyn, GFP-Dyn ∆PRD, GFP-
DynY231/597F, or GFP-DynK44A were incubated with AF 546-conjugated F(ab’)2-goat 
anti-mouse IgG (Life Technologies) for 20 min at 4
o
C to label the surface BCR.  Cells 
were washed and then adhered to poly-lysine-coated slides (Sigma-Aldrich) for 20 min at 
4
o
C and then chased at 37
o
C for varying lengths of time to allow for the internalization of 
the BCR.  For some experiments, cells at different time points were fixed with 4% 
paraformaldehyde, permeabilized with 0.05% saponin in DMEM supplemented with 10% 
FBS, 10mM Hepes, and 10mM glycine, and incubated with a monoclonal Ab specific for 
lysosome-associated membrane protein 1 (LAMP-1) (ID4B, ATCC, Manassas, VA) or 
goat-anti-Abp1, followed by fluorescently conjugated secondary Abs.  Cells were 
analyzed using a confocal laser scanning microscope (LSM 510 or LSM710; Carl Zeiss 
Microscopy).  The correlation coefficients of Dyn2 constructs with the BCR, or the BCR 
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with LAMP-1 in the A20 B-cells before and after BCR crosslinking was determined 
using the LSM Zen software, from over 100 cells per time point from three independent 
experiments.  Abp1 recruitment in A20 cells transfected with the various Dyn2 mutants 
was assessed visually.   
 A20 B-cells were also treated with the small molecule inhibitor specific for Dyn 
GTPase function, Dynasore (254).  Cells were pre-treated, as well as continuously treated 
throughout the experiment with 50 µM Dynasore.  After pre-treatment with Dynasore, 
surface BCRs were labeled with AF 546-conjugated F(ab’)2-goat anti-mouse IgG for 20 
min at 4
o
C, washed, adhered to poly-lysine-coated slides for 20 min at 4
o
C, and then 
chased at 37
o
C for 30 min to allow internalization of the BCR.  Cells were fixed, 
permeabilized, and labeled with rat anti-LAMP-1 Ab, followed by AF633 anti-rat IgG 
(Life Technoliges).  Cells were analyzed using a LSM 510 or LSM710 confocal 
microscope.  Distribution patterns of the BCR with LAMP-1 at 30 min were quantified 
by visual quantification in greater than 100 cells per time point per experiment. 
3.3.3 Flow cytometry. 
A20 B-cells untransfected and transfected with GFP-Dyn, GFP-Dyn ∆PRD, GFP-
DynY231/597F, or GFP-DynK44A were incubated with biotinylated F(ab’)2-goat anti-
mouse IgG (20 µg/ml; Jackson ImmunoResearch) for 30 min at 4
o
C to label surface 
BCRs.  After washing off unbound antibodies, cells were chased at 37
o
C for varying 
lengths of time.  The chase was terminated by adding ice-cold DMEM containing 6 
mg/ml BSA (DMEM-BSA).  The biotinylated antibodies remaining on the cell surface 
after the chase were stained with PE-streptavidin (5 µg/ml; BD Bioscience) at 4
o
C.  The 
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cells were then fixed with 4% paraformaldehyde and analyzed using a flow cytometer 
(FACSCalibur or FACSCanto II, BD Bioscience).  GFP-expressing cells were gated for 
analysis. The data were plotted as a percentage of the mean fluorescence intensity of cell-
surface PE-streptavidin at time 0. 
To analyze B-cell signaling in A20 B-cells untransfected and transfected with 
GFP-Dyn or GFP-DynK44A, cells were activated with 10 µg/ml F(ab’)2-goat-anti-mouse 
IgG (Jackson ImmunoResearch), fixed, permeabilized, and stained with Abs specific for 
phosphotyrosine (pY) mAb 4G10 (EMD Millipore), or pJNK (Cell Signaling 
Technology) followed by fluorescently conjugated secondary Abs.  Cells were gated into 
GFP
+
 populations, and analyzed for up-regulation of pY or pJNK using a FACSCanto II 
(BD Biosciences).   
3.3.4 TIRF analysis 
Images were acquired using a Nikon laser TIRF system on an inverted 
microscope (Nikon TE2000-PFS, Nikon Instruments Inc.) equipped with a 60X, NA 1.49 
Apochromat TIRF objective (Nikon), a Coolsnap HQ2 CCD camera (Roper Scientific), 
and two solid-state lasers of wavelength 491 and 561 nm. Interference refection images 
(IRM), AF488, and AF546 were acquired sequentially.  A20 B-cells untransfected and 
transfected with GFP-Dyn or GFP-DynK44A were incubated with mB-Fab’-anti-Ig-
tethered lipid bilayers at 37ºC for varying lengths of time. Cells were then fixed with 4% 
paraformaldehyde, and imaged for the recruitment of GFP-Dyn, GFP-K44A, or BCRs.  ,.  
The B-cell contact area was determined based on IRM images using MATLAB software 
(The MathWorks). The total and mean fluorescence intensity (TFI and MFI) of the BCRs 
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or GFP-constructs in the B-cell contact zone was determined using Andor iQ software 
(Andor Technology).  Background fluorescence generated by mB-Fab’-anti-Ig tethered to 
lipid bilayers in the absence of B-cells or secondary antibody controls, was subtracted. 
For each set of data, more than 50 individual cells from three independent experiments 
were analyzed.      
3.4 Results 
3.4.1 The PRD of Dyn2 is necessary for its recruitment to the BCR upon activation.     
Previous studies have shown that BCR crosslinking results in the recruitment of 
Dyn2 to the cell surface, where it binds to the plasma membrane via its PH domain, and 
participates in receptor mediated endocytosis.  To determine the domain or functions of 
Dyn2 necessary for its recruitment to the plasma membrane, I examined the effect of 
various mutations, including a deletion of the PRD, mutation of two tyrosine 
phosphorylation sites, and a GTPase-dead mutation on Dyn2 recruitment to the plasma 
membrane upon BCR crosslinking.  A20 B-cells were transiently transfected with GFP-
Dyn, GFP-Dyn ∆PRD, GFP-DynY231/597F, or GFP-DynK44A, and the cells were 
incubated with AF 546-conjugated F(ab’)2-goat anti-mouse IgG at 4
o
C to label the 
surface BCR and warmed to  37
o
C for 2 min to activate BCR signal transduction.  
Calculation of the Pearson’s colocalization coefficient between the GFP-Dyn proteins 
and the BCR, used to indicate Dyn2 recruitment to the B-cell surface, was assessed after 
imaging by confocal fluorescence microscopy.  A negative correlation coefficient 
indicates that the two proteins mutually exclude one another, while a score of 0 implies a 
random pattern of colocalization, and a score of 1 implies 100% colocalization of two 
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proteins.  After 2 min of activation, the cellular distribution of the full length GFP-Dyn 
changed from a cytoplasmic distribution at zero minutes, to a cell surface distribution 
pattern, where it colocalized with the BCR (Fig. 3.1A).  Similarly, GFP-DynY231/597F 
and GFP-DynK44A appeared at the plasma membrane after 2 min of stimulation 
(Fig.3.1A).  In contrast, GFP-Dyn ∆PRD remained in a cytoplasmic distribution (Fig. 
3.1A).  The data (Fig 3.1B), showed significant increases in the correlation coefficient of 
full length GFP-Dyn, the Dyn GTPase mutant (GFP-DynK44A), and the Dyn 
phosphorylation mutant (GFP-DynY231/597F ) after the 2 min stimulation.  However, 
the colocalization between the BCR and the truncated Dyn mutant lacking its PRD (GFP-
DynΔPRD) did not significantly increase (Fig. 3.1B).  Further examination of the 
distribution patterns of the various Dyn2 constructs after 30 min of BCR stimulation 
shows that while the GFP-DynΔPRD remained predominantly cytoplasmic, GPF-
DynK44A appeared to accumulate at vesicles intimately associated with the plasma 
membrane (3.2A-B).  We hypothesize these may be partially endocytosed vesicles which 
are stalled at the pinching off phase of internalization.  Also, the GFP-DynY231/597F 
transfected cells showed greater percentages of cells with GFP-DynY321/597F localized 
to plasma membrane vesicles as well as evenly distributed at the plasma membrane after 
30 min of activation, compared to GFP-Dyn and GFP-DynΔPRD transfected cells (Fig. 
3.2A-B).  The results show that the PRD, but neither Dyn2 phosphorylation nor its 
GTPase function, is required for recruitment to the plasma membrane upon BCR 
activation, and that the GTPase function and phosphorylation of Dyn2 are required for its 






Fig. 3.1 Dyn2 PRD domain necessary for its recruitment to the B-cell membrane.  
(A-B)  A20 cells transfected with different GFP-dynamin mutants were activated with AF 
546-conjugated F(ab’)2-goat anti-mouse IgG for 2 min.  Cells were fixed, and imaged by 
laser scanning confocal microscopy.  Shown are representative images (A) (n=3, scale 
bar = 5 µm).  Shown are the correlation coefficients of GFP-dynamin with the BCR at 






















Fig. 3.2  GFP-DynK44A and GFP-DynY231/597F mislocalized to cell surface  at 
later time points of B-cell activation.  A20 cells transfected with different GFP-
dynamin mutants were activated with AF546-conjugated F(ab’)2-goat anti-mouse IgG for 
30 min, fixed, and imaged by confocal microscopy.  GFP
+
 cells were visually quantified 
into four categories. Shown are representative images of the major categories of Dyn 
distribution after 30 min of BCR stimulation. (n=3)  
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3.4.2 Dyn2’s phosphorylation, PRD domain, and GTPase activity are necessary for 
BCR trafficking to late endosomes.    
To examine the domains or function of Dyn2 necessary for internalization of the 
BCR from the cell surface and its movement to late endosomes, a process necessary for 
antigen processing, I analyzed the ability of A20s transfected with GFP-Dyn, GFP-Dyn 
∆PRD, GFP-DynY231/597F, or GFP-DynK44A to internalize cross-linked BCRs and to 
transport the BCR to late endosomal compartments in these B-cells, using flow cytometry 
and immunofluorescence microscopy.  To analyze BCR internalization, I labeled the 
surface BCRs on the transfected cells with biotinylated goat anti-mouse IgG at 4
o
C.  The 
cells were washed, and then chased at 37
o
C for varying lengths of time.  After the chase, 
the biotinylated antibodies remaining at the cell surface after the chase were stained with 
PE-streptavidin.  The cells were fixed and analyzed by flow cytometry.  Cells were gated 
as GFP
+
 (experimental), or GFP
-
 (control) cells.  The data were plotted as a percentage of 
the mean fluorescence intensity of cell-surface PE-streptavidin at time 0.  Full length 
GFP-Dyn and GFP-DynY231/597F transfected cells showed similar levels of BCR 
remaining at the cell surface compared to control cells (Fig3.3 A and D), while GFP-
DynK44A transfected cells showed slightly reduced, but non-significantly altered levels 
of BCR remaining at their surface compared to control cells (Fig. 3.3C).  Cells 
transfected with GFP-DynΔPRD exhibited significantly sustained levels of BCRs 
remaining at the cell surface at all time points compared to control cells (Fig. 3.3D).   
As the streptavidin used in the endocytosis analysis described above may not have 
access to biotin labeled BCRs within clathrin-coated pits that fail to detach from the 




Fig. 3.3 Percent of labeled surface BCRs. (A-D)  A20 cells transfected with different 
GFP-dynamin mutants were labeled and activated with biotin conjugated  F(ab’)2-goat 
anti-mouse IgG for various times.  Biotin-anti-mouse IgG left at the cell surface was 




 populations, and the data were plotted as the percentage of the surface-
labeled BCR at time 0.  Shown are the averages (S.D., n=3). *, p<0.05, **, p<0.01. 
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BCR internalization by examination of the colocalization of the BCR with the late 
endocomal marker LAMP-1 using immunofluorescence microscopy.  Cells were 
incubated with AF546-conjugated F(ab’)2-goat anti-mouse IgG at 4
o
C to label and 
activate the surface BCR, and then chased at 37
o
C for 30 min to allow BCR 
internalization.  After 30 min, the cells were fixed, permeabilized, and labeled with an Ab 
specific for LAMP-1.  The cells were analyzed with a confocal laser scanning 
microscope.  I again utilized software to calculate the Pearson’s correlation coefficient, 





control cells.  In line with the flow cytometry analysis, full length GFP-Dyn showed 
similar colocalization between the BCR and LAMP-1
+
 compartments after the 30 min 
chase when compared to GFP
-
 control cells (Fig. 3.4A and B), while the GFP-DynΔPRD 
B-cells showed significantly reduced BCR/LAMP-1 colocalization compared to control 
cells (Fig 3.4A and C).  Unlike the results from the flow cytometry analysis, cells 
expressing the GPF-DynY231/597F and GFP-DynK44A showed significantly reduced 
BCR/LAMP-1 colocalization when compared to control cells (Fig. 3.4A, D and E).  
Similar to what we observed at 2 and 30 min, the distribution of GPF-DynK44A and the 
GFP-DynY231/597F remained on vesicles intimately associated with the plasma 
membrane (Fig. 3.1A, 3.2, and 3.4).  These results suggest that the PRD as well as the 
GTPase function and phosphorylation of Dyn2 are necessary for internalization and 
trafficking of the BCR to the late endosome.   
To further confirm the requirement of the Dyn2 GTPase for BCR internalization, 
we examined the effect of the small molecule inhibitor of Dyn2 GTPase activity, 















      
Fig. 3.4  Dyn2’s PRD domain, GTPase activity, and phosphorylation are necessary 
for BCR translocation to LAMP1
+
 compartments.  A20 cells transfected with different 
GFP-dynamin mutants were activated with AF 546-conjugated F(ab’)2-goat anti-mouse 
IgG for 30 min to allow internalization of the BCR.  The cells were fixed, permeabilized, 
and labeled with an Ab specific for LAMP-1 then imaged with a confocal laser scanning 
microscope. Shown are representative images, arrows indicate GFP
+
 cells (A) (n=3).  
Shown are the correlation coefficients of the BCR with LAMP-1 in untransfected (GFP
-
) 
control cells and GFP
+
 cells at 30 min (B-E).  Data generated from >200 cells  per 
condition (n=3). *, p<0.05 
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Dynasore before BCR labeling and crosslinking at 4ºC and throughout the duration of a 
30-min chase at 37
o
C to allow BCR internalization.  Using immunofluorescence 
microscopy, we quantified the percentage of cells showing either no BCR/LAMP-1 
colocalization, colocalization at surface vesicles, scattered vesicle colocalization, or 
extensive colocalization.  Our results show that while most of untreated cells display 
extensive BCR/LAMP-1 colocalization at the perinuclear region, BCRs in most of the 
Dynasore-treated cells localized at surface vesicles after 30 min of activation (Fig. 3.5A-
C).  Collectively these results indicated that the PRD and GTPase function, as well as the 
tyrosine phosphorylation of Dyn2, are all involved in BCR internalization and transport 
of actively signaling BCRs to the late endosome.      
3.4.3 Dyn2 PRD domain is necessary for Abp1 recruitment. 
Our lab previously showed the interaction between Abp1 and Dyn2, mediated by 
the PRD and SH3 of Dyn2 and Abp1 respectively, to be necessary for BCR 
internalization after BCR crosslinking (150).  To further investigate which domain or 
function of Dyn2 is necessary for Abp1 recruitment to the plasma membrane upon BCR 
crosslinking, we transfected A20 B-cells with GFP-Dyn2 constructs, including GFP-Dyn, 
GFP-Dyn ∆PRD, GFP-DynY231/597F, or GFP-DynK44A, and monitored the 
recruitment of Abp1 to the plasma membrane upon BCR crosslinking.  Abp1 was labeled 
with a goat-anti-Abp1 Ab after permeabilization and analyzed by confocal microscopy.  
Abp1 recruitment to the plasma membrane was visually assessed, and quantified.  My 
preliminary analysis showed that while GFP-Dyn, GFP-DynK44A, and GFP- 
















Fig. 3.5  Dynasore reduces BCR internalization to late endosome.  (A-B) A20 cells 
were activated with AF 546-conjugated F(ab’)2-goat anti-mouse IgG for 30 min to allow 
internalization of the BCR either with our without 50 µM Dynasore.  The cells were 
fixed, permeabilized, and labeled with an Ab specific for LAMP-1 then imaged with a 
confocal laser scanning microscope. Shown are representative images from 0 and 30 min 
(A). Bar, 5 µm (n=3).  Visual quantification of BCR colocalization with LAMP-1 at 30 
min in greater than 225 cells per condition (B). (n=3).  Schematic representation of 




with the GFP-DynΔPRD were defective in the recruitment of Abp1 to the cell periphery 
(Fig 3.6A-B).  The preliminary results suggest that the interaction between Abp1 and 
Dyn2, via their SH3 domain and PRD respectively, is necessary for BCR induced 
recruitment of Abp1 to the plasma membrane.   
3.4.4 Dyn2 GTPase deficiency augments BCR clustering, but not B-cell spreading.   
As Dyn2 has been implicated to function in both actin dynamics and receptor 
internalization, both of which influence signaling (149, 150, 220-222), we examined the 
impact of Dyn2 on the actin-mediated events of BCR clustering and B-cell spreading, 
using IRM and TIRF.  A20 B-cells transfected with the either GFP-Dyn or GFP-
DynK44A, the GTPase defective mutant of Dyn2, were activated with Fab’-anti-Ig 
tethered-lipid bilayer for various times, and imaged by IRM to analyze the the area of the 
B-cell membrane contacting antigen-presenting surface (B-cell contact area) and TIRF to 
monitor BCR clustering and GFP-Dyn or GFP-DynK44A recruitment.  My results show 
that B-cell spreading on the antigen presenting surfaces was not affected by the 
expression of Dyn-GFP or Dyn-GFPK44A when compared to control non-transfected 
(NT) cells (Fig. 3.7A-B).  Similar to non-transfected controls, GFP-Dyn (Dyn) 
expressing cells showed a gradual increase in BCR clustering at the B-cell contact site 
over time (Fig. 3.7A and C).  However, the cells transfected with the GTPase mutant of 
Dyn2 (K44A) exhibited elevated levels of BCR clustering throughout the time course of 
activation compared to GFP-Dyn transfected cells (Fig. 3.7A and C).  Both GFP-Dyn and 
GFP-DynK44A were recruited to the contact zone with similar kinetics (Fig. 3.7A and 




Fig. 3.6 Dyn2 PRD domain necessary for recruitment of actin adaptor Abp1.  (A-B)  
A20 cells transfected with different GFP-dynamin mutants were activated with AF 546-
conjugated F(ab’)2-goat anti-mouse IgG for 2 min.  Cells were fixed, permeabilized, and 
labeled with anti-Abp1 and fluorescent secondary antibody.  Cells were imaged by laser 
scanning confocal microscopy.  Shown are representative images defining recruited or 
non-recruited Abp1 (A) (n=2, scale bar 5 µm).  GFP
+
 cells were visually quantified as 




recruitment of Dyn-GFP or GFP-DynK44A.  These results suggest that Dyn2 contributes 
to the negative regulation of BCR clustering, but not to B-cell spreading in GTPase-
dependent manner.   
3.4.5 Dyn2 GTPase function is involved in the regulation of BCR signal 
transduction.  
 Our finding on the regulatory roles for Dyn2 in BCR clustering, BCR 
internalization, and BCR-induced Abp1 recruitment suggests that Dyn2 can modulate 
BCR signaling indirectly through the above activities. To test this hypothesis, A20 B-
cells transfected with either GFP-Dyn or GFP-DynK44A were activated with soluble 
F(ab’)2-goat-anti-mouse IgG for varying lengths of time. The overall signaling activity of 
the cells was measured by the levels of tyrosine phosphorylation using phosphotyrosine 
mAb (pY ) and flow cytometry.  Examination of pY up-regulation in BCR stimulated 
GFP
+
 populations of GFP-Dyn or GFP-DynK44A transfected A20 B-cells showed an 
increase in pY in the GFP-DynK44A transfected cells throughout the time course when 
compared to the GFP-Dyn transfected cells (Fig 3.8A).   Furthermore, BCR stimulated 
GFP-DynK44A transfected cells showed enhanced activation of the MAPK JNK 
throughout the time course when compared to GFP-Dyn transfected A20 cells (Fig. 
3.8B).  These results suggest that the GTPase function of Dyn2 is necessary for 
appropriate signal transduction from the BCR, and that elimination of Dyn2 GTPase 












Fig. 3.7  Dyn2 GTPase deficiency augments BCR clustering but does not affect B-
cell spread. (A-D) IRM and TIRF analysis of GFP-Dyn and GFP-DynK44A transfected 
A20 B-cells incubated with Fab’-anti-Ig-tethered lipid bilayers. Representative images, 
bar 5 µm, (n=3) (A). Average contact area (B),  TFI of labeled BCRs (C), and MFI of 
GFP-Dyn or GFP-DynK44A in contact zone (D) from > 50 cells per time point (n=3), 

























Fig. 3.8 Dyn2 GTPase function necessary for BCR signal transduction.  (A-B) Flow 
cytometry analysis of GFP-Dyn (Dyn) and GFP-DynK44A (K44A) transfected A20 B-
cells activated with AF 546-conjugated F(ab’)2-goat anti-mouse IgG, fixed, 
permeabilized, and labeled with anti-phospho-tyrosine (pY - A) or anti-phospho-JNK 







Dyn is a large mechano-enzyme necessary for membrane scission of newly 
budding vesicles from membranes, including removal of endocytosed BCR containing 
vesicles from the B-cell surface for antigen processing and presentation (160, 218, 255, 
256).  Recent research has implicated a role for Dyn in both actin modulation as well as 
signal propagation via interaction with signaling intermediates (150, 218, 219, 256).  This 
study reveals that the different domains of Dyn2 are necessary for BCR/antigen uptake 
and signaling. My results show that the PRD of Dyn2 is required for its recruitment to the 
plasma membrane upon BCR crosslinking, while the PRD, GTPase domain, and tyrosine 
phosphorylation are all required for efficient BCR internalization and trafficking to 
LAMP-1
+
 compartments.  Only the PRD of Dyn2 appears to be necessary for the 
recruitment of Abp1, an actin adaptor protein that is involved in both BCR endocytosis 
and signaling, to the cell surface upon B-cell activation.  This study also shows that the 
GTPase activity of Dyn2 contributes to the negative regulation of BCR clustering but not 
B-cell spreading along antigen presenting surfaces.  Consequently, A20 B-cells 
transfected with the GTPase dead mutant of Dyn2 showed elevated levels of 
phosphorylated tyrosine and the MAPK pJNK upon BCR stimulation.         
This study revealed that the PRD of Dyn2 is required for its recruitment to the 
plasma membrane, and colocalization with the BCR at the early times of BCR mediated 
activation, which is in accordance with studies in other cell types.  Shpetner et al. 
previously showed that while full length Dyn2 bound to clathrin coated pits on Cos-7 cell 
plasma membranes, mutations of the Dyn2 PRD disrupted this interaction (200).  
Furthermore, a study by McNiven et al. showed that Dyn2 recruitment to membrane 
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ruffles and lamellipodia of fibroblast cells treated with platelet-derived growth factor 
(PDGF) was dependent upon its interaction with the actin modulating protein cortactin, 
and disrupted by deletion of the cortactin SH3 domain or Dyn2 PRD (257).  However, 
the exact molecular framework necessary for Dyn2 recruitment to the plasma membrane 
of B-cells remains to be dissected.  Our lab has previously shown that B-cells treated with 
the Src kinase inhibitor PP2 showed reduced recruitment of Dyn2 upon BCR crosslinking 
(Bruce K. Brown, PhD, unpublished data); however, we show here that the tyrosine 
phosphorylation mutant of Dyn2 (GFP-DynY231/597F) was recruited normally to the 
plasma membrane where it colocalized with the BCR.  This finding suggest that while 
phosphorylation of Dyn2 at its conserved pY sequences is not required for its 
recruitment, Src family kinases can trigger the recruitment of Dyn2 to signaling active 
BCRs at the cell surface by phosphorylation/activation of other molecules.  Collectively, 
the data indicate that Dyn2 recruitment relies upon interaction with an as of yet unknown 
SH3 domain containing protein(s), and Src-mediated phosphorylation/activation of an 
unknown binding partner(s).  While Dyn has been shown to interact with a wide variety 
of SH3 domain containing molecules, such as Grb2, amphiphysin, cortactin, etc.  (141, 
144, 210, 214, 218, 219, 257, 258) the identification of the precise protein interaction 
necessary for Dyn recruitment to signaling active BCRs will be the focus of our future 
studies.  One approach to address this question is overexpression of SH3 domains of 
suspected Dyn2 interacting partners, after which we could examine BCR mediated Dyn2 
recruitment to the signaling active BCRs.  
One of the new findings of this study is that BCR internalization and trafficking to 
late endosomes requires multiple domains of Dyn2, including the PRD, GTPase function, 
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and its tyrosine phosphorylation sites.  However, the function of each Dyn2 domain in the 
process has not been fully characterized. My results show that the GFP-DynΔPRD 
construct fails even the initial step of recruitment to signaling active BCRs, indicating a 
role for the PRD in the surface recruitment of Dyn2.  My finding that GFP-DynK44A 
expression leads to the accumulation of BCRs stuck in membrane associated vesicles 
further suggests a role for Dyn2 GTPase function in membrane scission for BCR 
internalization.  The role of phosphorylation in Dyn2 function is inconsistent in the 
literature (215-217).   Here we show that the phosphorylation, while unnecessary for 
Dyn2 recruitment, is required for BCR endocytosis and trafficking to the late endosomal 
compartments.  As such, it is likely that Src kinase phosphorylation of another molecule 
is necessary for Dyn2 recruitment to the B-cell membrane, which would explain reduced 
Dyn2 recruitment in cells treated with PP2.  My data also suggest that Dyn2 
phosphorylation after recruitment to signaling active BCRs may be required for 
interaction with a SH2 domain containing protein, and that this interaction is crucial at 
later stages of BCR internalization.     
Previous reports utilizing other cell types and model membranes suggest that  
Dyn2 GTP hydrolysis is the driving force for the final pinching off phase of the endocytic 
process (206, 209).  Consistent with these reports, my data show both labeled BCR as 
well as GFP-DynK44A stuck at surface localized vesicles at both early (2 min) and late 
time points (30 min) of activation.  However, my flow cytometry-based BCR 
internalization analysis did not corroborate my confocal immunofluorescence analysis, 
showing no significant differences in the percentage of surface-labeled BCRs available 
for PE-streptavidin binding.  It is possible that the flow cytometry-based method is 
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unable to differentiate between BCRs in budding vesicles and in fully endocytosed 
vesicles, due to inaccessibility of PE-streptavidin, a relatively large protein complex, to 
nascent vesicles budding from the plasma membrane which are moderately constricted by 
Dyn2 oligomer formation.  As such, different techniques are required to support our 
results from the immunofluorescence analysis.            
This study also revealed that the GTPase function of Dyn2 is necessary for the 
negative regulation of the actin-dependent event of BCR clustering, but does not play a 
role in B-cell spreading upon interaction with membrane-bound antigens.  There are two 
possible mechanism by which Dyn2 may aid in down regulation of BCR clustering; by 
promoting BCR internalization and by modifying actin remodeling. Dyn2 has been 
shown to be linked to the actin cytoskeleton in a variety of cells types, via interaction 
with a growing list of actin modulating proteins (148, 150, 219, 256).  Our lab has 
previously shown that Dyn2 constitutively interacts with the actin adaptor protein Abp1 
via the Dyn2 PRD and Abp1 SH3 domains (150).  This interaction links the actin 
cytoskeleton to Dyn2, enabling actin to facilitate the Dyn2-mediated membrane scission 
step of BCR internalization (150).  The data presented here further suggest that this 
interaction occurs via interaction between the Dyn2 PRD, and Abp1 SH3 domain.  My 
results here show that this interaction is responsible for recruitment of Abp1 to the 
plasma membrane upon BCR stimulation.  These data further suggest that Dyn2 can 
indirectly interact with the actin cytoskeleton via Abp1. 
While B-cell spread was unaffected in B-cells transfected with GFP-DynK44A, it 
is important to note that A20 B-cells (a cancer cell line) show different spread kinetics 
compared to primary B-cells.  Primary B-cells in contact with antigen presenting surfaces 
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spread optimally by 3 min of activation, and gradually, as F-actin within the contact site 
begins to decrease, the cells contract to aid in the coalescence of BCRs for signal 
attenuation.  In contrast, A20 B-cells do not appear to significantly contract even after 30 
min of activation with membrane bound antigen (lab unpublished data, (163)), which 
may be a common characteristic of cancerous B-cells (259).  As such, unlike primary B-
cells, A20 B-cells may have a modified mechanism by which they signal B-cell spread, 
or they may have an overriding signal which prevents their contraction.  In this case, we 
are unable to determine whether Dyn2 has a regulatory function in B cell contraction and 
signal attenuation using A20 cells. To examine whether Dyn2 plays a role in B-cell 
spread kinetics, we could attempt to transfect primary B-cells with the Dyn2 mutants.  
However, primary lymphocyte transfection remains very difficult, with very low resultant 
transfection efficiencies, and exacerbated cell death.   
BCR activation requires receptor clustering at the cell surface (114, 161, 162).  As 
such, it is no surprise that the increased BCR clustering observed in cells expressing the 
GTPase dead mutant of Dyn2 is associated with higher levels of pY, as well as the 
MAPK pJNK.  In agreement with this data, Chaturvedi et al. showed that cells treated 
with GTPase inhibitor of Dyn2 (dynasore) have dysregulated (and in many cases 
elevated) phosphorylation of key proximal and distal signaling elements of the BCR 
(160).  Dynasore-mediated signal dysregulation was suggested to be caused by 
mislocalization of the BCR and signaling molecules.  Signaling molecules which would 
normally be localized and activated within the interior of cells are erroneously recruited 
to the plasma membrane-associated vesicles where BCR endocytosis is stalled.  
Chaturvedi et al. postulated that BCRs signal continuously even after BCRs enter 
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endosomal compartments, after which, they are exposed to different kinases, 
phosphatases, or lipid environments from those found at the plasma membrane.  
However, this hypothesis has yet to be tested.   
It should be mentioned that Dyn2 also functions in membrane dynamics and 
vesicle budding at various intracellular organelles, thereby possibly resulting in 
disruption of B-cell function at sites other than endocytosing BCRs at the plasma 
membrane.  One previous study showed that Dyn2, in conjunction with cortactin, links 
the actin cytoskeleton to transport of newly synthesized proteins from the trans-Golgi 
network (260).  In addition, Dyn has been implicated in caveolae-mediated endocytosis 
and late endosome to Golgi transport (203, 261).  Dyn function has also been shown to be 
important for mitochondrial fusion and fission, as well as cell division (207).  Therefore, 
the defects observed in the B-cells transfected with GFP-DynΔPRD, GFP-DynK44A, and 
GFP-DynY231/597F constructs may arise due to defects in multiple aspects of B-cell 
function that are necessary for cell survival or antigen response.    
The studies presented in this chapter further substantiate both the necessity of 
Dyn2 for BCR internalization and its proposed function as a modulator of actin and 
signal transduction during B-cell activation.  However, much more work will be 
necessary to fully outline the role Dyn2 plays in these activities.  Future work would 
include identifying protein(s) necessary for Dyn2 recruitment, further characterizations of 
the role of Dyn2 phosphorylation in the interaction of Dyn2 with its partners, and greater 
characterization of signaling defects in B-cells expressing different Dyn2 mutants.  These 
additional studies will help further our understanding of not only Dyn2’s role in BCR 
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internalization and signal propagation, but will generally better define the somewhat 
contested link between BCR signaling and internalization.    
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Chapter 4: General Discussion and Future Work 
4.1 General summary and working model 
B-cell function, namely B-cell generated humoral immune response towards 
invading pathogens, is critical to host defense against infectious pathogens.  Key to this 
protective function is regulated B-cell signaling of pathogen encounter, as well as 
processing and presentation of antigenic peptides to garner T-cell help for optimal B-cell 
activation.  More and more research suggests that these processes are linked, and that the 
nature, magnitude, and duration of the signals emanating from the BCR determine B-cell 
fate, and therefore necessitate tight control.  In this dissertation, I sought to better 
understand how the processes of BCR-mediated signal transduction, dynamic BCR and 
actin rearrangements, and subsequent BCR internalization for antigen processing are 
linked, with the goal of gaining further insight into how these processes work to 
collectively regulate host humoral immune response.  Critical examination of the 
molecular interactions and physiological responses which take place during B-cell 
signaling, BCR/antigen complex internalization, and subsequent processing and 
presentation, as well as how these processes are interrelated will help us better understand 
which processes are subverted, leading to B-cell mediated disease.  With a clearer 
understanding of these processes and how they are related we will be capable of 
generating enhanced targeted treatments to prevent or overcome the dysregulated cellular 
functions associated with B-cell related disease, and aid in discovery of novel vaccination 
strategies to enhance B-cell function.    
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The goals of this study were twofold:  (1) to dissect the molecular mechanisms by 
which Abp1 links actin remodeling to BCR signal transduction, and examine the impact 
of Abp1 deficiency on B-cell development and immune response, and (2) to examine the 
domains or functions of Dyn2 necessary for its recruitment, BCR internalization, and 
BCR mediated signal transduction.  While these research topics were pursued 
independently, the topics are intimately linked, as Abp1 and Dyn2 constitutively interact, 
and this interaction is necessary for the precise coordination of BCR signal transduction, 
dynamic actin rearrangement, and BCR/antigen internalization and trafficking.  As such, 
the molecular interplay between Abp1 and Dyn2 are necessary for optimal B-cell survival 
and initiation of humoral immune responses.        
My Ph.D. dissertation research demonstrates a novel function for the actin 
regulating protein Abp1 in BCR signal attenuation, which is critical for the regulation of 
peripheral B-cell differentiation and Ab responses.  My research was initiated based on 
the previous finding from our lab that Abp1 was required for efficient BCR-mediated 
antigen internalization, processing, and presentation, in part due to its interaction with the 
GTPase Dyn2 (150).  Here I showed that the actin regulating protein Abp1 is recruited to 
the surface of the B-cell in a BCR dependent manner.  Moreover, I showed that Abp1
-/-
  
B-cells displayed elevated levels of BCR triggered signaling, such as elevated pY, 
pBLNK, pMEK1/2, pERK, as well as increased levels of Cat
2+ 
flux.  The elevated level 
of signaling was concurrent with decreased recruitment and/or activation of the two 
known negative regulatory signaling molecules pSHIP1 and HPK1.  Examination of the 
early actin-dependent events of B-cell activation revealed that Abp1
-/-
 B-cells displayed 
enhanced spreading when activated with membrane-associated antigen, and enhanced 
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BCR clustering when activated with soluble or membrane-associated antigen, compared 
to wt B-cells.  The Abp1
-/-
 B-cells also exhibited defects in clearance of F-actin from the 
B-cell contact zone with membrane associated antigen, which was simultaneous with 
dysregulation in the recruitment/activation of the actin regulating proteins WASP and N-
WASP.  My work here also indicates a critical role for Abp1 in negative regulation of the 
development of MZ and B1a B-cells, as Abp1 deficient and Abp1
-/-
-Ch mice show 
elevated numbers of MZ and B1a B cells.  My results further show that Abp1 is involved 
in regulating the generation of spontaneous germinal center B-cells, as Abp1 deficient 
and Abp1
-/-
-Ch mice have increased numbers of spontaneous germinal center B-cells, as 
well as greater numbers and size of germinal centers in the spleen of un-immunized mice.  
In agreement with this data, the Abp1 deficient mice generate an enhanced non-specific 
antibody response as well as increased T-cell independent antibody response, while they 
are simultaneously defective in mounting antigen specific responses towards T-cell 





mice generate autoantibodies much earlier, and to much higher levels than control 
animals.  Collectively, the data have led us to propose the following working model (Fig. 
4.1), in which we suggest that Abp1 mediates its negative regulatory capacity by three 
major mechanisms:  1) by controlling B-cell spreading and subsequent contraction via 
modulation of the actin nucleating proteins WASP and N-WASP, 2) by recruitment and 
activation of the negative regulatory proteins HPK1 and SHIP1, and 3) finally by 
regulating BCR endocytosis (Fig. 4.1).  The absence of this regulatory capacity results in 
Abp1
-/-
 B-cells that display hyper-signaling profiles, and an inability to transition from the 
actively spreading to contracting phase normally associated with BCR signal attenuation, 
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and finally, an inability to clear F-actin and coalesce and internalize their actively 
signaling BCRs.  We postulate that these defects cumulatively result in the generation of 
an inappropriate germinal center response, where the hyper-activated B-cells migrate to 
the secondary lymphoid follicles, where they expand in the absence of T-cell signals.  
Consequently, the expanded B-cell populations produce elevated levels of non-specific 
and self-reactive antibodies, while simultaneously displaying defective T-cell dependent 
antibodies or undergoing affinity maturation (both of which require T-cells help).   
Work related to my second aim; examining the domains or functions of Dyn2 
necessary for its appropriate recruitment, BCR internalization, and BCR mediated signal 
transduction, revealed that the PRD of Dyn2 is necessary for its recruitment and 
colocalization with the BCR at the B-cell surface.  Examination of the transfected A20 
cells at later times of BCR stimulated activation revealed that the GFP-DynK44A 
construct appeared to be predominantly localized to intracellular vesicles intimately 
associated with the plasma membrane.  Additionally, the cells transfected with the GFP-
DynY321/597F have a larger proportion of cells showing a somewhat smooth cell surface 
distribution or cells surface vesicle distribution.  We suspect that these Dyn2 constructs 
are likely stuck on the necks of the endocytosing vesicles, unable to release from the 
membrane and return to a cytosolic distribution.  Flow cytometry evaluation of the 
percent of BCR remaining at the surface of A20 B-cells transfected with the various 
Dyn2 constructs revealed that only the cells transfected with the GFP-Dyn ∆PRD 
construct had a significantly higher percentage of BCRs remaining at the cell surface 
after BCR stimulated activation.  However, confocal microscopic examination followed 
by colocalization coefficient calculations in B-cell transfected with the various Dyn2 
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constructs, revealed that the PRD domain, as well as the GTPase function, and tyrosine 
phosphorylation sites all displayed reduced colocalization between the BCR and LAMP-
1, suggesting that they do in fact have reduced BCR internalization to LAMP-1
+
 
compartments after BCR crosslinking.   As mentioned in chapter 3, we suspect that the 
flow cytometry evaluation of percent BCR remaining at the B-cell surface, may not be 
sensitive enough to detect the difference between fully endocytosed BCR’s, and those 
stuck in partially endocytosed vesicles, unable to undergo the scission step necessary for 
vesicle release.  Therefore, the B-cells transfected with the GFP-DynK44A and GFP-
DynY231/597F may erroneously appear to have similar levels of endocytosed BCRs 
compared to control cells.  The role of the GTPase domain in moderating BCR 
internalization after crosslinking was further supported by the experiment utilizing the 
small molecule inhibitor of Dyn2 (Dynasore), which revealed that inhibition of the 
GTPase activity of endogenous Dyn2 results in reduced BCR/LAMP-1, and therefore 
reduced BCR internalization.  This study further confirmed that the PRD domain of Dyn2 
is required for recruitment of Abp1 to the B-cell plasma membrane.  Furthermore, I show 
that Dyn2 GTPase deficiency augments BCR clustering, but not B-cell spreading, and its 
GTPase function is involved in the regulation of BCR signal transduction.  Collectivly,  
results from previous studies, and those presented here, lead us to propose a model in 
which Dyn2 is necessary for BCR trafficking to late endosomes, and acts as a negative 
regulatory element in BCR mediated signaling via its capacity to 1) regulate BCR 
endocytosis, 2) and via interaction with known signaling intermediates as well as adaptor 





Fig. 4.1  Working model.  Antigen binding to the BCR promotes activation of Btk, 
which induces recruitment and activation of WASP.  WASP stimulates actin 
polymerization and suppresses activation of N-WASP.  Actin polymerization drives B-
cell spreading and facilitates BCR clustering and amplified signaling.  Later recruitment 
of Abp1 results in recruitment and activation of HPK1, and SHIP-1.  HPK1 drives signal 
attenuation by inducing phosphorylation and degradation of BLNK, while SHIP-1 
inhibits Btk, and thus WASP activation, thereby inducing activation of N-WASP.  
Activated N-WASP promotes clearance of actin from the contact zone, which stimulates 
the contraction and coalescence of BCR microclusters into a central cluster.  Dyn2 and 
Abp1 aid in subsequent BCR internalization all of which promotes BCR signal 
attenuation.  Image from Dr. Wenxia Song 
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4.2 Future Work 
4.2.1 Abp1 Project 
While this research has revealed novel roles for Abp1 in B-cell regulation, there is 




-Ch mice display elevated 
levels of autoAbs, characteristic of a B-cell intrinsic autoimmune phenotype, future work 
should include further characterization of the autoimmune phenotype and its disease 
presentation.  As a result of elevated levels of autoAbs produced in many autoimmune 
diseases, immune complexes deposit in the glomeruli of the kidneys, causing kidney 





-Ch mice for proteinuria and immune complex deposition in the 
glomeruli, which can indicate kidney damage (265, 266).  If there is immune complex 
deposition in the glomeruli, we will use immunohistochemistry to examine the kidneys 
for the presence of mesangial thickening and hypercellularity, which are indicative of 
sclerotic glomerulonephritis, which may be caused by immune complex deposition (266, 
267).       
In 2006 Connert et al. reported that Abp1
-/-
 mice displayed splenomegaly, lung 
emphysema, as well as four chamber dilation of the heart (230).  This group also noticed 
that by 60 to 290 days after birth, a large proportion of the Abp1 deficient mice had 
partial paralysis of the hind limbs, ruffled fur, muscle trembling, convulsions, as well as 
reduced body weight (230).  While several of these findings are likely linked to the 
reduced synaptic vesicle recycling observed in the Abp1
-/-
 mice (230), many of these 
symptoms may also arise as a result of autoimmune related inflammation.  Indeed, 
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autoimmunity has been linked to heart and lung disease, as well as overall poor health 
with resultant weight loss (268, 269).  Similar to previous studies, we found that Abp1
-/-
 
mice display splenomegaly (Fig.2.5E), and reduced body weight compared to their wt 
counterparts ((195, 249), and data not shown).  In the future we propose to determine if 
the enlarged lung and heart phenotypes have arisen as a consequence of autoimmunity 
within the Abp1
-/-
 mice. We will weigh and examine the histology of lung and heart 
tissues from the wt, Abp1
-/-
, wt-Ch, and Abp1
-/-
-Ch mice to determine if there are internal 
tissue/structural abnormalities including mononuclear or polynuclear cell infiltration, 
heart chamber dilation or fibrosis, as well as lung emphysema.  To more specifically 
examine whether the observed tissue enlargement observed in the Abp1
-/-
 animals was 
due in part to autoimmunity, we will assay wt, Abp1
-/-
, wt-Ch, and Abp1
-/-
-Ch mice for 
the presence of anti-cardiac myosin heavy chain and anti-Type-IV collagen/decorin/or 
elastin autoAbs by ELISA (270, 271), and for general immune complex deposition within 
the heart and lung tissues by immunofluorescence.  Furthermore, the frequency of plasma 
cells that secret heart or lung specific autoAbs could be assessed by ELISPOT using our 
previously published protocol (239).  In addition, we have backcrossed our Abp1
-/-
 
genotype onto a Balb/c background through greater than six generations, and future work 
will investigate possible development of autoimmunity and related disease state within 
this breed.    
As the spontaneous development of MZ, B1a, and GC B-cells, as well as autoAb 
production is likely the result of dysregulated negative BCR signing in the absence of 
Abp1, a better understanding of the role of Abp1 in this negative regulation is necessary.  
The data presented in chapter two demonstrate that Abp1 is necessary for the recruitment 
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and/or activation of the negative regulatory proteins HPK1, and SHIP1, however, it 
remains unknown how Abp1 influences these processes.  Abp1 has no enzymatic 
function, and therefore is not proposed to directly activate either HPK1 or SHIP-1.  As 
mentioned, Abp1 has been shown to directly bind to HPK1 in T-cells, where it is 
necessary for recruitment of HPK1 to the T-cell IS (232).  Therefore we hypothesize that 
Abp1 also directly binds HPK1 in B-cells, via their SH3 and PRD respectively, which we 
can experimentally test by co-immunoprecipitation (co-IP) or by a Duolink assay (272).  
The requirement of Abp1 protein expression for the recruitment of activated pSHIP-1 to 
the B-cell IS is a novel finding of this study, however, how Abp1 acts to regulate pSHIP-
1 localization remains to be elucidated.  Abp1 could possibly bind pSHIP-1 directly via 
their SH3 and PRD respectively or possibly through adaptor proteins, such as the 
scaffolding protein Grb2 (known to bind HPK1 and SHIP-1) (273, 274).  These possible 
interactions can also be tested with co-IP, and/or Duolink assays.  
Previously published studies from our lab showed that N-WASP was also 
involved in the recruitment of activated pSHIP-1(54), and we show here that Abp1 
facilitates the recruitment of activated N-WASP (pN-WASP) (249) to BCR 
signalosomes.  As Abp1 has been shown to directly bind to N-WASP in neurons (194), it 
is also a possibility that Abp1 regulates pSHIP-1 recruitment via forming a complex with 
N-WASP bound Grb2 (275).  While positively regulating N-WASP, Abp1 appears to 
selectively inhibit the activation of hematopoietic specific WASP, suggesting that Abp1 
regulates both WASP and N-WASP, but in different manners.  As such, it will be 
important to further characterize not only the link between Abp1 and pSHIP-1, but also 
Abp1 and WASP and N-WASP.  It is a possibility that Abp1 may differentially interact 
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with WASP and N-WASP or prefer interacting with one of the two. These complicated 
interactions could again be tested by co-IP, or Duolink assay, as well as colocalization 
studies utilizing confocal microscopy or TIRF, in combination with various knockout 
mice.       
4.2.2 Dynamin Project  
       While the research outlined in chapter three defines a novel role for the 
different domains or functions of Dyn2 in BCR signal transduction and subsequent BCR 
trafficking to late endosomes, how precisely the domains or functions moderate these 
outcomes remains to be fully explored.  First, how Dyn2 is recruited to the plasma 
membrane has not been fully resolved.  Here I show that the truncated form of Dyn2 
missing its PRD is not recruited to the plasma membrane upon BCR crosslinking, as 
such, it is likely that a SH3 domain containing protein is necessary for Dyn2 recruitment 
upon BCR activation.  To identify the protein that is responsible for recruiting Dyn2 to 
BCR-containing clathrin coated pits, possible studies include confocal microscopic 
examination of cells over expressing SH3 domains from known Dyn2 interacting proteins 
to determine if the over expression inhibits Dyn2 recruitment to the plasma membrane.   
The question of whether Dyn2 phosphorylation is required for endocytosis is 
somewhat contested (215-217).  Previously our lab showed that treatment with the Src 
kinase inhibitor PP2 resulted in defective Dyn2 recruitment to the plasma membrane 
upon BCR crosslinking (Bruce K. Brown PhD., unpublished data).  Here I show that the 
Y231/597F phosphorylation site mutations do not prevent Dyn2 from being recruited to 
the plasma membrane, however, the expression of the mutated Dyn2 does inhibit BCR 
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internalization.   These data implicate the possibility that Dyn2 is phosphorylated after 
recruitment to signaling active BCRs, which may be required for interaction with a SH2 
domain containing protein, and that this interaction is crucial for BCR internalization.  To 
test this theory, future studies might include an electron microscopic analysis of cells 
transfected with GFP-Dyn vs GFP-DynY231/597F to examine 1) the recruitment of 
transfected Dyn2 to the plasma membrane, and 2)  the internalization of gold labeled 
BCRs, to better understand the stage in endocytosis in which the phosphorylation mutant 
is stalled.  Furthermore, to identify proteins interacting with phosphorylated Dyn2, we 
can compare proteins co-immuneprecipitated with GFP-Dyn vs GFP-DynY231/597F, in 
an attempt to probe membranes for known SH2 domain molecules.   Possible candidates 
include Grb2, BLNK, and PLCγ2.        
While multiple studies have shown that the large GTPase Dyn2 acts as a 
“pinchase” to aid in scission of nascent endocytosing vesicle from the plasma membrane 
(206, 209, 210), how each domain of Dyn2 specifically contributes to BCR endocytosis 
remains to be fully outlined.  Liu et al. recently showed that while GTPase defective 
Dyn2 can still form collars around artificial lipid membranes, they are defective in 
releasing buds from the membrane (206).  Here I showed by confocal microscopy that the 
PRD, GTPase function, and tyrosine phosphorylation of Dyn2 are necessary for 
BCR/LAMP-1 colocalization after 30 min of B-cell activation.  However, my flow 
cytometry assay showed that there were similar levels of biotinylated BCRs left at the 
cell surface after BCR internalization in B-cells expressing the GTPase and 
phosphorylation mutants of Dyn2 compared to control B-cells. Thus we suspect that 
these mutants are recruited normally and form oligomers to constrict the necks of the 
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nascent vesicles, however, while these vesicles fail to be released from the plasma 
membrane, the membrane constriction acts to prevent PE-streptavidin from reaching the 
surface labeled BCRs.  To examine this possibility, future studies will include 
immunoelectron microscopy examination of BCR internalization in B-cells transfected 
with the Dyn2 mutants.  We could also use cryoEM to examine localization of Dyn2 
mutants stained with a gold labeled antibody towards Dyn2.  Observing the gold-labeled 
Dyn2 will allow determination of whether the molecule is being mislocalized or recruited 
to the plasma membrane, but possibly stuck at the membrane, or on the necks of 
endocytosing vesicles.  Observing the gold labeled BCRs will allow a much higher 
resolution view of the specific stage in which the Dyn2 mutants act to stall BCR 
trafficking to late endosomal compartments.       
As mentioned, Dyn2 has been implicated in signal transduction in multiple cells 
types, including B-cells, where Dyn2 has been shown to form a complex with Vav and 
Grb2 via the adaptor molecule LAB (218, 219).  Here we show that Dyn2 is required for 
appropriate BCR clustering kinetics, and our lab has previously shown that F-actin 
dependent BCR clustering is intrinsically tied to regulation of BCR signaling (54, 170, 
181, 249).  Furthermore, we further confirm here that Dyn2 is required for recruitment of 
the actin modulating protein Abp1, which is also known to aid in BCR signal attenuation. 
Finally, we did preliminary experiments with B-cells transfected with GFP-Dyn and 
GFP-DynK44A, and discovered that activation induced levels of pY and the MAPK 
pJNK was increased in the cells transfected with the GTPase dead mutant.  As we 
speculate that the Dyn2 mutations alter BCR transduced signaling, because they influence 
the location of the BCR (by blocking the BCRs in clathrin-coated pits), we will further 
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examine the activation of major proximal and distal signaling molecules in BCR 
signaling pathway by TIRF and flow cytometry in cells transfected with GFP-DynPRD, 
GFP-Dyn K44A, and GFP-DynY231/597F constructs.     
In total, that data from this dissertation provides insight into novel regulatory 
mechanisms within B-cells necessary for activation, survival, and humoral immune 
responses.  Collectively, a better understating of the mechanisms by which B-cells signal, 
internalize their antigen receptors for antigen processing and presentation, and how these 
processes are related will shed light on regulatory mechanisms which might be 
manipulated to either enhance humoral immune responses, or dampen B-cell mediated 
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